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Abstract 
 Virtual ligand screening has proven to be a successful strategy in drug design.  An 
in house-developed procedure (HierDock), a coarse grain docking method followed by a 
fine grain search procedure, was used to determine the binding site for sugars in the outer 
membrane protein A in E.coli, a key interaction in the pathogenesis of neonatal 
meningitis.  These results are being further extended in suggesting possible peptide 
antagonists and drugs for therapeutic strategies.   
 Prediction of binding site of ligands in proteins, starting with the apo-protein is 
one of the challenges in the field of virtual ligand screening. HeirDock was modified for 
accurately predicting the ligand binding sites in apo-proteins that undergoes significant 
structural changes on binding to a ligand.  The method was evaluated for finding the 
binding site for methionine in methionyl tRNA synthetase.  We followed up on our 
understanding of binding mechanism in aminoacyl tRNA synthetases by attempting to 
design these enzymes to bind to non-natural amino acids.  Using the computational 
protein design software (ORBIT), a phenylalanyl-tRNA synthetase variant that allows 
efficient in vivo incorporation of aryl ketone functionality into proteins was designed. 
 Ligand- induced conformation changes are commonly seen in proteins.  We have 
developed a procedure by combining computational protein design with methods from 
mean-field theory to design protein sequences capable of switching between two 
completely different protein folds on chelating to metal.  This method is potentially 
useful in characterizing protein sequence-structure relationships. 
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Chapter 1 
Introduction to Molecular Docking and Virtual Ligand 
Screening 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 I-3 
Protein interactions with ligands, other proteins, or surfaces are controlled 
by a complex array of intermolecular interactions.  Such interactions depend both 
on the specific interactions in the binding site as well as the non-specific forces 
outside the binding pocket.  This interplay of specific and non-specific forces 
controls all protein interactions ranging from bimolecular collisions in solutions to 
adhesion between cells.  The complexity of interactions between proteins and 
flexible target molecules, including other proteins, nucleic acids and small 
molecules, is often determined by the considerable flexibility of the protein binding 
sites and by the structural rearrangements that occur upon binding of the associated 
molecule.  
A goal of many biophysical studies is to determine the molecular forces that 
control biological interactions and to use this information to rationally manipulate 
protein function by modifying the protein, the interacting ligand, or both.  The 
forces that control protein behavior and their physical chemical origins are inferred 
from equilibrium binding kinetic measurements or are calculated with molecular 
models.  Calculated energies are used to identify the role of the physical and 
chemical interactions in protein function and behavior.  Although detailed 
calculations are feasible for small molecules, such calculations become prohibitive 
as the size and complexity of the biological macromolecules increase.  Time-
dependent forces between soft or mobile species add yet another degree of 
complexity, while static models of interactions do not describe the full range of 
parameters that influence biological behavior.   
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As we approach the post-sequencing phase of many genome projects, it is 
estimated that the number of potential drug targets will increase from about 500 to 
5000-10000 in the next few years (Drews, 2000).  The scope and the importance of 
structure-based drug design will also increase significantly.  Virtual ligand 
screening using in silico methods can provide prospective leads and is a practical 
alternative to high-throughput screening of large compound libraries provided the 
binding modes and affinities of the distinct ligands can be predicted correctly.  The 
docking and scoring problems countered in this endeavor are central to the theory of 
bimolecular interactions and are ultimately determined by the nature of the 
underlying binding energy landscape.  However, the desired synergy of adequate 
conformational sampling combined with accurate evaluation of energetics has been 
difficult to achieve with any computational model.    
Computational structure prediction of ligand-protein complexes using 
docking methods, like DOCK, FLEXx, and GOLD (Ewing et al., 2001; Jones et al., 
1997; Kramer et al., 1999), in combination with empirical scoring functions are 
used to predict ligand orientations in binding sites and binding affinities of ligands 
to proteins.  While the binding geometries depend on the docking methods, binding 
energy estimates rely heavily on the potential functions used to calculate them.  
Knowledge based potentials fo llow rules based on statistical analysis of binding 
affinities and geometries of experimentally determined protein- ligand complexes.  
These rules are converted to “pseudo-potentials” which are then applied to score 
computer generated ligand orientations (Gohlke et al., 2000; Muegge & Martin, 
1999).  A major concern with such methods is that they might only select for those 
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orientations that have been observed in the crystal structures used to derive the 
potential.   
Regression-based scoring functions estimate binding affinities by adding up 
interaction terms derived from the weighted structural parameters of the complexes.  
The weights are assigned by regression methods by fitting predicted and 
experimentally determined affinities to a given set of training complexes (Bohm 
and Stahl, 1999).  A concern with these methods is the dependence on the size, 
composition, and generality of the training set used to derive the weights (Tame, 
1999).  Moreover, such methods can only interpolate and thus, are unable to 
identify new molecular scaffolds that are not present in the training set.  
Nevertheless, improvements in regression-based methods have contributed to some 
encouraging examples demonstrating the potential of such techniques (Rognan et 
al., 1999).   
First-principle-based approaches also approximate binding free energy by 
adding up individual contributions of different interactions.  However, the 
individual energy terms are derived from physico-chemical theory and are not 
determined by fitting to experimental affinities.  In most cases, gas phase molecular 
mechanical contributions are combined with solvation free energies.  Evaluation of 
solvation energy is a challenge both in terms of computational demands and 
accuracy (Massova and Kollman, 2000).  The methods used to calculte solvation 
include implicit solvent methods like Possion-Boltzmann and surface generalized 
Born methods (Shoichet et al., 1999). The gas phase energy calculations depend on 
the type of the force field, for example, AMBER, CHARMM, DRIEDING (Brooks 
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et al., 1983; Mayo et al., 1990).  First-principle based approaches often calculate 
the correct order of the binding free energies but the numbers generally exceed the 
experimental values significantly.   
Protein flexibility and the dynamics of inter molecular interfaces can 
regulate binding affinity and specificity in molecular recognition.  It has been 
suggested that structural stability and flexibility during molecular recognition are 
associated with the ruggedness of the underlying binding energy landscape and can 
be related to various functions, such as specificity or permissiveness in recognition.  
However, predicting the correct substructures of the protein- ligand complexes is 
extremely difficult, especially in cases where the binding site of a flexible protein is 
unknown.  Hierarchical approaches incorporating both ligand and protein 
flexibilities have contributed to recent progress in ligand-protein docking.  Such 
procedures include multistage docking approaches and a hierarchy of energy 
functions that aim to capture the subtleties of protein flexibility on ligand binding.   
Our method of virtual ligand screening, called HierDock (Figure I-1), uses 
flexible ligand docking using DOCK 4.0 as a coarse grain search followed by fine 
grain dynamics based on first principles.  An advantage of using DOCK 4.0 is that 
its fragment-based ligand reconstruction scheme can effectively generate a large 
number of ligand conformations in a very short time using a fast, although crude 
scoring function based on van der Waal’s and columbic interactions.  The ligand 
ensemble generated from DOCK is then passed on to the next level: a finegrain 
molecular dynamics simulation where the ligand is allowed to optimize in the 
binding pocket.  The fine grain optimization step involves simulations with implicit 
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solvent and also allows protein flexibility. Our results are verified with 
experimental observations aimed at improving the fine grain optimizations scoring 
techniques.  Besides trying to improve the HierDOCK procedure, we have also 
applied the technology in trying to answer interesting biological questions and have 
found our current technology can be leveraged to understand pathogenesis of E. coli 
meningitis (Chapter 2).  By combining docking with quantum chemistry, we have 
delineated an interesting biological mechanism by which antibodies oxidize water 
molecules to produce hydrogen peroxide (Chapter 3).   In searching for binding site 
for small ligands in large, flexible globular proteins, we have incorporated 
modifications in both the coarse and fine grain levels and have been successful in 
finding the binding region of methionine in methionine tRNA synthetase (Chapter 
4).   
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Select all possible binding site regions (may include full 
protein but exclude parts that cannot be binding sites. For example, 
regions interaction with the lipid bilayers in membrane proteins) 
Coarse grain search using Monte Carlo methods use 
DOCK4.0  
(Kuntz et al UCSF) Select 1% to 10% that pass bump tests 
 
Optimize Protein plus ligand and select  
Score using PBF/SGB/AVGB solvation and select 
best few    
Fine grain MD search  
Dreiding FF and QEq charges with solvation) Obtain optimum local 
conformation Select best 10% 
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Chapter 2 
 
Interaction of E. coli Outer Membrane Protein A with Sugars on the 
Receptors of the Brain Microvascular Endothelial Cells 
 
 
 
 
 
 
 
 
 
 
Adapted from Datta D., Vaidehi N., Floriano  W. B., Kim K. S., Prasadarao N. V. and 
Goddard III W. A, (2002);  Protein : Structure. Functions and Genetics (in press) 
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ABSTRACT 
E. coli, the most common gram-negative bacteria, can penetrate the brain 
microvascular endothelial cells (BMEC) during the neonatal period to cause meningitis. 
Experimental studies have shown that outer membrane protein A (OmpA) of E. coli plays 
a key role in the initial steps of the invasion process by binding to specific sugar moieties 
present on the glycoproteins of BMEC.  These experiments also show that polymers of 
chitobiose (GlcNAcb1,4-GlcNAc) block the invasion, while epitopes substituted with the 
L-fucosyl group do not.  
We have used a hierarchy of coarse grain docking method with molecular 
dynamics (MD) to predict the binding sites and energies for interactions of 
GlcNAcb1,4GlcNAc and other sugars with OmpA.  The results suggest two important 
binding sites for the interaction of carbohydrate epitopes of BMEC glycoproteins to 
OmpA.  We have identified one site as the binding pocket for chitobiose (GlcNAc1, 
4GlcNAc) in OmpA, while the second region (including loop 1 and 2) may be important 
for recognition of specific sugars.  We find that the site involving loops 1 and 2 has 
relative energies that correlate well with experimental observations.  This theoretical 
study elucidates the interaction sites of chitobiose with OmpA and the binding site 
predictions are testable either by mutation studies or by invasion assays. These results can 
be further extended in suggesting possible peptide antagonists and drug design for 
therapeutic strategies.  
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Introduction 
E. coli, a common gram-negative bacterium, causes meningitis during the 
neonatal period (1,2).  The morbidity and mortality associated with this disease has 
remained significant with case fatality rates ranging from 15% to 40% of the infected 
neonates while ~50% of the survivors sustain neurological sequelae (1,3).  Incomplete 
understanding of the pathogenesis and pathophysiology of E. coli meningitis has 
hampered the development of new therapeutic avenues, thus contributing to the high 
morbidity and mortality.  For example, E. coli meningitis develops as a result of 
hematogenous spread. However, it is not clear how the circulating E. coli traverses across 
the blood-brain barrier, which contains a single cell lining of the brain microvascular 
endothelial cells (BMEC).  Several cell surface structures (such as S-fimbriae) present in 
E. coli are involved in the pathogenesis of E. coli meningitis.  However, one of the more 
important steps involves the interaction of OmpA with the BMEC.  Prasadarao et al (4) 
showed that the expression of outer membrane protein A (OmpA) enhances the E. coli 
invasion of BMEC.  Thus  OmpA+ E. coli strains invade BMEC with 50- to 100-fold 
higher frequency than OmpA- E. coli strains (4).  Moreover, OmpA interacts with a 95 
kDa BMEC glycoprotein for E. coli invasion, which is specifically expressed in 
endothelial cells of brain origin but not of systemic origin (N. V. Prasadarao private 
communication). To examine the specificity of interaction of the sugar moietie s on Ecgp, 
the glycoprotein of BMEC, the BMEC was treated with wheat germ agglutinin (WGA), 
which blocked E.coli invasion (5).  Since WGA is specific to binding of GlcNAcb1-
4GlcNAc epitopes, it was concluded that WGA binds to GlcNAc-b1-4GlcNAc epitopes 
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on the glycoprotein on BMEC, thus preventing invasion.  However treatment of BMEC 
with WGA does not block the interaction of S-fimbriae (specific for NeuAc2,3-Galactose 
epitopes) binding to BMEC.  This suggests that the inhibition is specific to chitobiose and 
not a mere steric hindrance by lectin.  Other lectins such as ConA (specific to mannose) 
and AAL (specific to NeuAc2,3-Galactose) did not show such blocking activity (6).  In 
addition, during invasion OmpA+ E. coli induces actin filament rearrangement in BMEC, 
but this rearrangement is blocked significantly by both chitobiose and wheat germ 
agglutinin (7).  On the other hand, OmpA- E. coli did not exhibit any effect on actin 
rearrangement (7).  Moreover, chitobiose-sepharose chromatography shows binding of 
OmpA to chitobiose, suggesting that the observed inhibition is due to the direct 
interaction of OmpA with GlcNAcb1-4GlcNAc epitopes. 
Prasadarao and coworkers have further shown that masking of OmpA binding 
sites for GlcNAcb1-4GlcNAc epitopes with these chito-oligomers significantly reduces 
the incidence of meningitis in newborn rat model of hematogenous meningitis, 
suggesting the biological relevance of this interaction (6).  They tested simple 
disaccharides such as chitobiose, lactose, cellobiose and fucosyl substituted chitobiose for 
invasion assays and showed clearly that chitobiose blocks the invasion of BMEC by E. 
coli while lactose, cellobiose and fucosyl substituted chitobiose do not.  
Although the GlcNAcb1-4GlcNAc epitopes are universally present on many N-
linked glycoproteins, studies by Prasadarao et al., indicate clearly that OmpA interaction 
with GlcNAcb1-4GlcNAc epitopes on Ecgp is crucial for the establishment of the 
disease.  It has been demonstrated (8-10) that the same sugar or amino acid present on 
different proteins can contribute to specificity of the pathogen (5,6).  For example, 
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enteropathogenic E. coli binding to epithelial cells depends on type 1 fimbriae, which is 
specific to the mannose residue and can be blocked by mannose sugar (6). However, the 
same strain does not bind to BMEC very efficiently even though BMEC contain mannose 
residues.  This suggests that either the protein sequence and conformation around the 
GlcNacb1-4GlcNAc epitopes in Ecgp or the density of the carbohydrate-bearing proteins 
on BMEC differ from that of epithelial cells and might depend on the microenvironment 
of the cells. Thus these extensive biochemical studies provide evidence that OmpA 
interacts with chitobiose and that this interaction could be important in the initial steps of 
the E.coli pathogenesis.  
Experiments have also shown that two short synthetic peptides (the hexamer, 
Asn27-Gly32 and the pentamer, Gly65-Asn69) generated from the N-terminal amino acid 
sequence of OmpA exhibit significant inhibition of OmpA-contributed E. coli invasion of 
BMEC (5).  These results indicate that the interaction of amino acid residues in loops 1 
and 2 of the OmpA interact with GlcNAcb1-4GlcNAc epitopes for E. coli invasion of 
BMEC.   
On the other hand, OmpA mediated E. coli invasion was not observed with 
systemic endothelial cells such as HUVEC (5). Further studies on systemic endothelial 
cells revealed that the majority of GlcNAcb1-4GlcNAc epitopes are substituted with L-
fucose, thus possibly blocking the interaction with OmpA for E. coli invasion.  
These findings strongly implicate OmpA as the necessary microbial structure for 
the neurotropic nature of E. coli to invade BMEC, an important event in the pathogenesis 
of E. coli meningitis. Blocking of OmpA binding site by small molecules is a potential 
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strategy to prevent the penetration of E. coli into central nervous system.  Thus, to lay the 
groundwork for rational drug design, we initiated studies of the molecular level 
interactions of OmpA with chitobiose and other disaccharides already tested 
experimentally. 
OmpA is a highly conserved outer membrane protein of E. coli with a molecular 
weight of ~35 kDa (325 amino acids) containing eight transmembrane domains and four 
extracellular loops.  The crystal structure of the N-terminal 1-171 residues in the 
transmembrane domain of OmpA has been solved (11) to a resolution of 2.5Å and further 
refined to 1.65Å (12).  The crystal structure consists of a regular eight-stranded b-barrel 
with large water-filled cavities, but does not form a pore. The barrel is exceptionally long 
with an average length of 13 residues. The barrel interior is polar with salt bridge 
networks that form a barrier for passage of water or ions.  Nevertheless, it contains water 
filled cavities that could serve  as interaction sites with other proteins.  The four 
extracellular loops are mobile and not well defined in the crystal. The high-resolution 
structure of OmpA (12) is better resolved in the transmembrane regions, but there are 
several missing residues in other regions.  Hence our study uses the 2.5Å structure (pdb 
code: 1bxw) since this was complete (11).  The hexamer, Asn-27-Gly-32 and pentamer, 
Gly65-Asn69, tested for inhibition of E. coli invasion are present in the extracellular 
loops L1 and L2.  
We use the HierDock first principles simulation procedure (13) to predict the 
binding site of chitobiose in OmpA. The HierDock procedure finds two important 
interaction sites on OmpA favorable to chitobiose.  Substitution of fucosyl group on 
  
 II-7   
chitobiose makes the  epitope very unfavorable for binding to OmpA, providing an 
explanation for why E.coli does not invade the systemic endothelial cells.  
 
Methods and Validation 
To obtain an accurate description of the binding of small molecules to a protein 
requires an accurate description of the forces between them plus an accurate description 
of the changes in solvation that accompany binding.  Also required is a comprehensive 
conformation search over the potential binding sites while considering all plausible 
conformation changes in the ligand and the protein.  The best computational methods are 
believed to provide reasonably accurate predictions of relative binding energies (14-16); 
however, for cases where the binding site is not known it is not practical to use these 
most accurate methods at every possible site.  Thus we have developed the HierDock 
hierarchical strategy that starts with a coarse grain search (fast but not too accurate) over 
the full protein to identify the best sites for finer grain studies, which are followed by a 
succession of increasingly accurate but increasingly costly studies that ultimately include 
an accurate description of solvation and fully flexible protein and ligand.  HierDock has 
previously been applied successfully to predict the binding of non-natural amino acids to 
phenylalanyl t-RNA synthetase (17) and to predict the affinity of odorants to the 
mammalian olfactory receptor (13), a membrane-bound protein.   
HierDock uses a coarse grain Monte Carlo procedure [currently, DOCK4.0 (18)] 
to select an ensemble of conformations over which to do a hierarchy of more accurate 
(fine grain) Molecular Dynamics (MD) annealing (19) to optimize the ligand in the 
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various potential binding sites.  The MD calculations use an all-atom forcefield (FF) with 
continuum solvation calculations of the energies and forces arising from solvation for 
both the ligand and the protein receptor (20,21).  The Poisson-Boltzmann (PB) 
description (20) leads to accurate energies and forces to describe the solvent effects on 
the energies and structure of small molecules.  However, PB is too slow for MD. 
Consequently, we use the Surface Generalized Born (SGB) method (21), which leads to a 
reasonably accurate description of the solvent effects at considerably less cost.  We have 
found that the SGB method leads to results as accurate as the PB method in describing 
the electrostatic response of the solvent (22).  These solvation methods have been used in 
our calculations of scoring functions.  
FF Validation Studies: Critical elements of the HierDock protocol are the 
hierarchical sequence of conformational searching, the accuracy of the FF, and the 
inclusion of solvation in the calculating structures and binding energy.  
We use the DREIDING FF (23) with CHARMM (24) charges for the protein and 
charge equilibration (25) charges for the carbohydrate/sugar ligands.  This approach has 
been used previously to study the binding of chitin (a polysaccharide) to family 18 and 19 
chitinases (26,27).  Simulated annealing dynamics were reported (26) for hexaNAG 
substrate binding to family 18 chitinase.  The RMS in coordinates for all atoms in the 
binding site was 2.13Å, which is within the crystal resolution.   
In another study (28) the structure of sugars bound to proteins were predicted and 
compared to co-crystal structures available for these complexes.  Calculations for the 
binding of L-arabinose and D-fucose to the L-arabinose binding protein (pdb code: 1abe) 
were performed. Starting with the crystal structure (1abe) the ligands were removed from 
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the binding pocket and using the HierDock protocol (DREIDING FF) and we docked L-
arabinose and D-fucose to 1abe structure.  The predicted structures of the protein/ligand 
complexes are in good agreement with the crystal structures (coordinate RMS error of 
0.4Å compared to the crystal structure of L-arabinose in L-arabinose binding protein, 
1abe).  The coordinate RMS error for D-fucose binding to L-arabinose binding protein is 
1.4Å compared to the corresponding crystal structure (1abf).  Using a single target 
protein as a starting point we predicted the co-crystal structure of both L-arabinose and 
D-fucose binding to L-arabinose binding protein.  This is in fairly good agreement with 
co-crystal structures, of resolution 1.7 and 1.9Å for 1abe and 1abf respectively.   Other 
groups have also used the DREIDING FF for molecular dynamics for glycoproteins (29).   
Summarizing, a number of studies validate that our FF and charges should lead to 
reasonable binding sites and energies for sugar protein complexes such as in the current 
study.  Indeed we report here that the calculated binding energies for various sugars to 
OmpA correlate well with experimental invasion assays.  
Application of HierDock protocol to sugars binding to OmpA. 
A. Coarse grain docking ensemble 
Starting with the crystal structure of OmpA, we removed the waters so that the 
volume of the receptor site will be explored more completely.  The HierDock procedure 
was as follows. 
1. Sampling volume. The docking site was not known for OmpA and hence the 
negative image of the entire receptor's molecular surface was mapped as shown in Fig. 
II-1, and filled with a set of overlapping spheres.  A probe of 1.4 Å radius was used to 
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generate a molecular surface with 5 dots/Å.  Sphere clusters were generated for the whole 
binding site using the program Sphgen. 
2. Defining regions for docking: The sphere filled volume from step1 representing 
the possible binding sites, was partitioned into 12 regions. These regions included the 4 
loops, the space in between the loops, and the space inside the barrel till half way within 
the transmembrane region.  Since the barrel is very narrow and the ligands are reasonable 
big, it seemed improbable that the ligand would go deep into the barrel without any steric 
clashes. Moreover, the sugars are attached to Ecgp, the glycoprotein on the BMEC 
surface that will further prevent it from going far into the barrel cavity.  Also, the barrel 
has internal polar networks that form a prominent barrier in the barrel interior with 
ordered water molecules inside the b  barrel.  
3. Ensemble selection (scoring): To generate an ensemble of docked receptor-
ligand complexes, we used the program DOCK (version 4.0) to sample various 
orientations and conformations of the ligands in the receptor site.  We used flexible 
ligand docking option in DOCK4.0, with torsion minimization of ligands.  A non-
distance dependent dielectric constant of 1 and a distance cutoff of 10 Å were applied for 
calculating protein- ligand coulombic interaction energy. The energy score in DOCK4.0 
uses coulombic energy and van der Waals energy as described in reference 18. The 
conformations were ranked using energy scoring in DOCK4.0. The top 10-30 
conformations were selected by energy score for each ligand in each of the 12 potential 
binding regions. These selected conformations were further used for fine grain molecular 
dynamics calculations.   
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B. Fine grain MD search  
The next step in HierDock is to perform a fine grain MD with an all atom 
forcefield to optimize the ligand conformation inside the binding pocket.  
1. Annealing Molecular Dynamics: For each of the 12 regions, the 20 best scoring 
docked conformations from DOCK were subjected to five cycles of annealing dynamics 
(each from 50K to 600K and back to 50K with 25 picoseconds of MD at each 
temperature).  This allows for the optimization of the ligand conformation in the protein. 
One lowest energy conformation is stored from each cycle of annealing MD. The 
energies of the best-annealed structures were calculated using all atom DRIEDING 
forcefield (23) and SGB continuum solvation model.  We find that this step of ligand 
optimization is critical in getting energetically favorable conformations for the complex 
(Protein plus ligand).  
2. Binding Energy Calculation: The binding energies of the 20x5 annealed 
structures for each ligand in each of the 12 docking regions were calculated.  Binding 
energies were calculated using DREIDING forcefield, and charge equilibration (24) 
charges using MPSim simulation code (19). Solvation effects for ligand binding were 
calculated using the SGB description of the continuum solvent model. The binding 
energy is calculated as the difference between the total energies of the complex (protein 
+ligand) and the sum of the protein and ligand energies. The best conformation from this 
pool was selected by the binding energy for each of the 12 docking regions. 
Summarizing, the HierDock protocol uses a hierarchical strategy for conformation 
search and a corresponding scoring function to select a subset of structures for the next 
level.  The coarse grain level (DOCK4.0) uses a crude scoring function including just 
  
 II-12   
coulombic and van der Waals interactions of the ligand with the protein.  Using this 
scoring function a subset of conformations generated by DOCK4.0 is selected for the 
annealing step. At the fine grain level (annealing MD level) the scoring function uses an 
all tom forcefield and continuum solvation method to calculate the binding energies and 
select the best-bound structure of the ligand in the protein. 
C. Selection of the best two regions through application to Chitobiose 
A complete scanning of all possible docking regions for OmpA was done with 
chitobiose.  The structure of the ligands used is shown in Fig. 2.2. The final 1200 
structures in 12 regions (100 conformations from each region) were scored using SGB 
solvation and DREIDING forcefield. Comparison of the binding energies in various 
regions showed that regions 1 and 2 shown in Figure II-3 have the best binding energies.  
Hence, these two regions were ranked are possible binding sites. The binding energy of 
conformations of chitobiose in regions 1 and 2 were about –15 kcal/mol and –20 
kcal/mol, the difference being 5 kcal/mol, was small enough to treat these two regions on 
an equal footing.  Hence these two regions were kept as possible binding regions for 
chitobiose.  The binding energy of chitobiose in other regions was less than –5 kcal/mol 
and hence considered insignificant compared to regions 1 and 2.  
D. Application to all four ligands 
Having identified the probable binding sites for chitobiose, we then carried out 
the complete sequence of HierDock calculations over regions 1 and 2 for the three 
ligands using structure of the ligands shown in Figure II-2.   
Fucosylated chitobiose 
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Cellobiose  
Lactose 
Thus, these ligands were docked and the structures were further annealed using 
MD and all the resulting complexes (OmpA+ligand) were optimized (energy minimized) 
using conjugate gradient method. Finally, the binding energies of these ligands were 
calculated and ranked in these two binding sites.  
E. Optimization with the flexible binding site on OmpA 
Protein flexibility is critical to determining the binding conformation and the 
critical ligand protein interactions energies.  Hence, we performed five cycles of 50ps 
annealing MD heating from 50K to 600K and cooling from 600K to 50K for the best 
conformation of chitobiose bound to region 2. These simulations were performed 
allowing the ligand and all the amino acid residues that are in the top half of the barrel in 
Figure II-3 to be flexible but keeping the rest of the protein fixed.  These simulations 
optimized the hydrogen bonds and van der Waals contacts made by the ligand to 
particular residues in the binding cavity. The final conformation from these simulations 
was used for all analysis. 
Results and Discussion 
Using the procedure described above we predicted the binding site and binding 
energies of sugars in OmpA.  Regions 1 and 2 shown in Figure II-3 were ranked as the 
most favorable regions for binding of the best ligand (chitobiose) in OmpA.  The binding 
energy of the best conformation of chitobiose is –15.42 kcal/mol in regions 1 and–20.50 
kcal/mol in region 2.  In contrast the calculated binding energy of chitobiose in all other 
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regions was worse than -5.0 kcal/mol.  Hence we consider region 1 and region 2 as likely 
binding sites for chitobiose in OmpA.  Indeed peptides from region 1 [between external 
loop structures loop1 (L1) and loop2 (L2)] have been tested experimentally for inhibition 
of E.coli invasion.   
The binding energies of chitobiose, fucosylated chitobiose, lactose, and cellobiose 
in regions 1 and 2 are shown in Figure II-4.  The result is that chitobiose has the best 
binding energy in both regions 1 and 2.  This indicates that binding of chitobiose in these 
two regions of OmpA is specific. Experimentally, chitobiose dramatically reduced 
invasion (>95%) when BMEC are infected with E. coli K1 after pretreating with ligands 
(5), while none of the other ligands show reduced invasion.  Thus we find a good 
correlation between the binding energies of the ligands to OmpA and the experimental 
invasion assay measurements.  This suggests that binding to OmpA may be a necessary 
step in the pathogenesis of bacterial meningitis.  
Figure II-5 shows the contribution of the valence and non-bond energies to the 
binding energy. Interestingly, lactose and cellobiose (both similar in size to chitobiose) 
do not show good binding energies.  We attribute the lack of good binding energy for 
lactose compared to chitobiose to the absence of NHCOCH3 group.  The hydrogen bonds 
made by the NHCOCH3 group in chitobiose to His152, His20, and Arg157 are absent in 
lactose and cellobiose.  On the other hand fucosyl substituted chitobiose in region 1 has 
non-bond interactions similar to chitobiose but the binding is weakened by the steric 
clash with the bulky fucosyl substitution.  In region 2, fucosyl chitobiose does not have 
favorable non-bond interactions since it loses hydrogen bonds to His152 and Arg 157.  
  
 II-15   
Fucosyl chitobiose is a bulky ligand that does not bind to OmpA due to steric 
hindrance from the protein.  We observed that during step B.1 of the HierDock protocol 
(i.e., the ligand annealing MD for fucosyl chitobiose with OmpA fixed in region 2) the 
sugar ring was forced into a boat conformation due to steric clashes with the fixed 
protein.  We found that the ligand gets trapped in this conformation during the cooling 
phase of annealing MD, resulting in a strained state for fucosyl chitobiose.  Such a 
transformation to the boat form does not occur if annealing MD is performed with all 
protein atoms are allowed to move along with the ligand.  However, even with full 
relaxation (to the chair form) the binding energy of fucosyl chitobiose is still worse than 
chitobiose by 14.2 kcal/mol.  We consider that annealing MD with all atoms movable is 
too expensive computationally to do for all docked structures.  Thus we refined the 
HierDock procedure to identify the large strain energies (caused in this case by the chair 
to boat transformation) in the internal energy of the ligand during protein fixed annealing 
MD.  Then for structures leading to high internal strain energy, the HierDock procedure 
now carries out annealing MD with all protein atoms movable when calculating the 
binding energy.  
Chitobiose makes a number of critical contacts with residues on the loops in 
region 1 and region 2.  In region 1, it makes significant contacts with residues Val 68, Ser 
67, and Glu 69 on loop L2 and with Asn 27, Asn 28, and Ile 25 on loop L1 (Table 1).  
The NHCOCH3 group on chitobiose makes a critical hydrogen bond with Asn 27 as 
shown in Figure II-6.  There is experimental support of a role for residues in region 1.  A 
number of peptides have been tested experimentally for inhibition of E. coli invasion, but 
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only peptides from L1 and L2 were able to block invasion when compared against 
random peptides.  This correlates very well with our predicted site in region 1.  
Region 2 is in the water filled pocket between the extracellular loops. Chitobiose 
makes a number of contacts in this region including a number of van der Waals contacts 
with loops L1, L3, and L4, and with some residues in the b-barrel.  The residues that are 
within 5Å of chitobiose are listed in Table 1. Chitobiose is partially buried in the cavity 
between the loops (Table 1) and present in the boundary between the b-barrel and the 
loops. Chitobiose makes electrostatic contacts with Trp 103, Arg 157 and His 152 (shown 
in Figure II-7). On annealing MD with the protein cavity movable, the loops come closer 
to complex more strongly with the ligand. Loops 1 and 4 show maximum displacements 
from the original crystal structure (Figure II-8). Annealing dynamics suggest that 
chitobiose stays at the mouth of the cavity rather than going far into the cavity.  OmpA 
has a very narrow pore, which hinders chitobiose from inserting further into the cavity. 
We suggest experimental studies on invasion assays using the peptides from this list of 
residues in Table II-1.  
In this study we correlated the binding energies to the percentage invasion results 
from invasion assay experiments.  It should be noted that many other steps might be 
involved in the pathogenesis leading to invasion of BMEC by E.coli.  The correlation 
between the calculated binding energies and invasion assay results suggests that the 
binding of OmpA is a necessary step in the pathogenesis.  Of course there may be many 
other important factors.  To further validate this model, we suggest several experimental 
tests of the predictions made by the model:. 
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1. Synthesize peptides from binding region 2 on OmpA and test the efficacy 
of these peptides for blocking of E. coli invasion.  For example we recommend testing 
the following peptides for blocking invasion: QYHDTGLIH, QYHDT, HDTGL, TGLIH, 
DTGLI, GMVWRADTWS, GMVWR, ADTWS, VWRAD, KNHDT, NHDT, 
TNNIGDAHTIGTRPDNG, TNNIG, DAHTI, GTRPDNG, NIGDAHTIGTRPD, 
TRPDNG, NNIGDAHT, AHTIGTRPDN  
2. Carry out point mutation studies for OmpA, targeting the polar and 
charged residues within 3Å of chitobiose in region 2.  Our predicted binding site suggests 
that mutations of residues Asp117, Asn147, His152, Arg157, and Asp159 will lead to 
disruption of OmpA interaction with chitobiose.  
3. Design small molecule drugs that would bind more strongly than 
chitobiose to regions 1 and 2 to inhibit the OmpA invasion of BMEC.  We are currently 
using the data from our predicted sites to search for new compounds for experimental 
tests. 
 The glycoprotein (Ecgp) that interacts with OmpA has been sequenced 
and its two glycosylation sites have been recently identified by Prasadarao et al. 
(unpublished results).  Based on these modeling studies we propose two possible 
mechanisms of OmpA binding to the sugars in Ecgp.   
· One possibility is a two-step mechanism: Here the chitobiose is first 
recognized by the loop1 in region 1 and then transferred to region 2 for stronger binding.  
In this case it seems plausible that region 1 is a recognition region and region 2 is the 
binding region.  This recognition mode involving a sequence of two interaction regions 
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has been shown for such other membrane proteins as CCR5 (30), a cofactor of CD4 in 
HIV invasion.   
· A second plausible mechanism is that two sugar moieties from two 
glycosylated sites from Ecgp interact with both sites of OmpA at the same time. This 
might give stronger binding constants and additional selectivity. 
Conclusions 
We find two regions on OmpA that are potential interaction sites for GlcNAc1 
and 4GlcNAc epitopes on glycoproteins of BMEC.  For both the regions, we showed that 
OmpA of E. coli, binds most favorably to chitobiose as compared to cellobiose, fucosyl 
substituted chitobiose and lactose.  The difference in the binding energies of OmpA with 
chitobiose and fucosylated chitobiose is of significance in understanding the pathogenesis 
of E. coli meningitis.  Since most of the systemic cells of the body have fucosylated 
glycoproteins, this explains the specificity of E. coli invasion of BMEC.  A good binding 
between OmpA and chitobiose arises from specific interactions of the NHCOCH3 groups 
on chitobiose with the OmpA residues.  Lactose and cellobiose, although they have the 
same b1-4 linkage as chitobiose, they lack the NHCOCH3 group that is important in 
making favorable specific interactions.  Fucosylated chitobiose, on the other hand, makes 
good contacts with the receptor and has a high non-bonded energy but it has an 
unfavorable valence energy.  
The binding site predictions made are testable either by point mutation studies or 
by invasion assays.  It is important to note that we have studied the interaction of only 
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sugars with OmpA, because the experimental invasion assays were tested with the same 
sugars.  
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Table 1 : List of residues that are in the binding regions 1 and 2 of chitobiose. Residues 
listed here are within 5 Å of chitobiose in regions 1 and 2. Residues in bold are within 
 3 Å of chitobiose and make critical contacts with chitobiose.  
 
 
        Loop1         Loop2          Loop3           Loop4  Barrel 
Region1 Ile25  Asn26  
Asn27  Asn28  
Gly29   Pro30 
 
Ser67 Val68  
Glu69 
   
Region2 Gln18  Tyr19  
His29  Asp21  
Thr22  Gly23  
Leu24  Ile25  
His 20 
 Gly100    
Met101 Val102   
Trp103 Arg104   
Ala105 Asn115  
His116  Asp117  
Thr118 
Thr145  Asn146  
Asn147 Ile148 
Gly149 Asp150  
Ala151  His152  
Thr153  Ile154    
Gly155  Thr156   
Arg157  Pro158  
Asp159 Asn160  
Gly161 
Asp106  Thr107  
Tyr108  Ser109  
Lys114   
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Figure II-1 Sphere filled volume representing the possible binding sites on 
OmpA. (a) shows the side view of the protein and (b) represents the top view. 
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Figure II-2 Sugars used for Docking in the twelve regions of OmpA. 
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Figure II-3 OmpA region 1 and region 2.  Region 1 (weaker binding) is in 
between loops L1 and L2.  Region 2 (stronger binding) is in the water filled cavity 
between the 4 loops. 
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Figure II-4 Binding energies of the four ligands in regions 1 and 2.  Chitobiose 
has the best binding energy in both regions. 
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Figure II-5 Valence and non-bond energy contributions to the binding energy of 
lactose, chitobiose, cellobiose and fucosylated chitobiose in regions 1 and 2. (a) 
Valence energy components in region1.  (b) Non-bond energy components in 
region1.  (c) Valence energy components in region 2.  (d) Non-bond energy 
components in region.  
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Figure II-6.   Important residues within 5 Å of chitobiose in region 1 (between loops, L1 
and L2).   
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Figure II-7. Residues within 3Å of chitobiose in region 2.  Residues on loop4 
(which moves significantly) make important contacts with chitobiose.  Almost all 
residues within 3Å of chitobiose are either polar or charged 
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Figure II-8 Four loops move significantly on binding to chitobiose.  Loop4 and 
Loop1 show maximum change in structure. 
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Mechanism for Antibody Catalysis of the Oxidation of Water by  
Singlet Dioxygen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Adapted from Datta. D., Vaidehi N., Xu  X.,  and Goddard III W. A., Proc Natl Acad   
Sci U S A. 2002 ; 99: 2636-41.  
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Abstract 
Wentworth and coworkers (Wentworth et al. (2001), Science, 293,  1806-1811) 
recently reported the surprising result that antibodies and T-cell receptors efficiently 
catalyze the conversion of molecular singlet oxygen (1O2) plus water to hydrogen 
peroxide (HOOH).  Recently quantum mechanical (QM) calculations were used to 
delineate a plausible mechanism, involving reaction of 1O2 with two waters to form 
HOOOH (plus H2O), followed by formation of HOOOH dimer, which rearranges to form 
HOO-HOOO + H2O, which rearranges to form two HOOH plus 1O2 or 3O2.  For a system 
with 18O H2O, this mechanism leads to a 2.2:1 ratio of 16O:18O in the product HOOH, in 
good agreement with the ratio 2.2:1 observed in isotope experiments by Wentworth et al. 
In this paper we use docking and molecular dynamics techniques (HierDock) to 
search various protein structures for sites that stabilize these products and intermediates 
predicted from QM calculations.  We find that the reaction intermediates for production 
of HOOH from 1O2 are stabilized at the interface of light and heavy chains of antibodies 
and T-cell receptors.  This Inter Greek Key Domain Interface (IGKD) structure is unique 
to antibodies and T-cell receptors.   
IGKD interface is not present in b2-microglobulin, which does not show any 
stabilization in our docking studies.  This is consistent with the experimentally observed 
lack of HOOH production in this system. Our results provide a plausible mechanism for 
the reactions and provide an explanation of the specific structural cha racter of antibodies 
responsible for this unexpected chemistry.  
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1.   Introduction 
Recently, Wentworth et al. [1] reported surprising results that antibodies can 
convert molecular oxygen to hydrogen peroxide and they also showed that the antibodies 
catalyze the oxidation of H2O to H2O2 by singlet oxygen molecules, 1O2 [2].  This 
suggests that in addition to the well-known antigen recognition function of antibodies, 
they may also promote destruction of the molecules to which they bind.  This could have 
implications in the function (and malfunction) of the immune system and in the evolution 
of this system. 
Investigations of the long-term photo-production of H2O2 by antibodies and non-
immunoglobulin proteins reveal a remarkable difference [2].  It was demonstrated that 
the sustained high concentrations of H2O2 produced recursively could not have been by 
the oxidation of the amino acids in the antibodies.  Thus, production of H2O2 by 
antibodies remains linear for a much longer period than for all non- immunoglobulin 
proteins tested (up to > 50 mol equivalents of H2O2).  Furthermore, if the H2O2 generated 
during the assay is removed, antibodies are able to resume H2O2 production at the same 
initial rate as at the start of the experiment while other proteins that produce H2O2 do so 
by the photo-oxidation of the amino acids (e.g. tyrosine, tryptophan) and are not able to 
resume the same initial rate of H2O2 production.  These experiments strongly suggest that 
the antibodies play a catalytic role in converting 1O2 plus water to H2O2.   
Through isotopic labeling experiments Wentworth et al. [1] concluded that water 
was oxidized by the 1O2 generated.  However, the experiments have not provided a 
mechanism to understand how the antibodies and T-cell receptors (TCR) carry out this 
remarkable and unexpected chemistry.  They observed that only antibodies and TCR 
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catalyze this reaction, which implies that these molecules probably have unique structural 
features not present in other proteins.  One unique feature of these systems is the 
interfaces created by the Greek key motifs.  However, b-microglobulin also has a Greek 
key motif but does not convert 1O2 to H2O2.   
The goal of this paper is to determine which sites in the antibodies (and TCR) 
play a role in the process by which 1O2 interacts with H2O to produce H2O2.  A 
companion paper [3] presents quantum mechanical (QM) calculations that delineate 
plausible chemical reaction mechanisms for this chemistry, which are summarized in 
section 3.  Briefly, this mechanism involves formation of HOOOH from the reaction of 
1O2 with H2O dimer, followed by complexing with another HOOOH to form a dimer that 
rearranges to form two HOOH plus O2.  For a system with 18O H2O, this mechanism 
leads to a 2.2:1 ratio of 16O:18O in the product HOOH, in good agreement with the ratio 
2.2:1 observed in isotope experiments by Wentworth et al [1].   
In this paper, we use docking and molecular dynamics (MD) techniques to search 
various protein structures for sites that stabilize these products and intermediates 
predicted from QM calculations.  We used the HierDock docking and MD protocol [4] to 
find antibody sites that might stabilize the reaction intermediates.  These HierDock 
studies considered high-resolution (<2.0Å) crystal structures known to catalyze this 
chemistry (Several Fab fragments of antibodies with varying sequence homology and 
TCR) and other structures (b2-microglobulin) known not to.  We find that all antibodies 
and TCR have unique sites that stabilize the QM intermediates and products, whereas no 
such sites are found for the b2-microglobulin or other proteins.  The deduced catalytic 
sites are at the interface of light and heavy chains of the antibody and TCR.  
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These results suggest a specific structural characteristic of antibodies that is 
responsible for this unexpected chemistry.  Armed with such specific predictions it 
should be possible to design experimental tests that would help verify or discard some of 
the plausible mechanisms.  The predictions about specific important sites in the antibody 
could be used to design mutation studies in the antibodies and TCR to provide detailed 
tests on the role of the antibody.  Since the proposed mechanism does not require an 
energy or electron source (other than 1O2) one might be able to use these insights to 
design nanoscale biomimetics to carry out this remarkable chemistry in very different 
environments.    
 Section 2 presents the methods used in the HierDock protocol, section 3 
summarizes the QM results, section 4 describes the sites in antibody found to stabilize the 
catalytic intermediates, and section 5 discusses the results. 
2.0 METHODS 
To identify plausible catalytic sites in the antibodies, we used the HierDock [4] 
protocol to search the entire antibody structure for sites that would bind to the reaction 
intermediates in Eqn. 1 using the structures obtained from QM [3].  HierDock uses a 
hierarchy of coarse grain docking and fine grain MD methods (including continuum 
solvation forces) to sample possible binding sites for ligands in the protein to determine 
binding sites and energies.  HierDock has been applied successfully to such membrane-
bound proteins as the olfactory receptors [4] and outer membrane protein A of E. coli [5] 
and to phenylalanyl t-RNA synthetase [6].   
In this paper we first used HierDock to search the entire Fab structure for low 
energy binding sites.  Here we partitioned the entire Fab antibody structure into four  
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docking regions that could be searched in parallel.  First, we carried out a coarse grain 
search in each region to generate a set of conformations for ligand binding.  This 
procedure used DOCK 4.0 [7] to generate 20,000 configurations, of which 100 were 
ranked using the DOCK scoring function.  Docking the intermediates and products of this 
reaction was done using rigid ligand option in DOCK4.0    
We then selected the 20 best conformations from DOCK in each region and 
subjected each ligand to annealing MD to further optimize the conformation in the local 
binding pocket while allowing both the ligand and binding cavity (residues with an atom 
within 5Å of the binding ligand) to move.  In this step, the ligand and the binding cavity 
in the protein were heated and cooled from 50K to 600K in steps of 10K (0.05ps at each 
temperature) for 1 cycle.  This allows the protein cavity to readjust for the interaction 
with the ligand.  This fine grain optimization was performed using MPSim [8] and a full 
atom forcefield (FF) (DREIDING)[9].   
In addition we used the Surface Generalized Born (SGB) continuum solvent 
method [10] to obtain forces and energies resulting from the polarization of the solvent 
by the charges of the ligand and protein.  This allows us to calculate the change in the 
overall binding conformation resulting from differential solvation to obtain accurate 
binding energies.  The charges on the various ligands were obtained from quantum 
mechanics (Mulliken population densities at the atom centers), while the charges for the 
protein were from CHARMM22 [11].  A dielectric constant of 80.37 was used for the 
solvent field in the SGB calculation and 2.0 for the inside of the protein.    
From the 20 trajectories of annealing calculations in each docking region, we 
selected the 20 best conformations.  The relative binding energies of the 20 best 
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structures in each region were compared (DREIDING FF with solvation) to decide which 
of the four docking regions leads to good binding energies for the ligands.  In addition to 
the binding energies we also examined the population density of good binding structures 
in each region.  The most populated regions of good structures (structures with good 
binding energies) were chosen for analysis 
3.0 Summary of results from QM calculations and plausible mechanisms   
The QM studies [3] lead to plausible mechanisms for formation and 
decomposition of HOOOH and related compounds.  The most plausible mechanism 
involves several steps: 
a) Reaction of 1O2 with two waters to form HOOOH plus H2O (reaction 1 in Figure 
III-1) 
b) Formation of HOOOH dimer 
c) Unimolecular rearrangement of HOOOH dimer to form [HOO-HOOO + H2O] 
(reaction 2 in Figure III-1) 
d) Unimolecular rearrangement of this complex to form HOOH-OOO + H2O  
e) Unimolecular rearrangement  of this complex to form HOOH product + 
HOOOOH (reaction 3 in Figure III-1) 
f) Fission of the HOOOOH to 2 HOO and association to form cyclic HOO dimer 
(singlet or triplet) 
g) Rearrangement of cyclic HOO dimer to form HOOH product plus 1O2 or 3O2.   
For a system with 18O H2O, this mechanism leads to a 2.2:1 ratio of 16O:18O in the 
product HOOH, in good agreement with the ratio 2.2:1 observed in isotope experiments 
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by Wentworth et al [1].  Depending on the products from steps f and g, this QM based 
mechanism leads to a net reaction of  
2 1O2 + 2 H2O à 2 HOOH + 1O2     (A) 
2 1O2 + 2 H2O à 2 HOOH + 3O2     (B) 
The net reaction in (A) has a molecularity of 2 HOOH formed from each 1O2 is in 
agreement with the experimental results from Wentworth et al.  This excellent agreement 
with the experiments gives some credence to the QM based mechanism. To determine 
sites in antibodies and TCR that might play a role in enhancing these catalytic processes, 
we searched for sites in the antibody that bind 
The HOOOH product of reaction 1 (step a) (part of P1 and of R2)
 (1a) 
The HOOOH dimer (R2) of reaction 2 (step c)  
 (1b) 
The HOOH product of steps e and g (part of P3 in reaction 3)
 (1c) 
Given the clusters of binding sites favorable for these stable intermediates or products, 
we also examined if they would stabilize the reaction intermediates 
TS1: the H2O-H2O-1O2 transition state of reaction 1 (step a) 
 (2a) 
TS2: the transition state for reaction 2 (step c)  
 (2b) 
TS3: the transition state for reaction 3 (step e).   (2c) 
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The gas-phase structures for important intermediates and complexes are summarized in 
Figure III-1.  Some additional comments are: 
· Xu et al [3] finds that the barrier for the direct reaction of 1O2 with H2O to form 
HOOOH is over 60 kcal/mol, whereas the reaction of 1O2 with H2O dimer (R1 of 
Figure III-1) has a barrier (TS1) of ~ 30 kcal/mol.   
· Xu et al [3] find two stable structures for the monomer: trans (P1 of Figure III-1) and 
cis (shown in R2 of Figure III-1).  The cis structure is 2.4 kcal/mol higher in energy 
than the trans structures.  We docked both conformations.  
· Xu et al [3] find 12 stable but distinct structures for the dimer, (HOOOH)2.  The most 
relevant for the formation of HOOH is R2 in Figure III-1. This structure is 4.9 
kcal/mol more stable than the cis-monomer.  We docked this dimer conformation. 
4.0 The Catalytic Site in Antibodies for Catalytic Transformation of 1O2 and H2O to 
HOOH 
4.1 Binding sites in the Fab antibody fragment [crystal structure (4c6.pdb)] 
To seek plausible reaction sites for various steps in the QM mechanism we used 
the 1.2Å Fab crystal structure 4c6.pdb[12], which is the highest resolution Fab crystal 
structure available.  The crystal structure was supplemented by adding hydrogens at 
standard geometries (as given by DREIDING) and hydrated counterions Na+ and Cl- 
were also added to charged side chain residues to maintain neutrality [13].   
The crystal structure was optimized using the FF, charges, and continuum 
solvation methods described in section 2.  This minimized structure has a coordinate 
RMS error of 0.71Å to all atoms of the crystal structure.  (The experimental resolution of 
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the crystal structure is 1.2Å.)  This indicates that the FF, charges, and solvation methods 
are sufficient to describe the system.  We used this optimized 4c6 Fab structure in the 
HierDock protocols to search for sites in the 4c6 Fab structure that strongly bind 
HOOOH, HOOOH dimer, and H2O2 (see Eqn. 1).  In addition, we examined the 
stabilization of the transition states in Eqn. 2 at the predicted binding sites for Eqn. 1.   
4.1.1 Binding sites for HOOOH monomer and dimer 
We find three sites (denoted I1, I2, I3) that strongly bind HOOOH monomer and 
dimer.  Two of these sites (I1, I2) are at the interface of VH and VL and one site (I3)  is 
between CH1 and CL, as shown in Figure III-2a.  To help a reader to locate sites I1, I2, I3 
in the 3D structure, table 1 lists the residues at each site within 5Å of the bound HOOOH 
dimer.  It is interesting that near I1 is trp109 on the heavy chain that is conserved across 
all antibodies and could be a potential sensitizing residue for the singlet oxygen.  
All three sites are at the interface of two Greek key domains and hence we call 
this interface region as “Inter Greek Key Domain Interface” or IGKD.  The two xenon-
binding sites reported by Wentworth et al. [1] in the 4c6 structure lie in the IGKD, very 
close to the sites I1 and I2.  Thus Xe1 is 18.4Å from Site I1 while Xe2 is 11.8Å from site 
I1 and 13.0Å from site I2.  
Since the QM predicted mechanisms require two H2O for the reaction with 1O2, 
we would expect that the reaction site should have ordered water clusters at this site.  
Indeed Figure III-4a and 4b show that the crystal has higher ordered water clusters at site 
I1, I2, and I3, with several water dimers and trimers. Although the QM calculations use a 
second H2O to catalyze the reaction of 1O2 with H2O, it is possible that these IGKD sites 
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that stabilize the water clusters, might also be able to replace the catalytic role of the H2O 
(that is protons from the amino acids surrounding these sties might play similar roles).  
4.1.2 Binding sites for product H2O2 
The same HierDock procedure was used to search for sites in the 4c6 antibody 
structure that would stabilize the product H2O2.  Here we find the two clusters (P1 and P2 
shown in Figure III-2b) containing most of the highest binding structures.  P1 is at the 
base of the antigen-binding site, completely overlapping the Xe2 site reported by 
Wentworth et al. [1].  P2 is between the CL and CH1 domains and overlaps region I3.  
Both P1 and P2 are in the hydrophobic region between the barrel like interface of the 
variable and constant domains.  In contrast to I1, I2, and I3, sites P1 and P2, do not 
exhibit bound water in the crystal structure, indicating that they are buried hydrophobic 
pockets.   
The results derived from our docking studies of the intermediates and the product 
suggest that this catalytic reaction takes place in the interface regions of the variable and 
constant domains.  This is supported by experimental evidence that shows strongly bound 
water dimers and trimers in these regions and the Xe binding studies suggesting that these 
regions are hydrophobic.  Both predicted regions seem to be ideal for the reactions 
because of their ability to stabilize the key intermediates of the reaction cascade. 
We also verified that the sites I1, I2, and I3 also stabilize the transition states for 
the reaction by performing a HierDock calculation for TS1, TS2, and TS3 [defined in 
Figure III-1 and Eqn. (2)] in the I1, I2, and I3 regions of the 4c6 structure.  The transition 
state structures were kept rigid in all these docking studies.  We found that the transition 
states cluster favorably in these regions.  
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4.2 Binding sites for HOOOH dimers, monomers, and H2O2 in other Immunoglobulin 
Fab fragments. 
The formation of H2O2 has been observed for a large number of antibodies (over 
200), all of which have been observed (1,2) to catalyze the conversion of 1O2 to HOOH.  
This suggests that the reaction center is highly conserved across all antibodies.  This may 
seem surprising since these antibodies include a reasonable diversity in sequences.  
However, the sites I1-I3 and P1-P2 we find to be important are associated with a unique 
structural motif of the fold in antibodies (and TCR) which might be rather insensitive to 
sequence.  To test whether these sites would stabilize the intermediates for a range of 
antibodies, we selected three high-resolution (< 2Å) Fab structures (pdb codes: 2fb4, 
1c5c, 1e60) that have maximally diverse sequences.  This selection of structures was 
accomplished using the ClustalW sequence alignment program[14].  The three Fab 
structures selected have sequence identities of 47% to 68% with each other and with 
4c6.pdb.   
HierDock was performed across the entire antibodies to prevent a bias towards 
any particular sequence in docking protocol.  In each case we find three clusters 
corresponding to I1-I3 and two corresponding to P1-P2 at the same positions as for 4c6.  
Thus the bound HOOOH dimer and monomer cluster along the VH and the VL interface 
of the IGKD for all three additional structures.  This study confirms that IGKD fold is 
important in the catalysis of this reaction and the commonality of the binding sites for 
different sequences supports the IGKD region as the catalytic site.  
4.3 Predicted binding sites of intermediates in T-cell receptor (TCR) 
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Experimentally it is known that TCR produces HOOH from 1O2, just as for 
antibodies.  To determine whether our procedure would explain this  observation, we 
examined TCR (pdb code: 1tcr), which has the Greek key motif and the IGKD just as in 
antibodies.  Again we used the HierDock protocol to perform an unbiased search for 
binding site across all regions of the TCR.   
We found that the HOOOH monomers and dimers cluster at the heavy and light 
chain interface (sites I1-I3) of the TCR.  This is consistent with the experimental 
observation that TCR does produce H2O2.  Since, the sequence similarity between 4c6 
and TCR is only 25%, this suggests tha t the essential feature is structural not sequence 
specific.  These results support the conclusion that it is the IGKD interface created by the 
arrangement of immunoglobulin domains that is required for the stabilization of the 
intermediates. 
4.4 Predicted binding sites of intermediates in b2-microglobulin:  
b2-microglobulin has the characteristic Greek key motif present in antibodies, but 
it is monomeric and hence does not have the barrel- like interfacial structure of the TCR 
and the Fab region of antibodies.  Consequently, we use HierDock to perform an 
unbiased search for binding sites across all regions of ß2-microglobulin (pdb code: 1duz) 
to find favorable binding regions for HOOOH monomer, its dimer, and the transition 
states.  However, we found no common consensus-binding region for the monomer and 
dimer in b2 microglobulin.  The bound structures did not have a high population of 
docked conformations in any one region.   
This indicates that the immunoglobulin fold by itself is not sufficient to catalyze  
the reaction.  Rather, we require an interface created by the arrangement of 
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immunoglobulin domains, IGKD, to create the environment required for the stabilization 
of the intermediates.  This is consistent with the results of Wentworth et al., who showed 
experimentally that b2 microglobulin does not produce H2O2 from 1O2.  We attribute the 
lack of H2O2 production in b2 microglobulin to the absence of a hydrophobic interface 
lined with organized water molecules.  This suggests that the unique feature responsible 
for the catalysis is the IGKD (only present for antibodies and TCR), not the Greek key 
fold (which is present in all immunoglobins, including b2-microglobulin and other 
proteins).   
5.0 DISCUSSION 
5.1 Nature of binding site for HOOOH monomer and dimer: 
 The two catalytic sites predicted here are at the interface of light and heavy chains 
of the antibody, a structure unique to antibodies and TCR.  This IGKD interface of two 
Greek key domains is shown in Figs 3a and 3b.  The two binding sites are each located 
on the sides of the barrel- like structural motif [15] at the interface of VH and VL, as shown 
in the inset of Figure III-3b.  This structure has the beta sheets of VH and VL separated by 
~ 5 Å, favoring the binding of the water sheet observed experimentally.  The residues 
lining these sites shown in bold face in table 1 are strictly conserved and those in italics 
are conservative replacements.  These results were obtained by performing a clustalW 
sequence alignment of the 37 Fab sequences having structure resolved to within 2.0Å. 
Trp109 in the I1 binding site is conserved across all antibodies and could be a potential 
sensitizing residue for the singlet oxygen.  
There are a number of well-ordered crystallographic waters on the sides of this 
interfacial barrel- like structure between the VH and VL, as shown in Figure III-4a and 4b.  
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These waters are ordered in dimers (O--O distances approximately 2.6Å), trimers (O--O 
distances varying from 2.6 to 3.3Å), and a pentamer cluster (see Figure III-4a) with 
distances of 2.54 to 2.79Å.  This pentamer ring of H2O is in region I2 (it is formed by the 
crystallographic waters: Wat 12, 54, 60, 249, and 339).  The water dimers shown in 
Figure III-4b are Wat5 and Wat404.  Such well-ordered water clusters can be observed 
only in high-resolution crystal structures, such as 4c6 structure with 1.2Å resolution.   
We consider that these water clusters are the H2O structures that react with 1O2, to 
form HOOOH, which subsequently reacts with a second HOOOH or 1O2 to form H2O2 
and the other reactive intermediates discussed above.  Thus the first step of our QM 
mechanism involves two waters in a dimer-like structure, just as in Figure III-4a or 4b, 
with one of the waters acting as a catalyst in this step.  
The I1, I2 sites determined using HierDock seem quite appropriate for the 
reaction to generate HOOOH from 1O2 plus two H2O.  This product HOOOH is also 
favorable in this same site or in I3.  It is plausible that a second HOOOH (formed from an 
additional 1O2 and another H2O dimer) could remain in these regions to combine with the 
first to form HOOOH dimer at either I1-I2 or at I3.  This could then form H2O2 as in the 
QM mechanism.  This H2O2 might then migrate to the sites P1-P2 that we find most 
favorable for H2O2. 
A closer look at the interface of light and heavy chains of all antibodies shows 
that the bottom of the channel or barrel is capped by polar amino acids.  For most 
antibodies these are glutamines forming a hydrogen bond network, as shown in Figure 
III-3b.  We suggest that these residues could serve two functions.   
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· One, they could gate the reactants and various intermediates from entering the 
hydrophobic channel.  Instead, these intermediates would go to the side of the barrel 
at the interface of light and heavy chain as shown in Figure3a.   
· Second, they could prevent the H2O2 formed from escaping from the bottom of the 
barrel.  This might direct them to be released towards the antigen-binding site.   
To determine if these glutamines play a role in capping the products from the 1O2 
chemistry, it would be interesting to examine systems where the glutamines are mutated 
to hydrophobic residues. 
For Fab our studies of binding HOOOH and its dimer and of H2O2 suggest the 
model that the IGKD motif is essential for H2O2 production from singlet oxygen.  Since 
the Fc structure of antibodies have one such IGKD interface compared to two in the Fab 
structure, this suggests that the efficiency of HOOH production in Fc should be half that 
of Fab.  Indeed Wentworth and Lerner[16] have shown that Fc structures have half the 
efficiency of Fab structures.  
5.2 Geometric Pathway for the conversion of 1O2 to HOOH. 
A schematic geometric roadmap based on our proposed mechanism is given in 
Figure III-5 (for the 4c6 Fab structure).   
a) We assume that 1O2 may enter the antibody from near the Xe1 (and Xe2) xenon-
binding site to migrate through the hydrophobic environment of VH and VL to the 
IGKD interface region (sites I1 and I2).   
b) Here it 1O2 can convert the clustered waters at this site to HOOOH.   
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c) This HOOOH might react with a second 1O2 or it might migrate to the I3 site where it 
could react with a second HOOOH.  In either case this reaction produces two HOOH.  
The HOOH products of this reaction might migrate to sites P1 and P2.   
d) Subsequently these HOOH might migrate towards the interior of the barrel where 
H2O2 (or other intermediate such as HOOOH or the (HOO)2 dimer) could react with 
the antigen.  This might mark it for destruction.   
Such a destructive role of consistent with the observation that 1O2 is produced in 
processes involved with the macrophage engulfing the antigen bound antibody.   
6.0 Conclusions:  
Based on the experiments by Wentworth et al. showing that antibodies can 
catalyze 1O2 to oxidize water to form H2O2 and based on the QM computational studies of 
Xu et al showing that the chemical mechanism involves production of HOOOH and 
subsequent reactions to form a series of products culminating in H2O2, we searched 
various proteins for special sties compatible with this chemistry. 
Our HierDock studies lead to the conclusion that the interfacial motif IGKD, 
between two Greek keys (present only in antibodies and TCR and not present in b2 
microglobulin) is critical to catalysis of 1O2 to oxidize water to form HOOOH and H2O2.  
For both antibodies and TCR, we found sites (I1-I3) in the region favorable for binding 
the HOOOH reaction intermediates and sites (P1-P2) favorable for the H2O2 product.  
Based on these docking results and on the QM calculations, we propose a sequence of 
steps by which antibodies can produce HOOOH and H2O2 from 1O2.  These results 
suggest that such reactive intermediates as HOOOH and (HOO)2 and the product HOOH 
are favorably formed in the IGKD paired Greek key barrel region close to the antigen.  
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We speculate that the conversion of 1O2 to HOOOH and/or HOOH might provide for a 
protective function against singlet oxygen (which can attack dienes and other molecules 
in cells).  
Alternatively these reactive intermediates might react with the antigen to help 
make the protein recognized by the antibody more susceptible to attack by other enzymes 
in the macrophage.  This might provide a defense mechanism against the proteins having 
antigens to these antibodies.  Here the HOOOH and/or HOOH might react selectively 
against just the antigen recognized.  Based on the detailed prediction of binding sites 
involved in various steps, one can imagine a variety of biological experiments that might 
test our QM and HierDock results.  Thus elective mutations could be made to enhance or 
inhibit various steps.  These results suggest a number of experimental tests and provide a 
guideline for how to build biomimetic nanoscale systems to producing HOOH (or 
HOOOH).    
These computational studies provide mechanistic insight to the experimental 
observations by Wentworth et al. that antibodies and TCR can catalyze the conversion of 
1O2 plus water to H2O2.  The results gives very close agreement with observed isotope 
ratio of 2.2:1.  In particular the results explain the observed molecularity of 2.0 for the 
number of HOOH produced per 1O2.  This supports strong support for the QM 
mechanism. 
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I1 
VL             VH 
I2 
VL           VH 
I3 
CL              CH1 
Ser 48 Gln 3 Asp 1 Lys 45 Val164 Leu 147 
Lys 50 Leu 4 Pro 100 Glu 47 Leu 165 Lys 149 
Arg 51 Gly 107 Tyr101 Trp 48 Asn 166 Phe 172 
 Ser 108 Thr 102 Asn 61 Ser 167 Ala 174 
 Trp 109  Pro 62 Ser 181 Pro 173 
 Gly 110  Ser 63 Ser 182 Val 175 
    Thr 183 Tyr 181 
     Thr 182 
     Leu 183 
     Ser 184 
 
 
 
 
 
Table III-1 : List of residues in the 4c6 Fab structure in the three 
predicted binding sites I1, I2 and I3 of the HOOOH dimers. The bold 
face residues are strictly conserved across 37 aligned sequences of Fab. 
The residues in italics are conservative replacements.  
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Figure III-1.  Gas phase structures (optimized using quantum mechanics, see reference 
[3]) for various clusters and transition states.  These structures were used in the docking 
studies.    
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Figure III-2. (a) Clustering sites for docking of HOOOH dimers.  All sites are located 
between the VL and VH interface.  This shows Regions I1 and I3 in front.  Region I2 is 
opposite region I1 in the back.  The inset shows where this region is relative to the overall 
immunoglobulin.  Regions I1-I3 are in the Inter Greek Key Domain Interface (IGKD) 
unique to antibodies and TCR. (b) Clustering sites for docking of H2O2.  Region P1 is 
situated within the Beta-barrel created by the VH and VL interface.  P2 is located between 
the CH and CL interface.  Regions P1-P2 are in the Inter Greek Key Domain Interface 
(IGKD) unique to antibodies and TCR. 
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Figure III-3. (a) The purple dots indicate two regions (A and B) of the Fab antibody 
fragment that bind strongly to the HOOOH dimer and which we conclude are plausible 
regions for the catalysis of 1O2 plus H2O dimer to form HOOOH.  Here A is on the left 
and B is on the right.  These sites are at the interface of the VH and VL in a region 
containing well-ordered crystallographic waters (shown with half bonds).  Regions A and 
B are in the Inter Greek Key Domain Interface (IGKD) unique to antibodies and TCR.  
The inset shows a schematic antibody structure with a yellow circle to indicate the region 
magnified.  (b) The structure in (a) is rotated 90º about the horizontal axis to show the 
hydrophobic channel bounded by Gln38 from VL and Gln39 from VH.  This forms a 
hydrogen bond network at the mouth of the barrel.  (Region A is again at the left)  The 
inset shows the barrel like structure (containing two Greek keys) unique to antibodies that 
we suggest is critical to the catalysis.    
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Figure III-4: Ordered water molecules found in the crystal structure at the IGKD 
interface of the Fab antibody fragment.  (a) A pentamer ring of H2O molecules with each 
hydrogen bonded to two others.  (b) An example water dimer where hydrogen from one 
water molecule is pointing towards the oxygen of the other molecule 
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Figure III-5.  The geometric pathway for the sequence of reactions converting 1O2 and 
water to HOOOH and then to HOOH.  Here we assume that 1O2 enters the hydrophobic 
region near Xe1 (and Xe2).  At I1 (or I2) it can react with a water dimer (or trimer) to 
form HOOOH.  The HOOOH may stay at I1 (or I2) but it may go to I3, which does not 
have crystallographic waters.  This HOOOH may react directly with a second 1O2 or with 
the HOOOH from a previous reaction to form the HOOOH dimer.  This may occur at I3.  
The HOOOH dimer can rearrange through a series of steps to form HOOH, which may 
go to sites P1 or P2 (there are no crystallographic waters at these points).  Here the 
HOOH is positioned close to the region at which antigen may be bound (HOOOH may 
also go to this region).  From here the HOOH (or HOOOH) might react directly with the 
part of a protein whose antigen is recognized by the antibody. 
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Abstract 
In vivo incorporation of amino acids in protein biosynthesis is a precisely 
controlled mechanism.   The accuracy of this process is controlled to a significant 
extent by a class of enzymes called the aminoacyl tRNA synthetases.   Aminoacyl 
tRNA synthetases achieve this control by a multi-step identification process that 
includes “physical” binding and “chemical” proofreading steps.   However, the 
degree to which each synthetase uses these specificity-enhancing steps to distinguish 
their cognate amino acid from the non-cognate ones vary considerably.   We have 
used Hier-Dock computational protocol to elucidate this binding mechanism in 
methionyl tRNA synthetase (MetRS) by first predicting the recognition site of 
methionine in the apo form of methionyl tRNA synthetase (apo-MetRS).   We have 
developed this generalized procedure, which can be used to search for ligand binding 
region in globular proteins with no prior information about the binding site.   We have 
further investigated the specificity of MetRS towards the binding of 19 other natural 
amino acids to both apo-MetRS and to the co-crystal structure of MetRS with 
methionine bound to it (co-MetRS).   We have established through our computed 
binding energies that the discrimination towards the non-cognate substrate increases 
in the second step of the physical binding process that is associated with a 
conformation change in the protein.    
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 Introduction 
Specific recognition of amino acids by their corresponding tRNAs and 
aminoacyl-tRNA synthetase (aaRS) is critical for the faithful translation of the 
genetic code into protein sequence information.   The aaRSs catalyze a two-step 
reaction in which amino acids are esterified to the 3? end of their cognate tRNA 
substrates [1].   In the first step, the amino acid and ATP are activated by the aaRS to 
form an enzyme-bound aminoacyl-adenyla te complex.   In the second step, the 
activated amino acid is transferred to the 3?-ribose of the conserved CCA-3? end of 
the cognate tRNA.   The fidelity of protein synthesis depends, in part, on the accuracy 
of this aminoacylation reaction.   aaRSs bind their cognate amino acid through a 
multi-step recognition process and correction mechanisms that include physical 
binding and a chemical proof reading [2].   The four major steps involved in the 
transfer of aminoacyl group to the t-RNA are: 
1.   Binding of amino acid and ATP 
2.  Conformational change in the aaRS induced by binding and formation of the 
aminoacyl-adenylate complex.    
3.  Proof reading of misactivated non-cognate aminoacyl adenylate complex 
4.  Transfer of aminoacyl to the tRNA and proof reading  
The physical binding of the amino acid and ATP to aaRS is achieved in steps 1 
and 2, which is accompanied by a conformation change in the aaRS.  However, this 
binding event is necessary but not sufficient for the incorporation of the analog or the 
cognate amino acid during protein biosynthesis.  Binding is followed by chemical 
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proof reading steps 3 and 4 which are termed as the pre-transfer and the post-transfer 
proof reading steps, respectively.  With every step, the aaRS recognizes its cognate 
amino acid with increased specificity, while discriminating more efficiently against 
the non-cognate amino acids.  However, the degree to which each aaRS uses the 
specificity enhancing steps varies considerably with regard to the twenty naturally 
occurring amino acids and the type of aaRS.  For example, tyrosyl t-RNA synthetase 
has the highest specificity in the first binding step whereas isoleucyl tRNA 
synthetase, achieves maximum discrimination in the pre-transfer proofreading step 
[3-6].   
Many research groups have focused on the use of in vivo methods for 
incorporating the non-natural amino acid analogs into proteins.  It has been 
demonstrated that the wild-type translational apparatus can use non-natural amino 
acids with fluorinated, electroactive, unsaturated and other side chain functions [7-
13].  However, the number of amino acids shown conclusively to exhibit translational 
activity in vivo is small, and the chemical functionality that has been accessed by this 
method remains modest.  Only those analogs that are able to successfully circumvent 
the multi-step filter mechanisms of the natural synthetases eventually get 
incorporated.   
With an increase in efforts of incorporating artificial amino acids in vivo, it has become 
vital to enhance our understanding of the molecular level mechanism at different steps 
that aaRSs utilize to ensure high fidelity in translation.  A better understanding of this 
mechanism will also be very useful in allowing us to design mutants of aaRS for 
incorporation of specific analogs and also in suggesting analogs that are more efficiently 
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incorporated [14-16].  In this study, we have implemented a computational procedure to 
gain insight into the binding mechanism of methionyl- tRNA synthetase (MetRS).  
Computational methods are becoming increasingly important to understand the molecular 
level mechanisms that are not feasible with experiments and also for faster virtual 
screening of analogs prior to synthesis.   
MetRS is a class I aaRS, and undergoes a large conformational change on 
upon binding to methionine.  It is a dimeric protein and the crystal structures of E.  
coli MetRS in its apo form and as a co-crystal with its native ligand, methionine, have 
been solved to 1.85Å and 2.03Å resolution, respectively.  [We refer to the apo form 
of MetRS protein structure as apo-MetRS(crystal) and the co-crystal structure of E.  
coli MetRS with methionine as Met/MetRS(crystal).  Note that the protein 
conformations in both these crystal structures are different especially in the binding 
site.  The symbol MetRS always denotes the E.  coli  MetRS unless otherwise 
specified.  ] Both in vivo incorporation of methionine analogs into proteins and their 
in vitro measurements of the rate of incorporation have been studied extensively and 
it has been demonstrated that MetRS is one of the more permissive aaRS for the 
incorporation of a large number of analogs [9].  We are interested in computationally 
determining the specificity of MetRS for the natural non-cognate amino acids and 
methionine analogs in the steps of amino acid recognition and binding.  A better 
understanding of its binding mechanism would be useful to streamline a virtual 
screening approach for the incorporation of non-natural amino acids.   
We have used the HierDock computational protocol to first predict the 
binding site of methionine in MetRS in the apo-MetRS (crystal) [17].  We scanned 
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through the entire protein (except the anticodon recognitio n region) for predicting the 
preferential binding site for methionine using no knowledge from the crystal structure 
of Met/MetRS (crystal).  We refined the HierDock protocol and derived what we call 
as the “recognition site” which includes all the residues in the binding pocket of 
methionine as seen in Met/MetRS (crystal) however, methionine is oriented in this 
pocket with its side chain exposed to solvent.  Our results indicate that the first step to 
amino acid binding is the recognition of the zwitterion part of the ligand which is 
referred to as the “recognition mode”.  We find that apo-MetRS is able to distinguish 
methionine  from the non-cognate natural amino acids but has cysteine and serine as 
competitors.  We also find that MetRS in the Met/MetRS (FF) protein structure has 
better discrimination for the twenty amino acids and once again methionine has the 
best binding energy in this structure with Gln as a close competitor.   
The calculated binding energies of methionine analogs are correlated with 
either the in vivo incorporation results or the in vitro measurements of rate of the 
aminoacyl adenylate formation.  We find that in Met/MetRS (FF) protein, the analog 
with high incorporation rates bind better than those that do not get incorporated.  In 
an attempt to incorporate novel methionine analogs Kiick et al. reported that 
Homopropargylglycine (myag) replaces methionine most efficiently  utilizing the 
natural translation apparatus of E.  coli while cis-crotglycine (ccg) shows almost no 
incorporation [18].  Our calculated binding energies correlate well with the in vivo 
incorporation trends exhibited by these analogs and with the binding energies 
calculated by in vitro methods.   
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Methods  
Preparation and Optimization of Structures.   
Ligand Structures:  Both the neutral and the zwitterion forms were used for all the 
twenty natural amino acids as well as the five methionine analogs.  The ligand 
conformations were optimized in the extended conformation at the Hartree-Fock level 
of theory with a 6-31G** basis set, including solvation according to the Poisson-
Boltzman functional using the Jaguar computational suite [19] (Schrödinger, 
Portland,  OR).  The Mulliken charges ascertained from this calculation were retained 
for the subsequent molecular mechanics simulations.  The conformations of the 5 
methionine analogs are shown in Figure IV-4a.   
Preparation and Optimization of Protein Structures: The 2.03Å E.  coli apo-MetRS 
structure was obtained from PDB database  (pdb code: 1QQT) that included the fully 
active monomer a chain of a homodimer, crystal waters, and a zinc (II) ion [20].  
CHARMM22 charges with the nonpolar hydrogen charges summed onto the heavy 
atoms were assigned to the a chain according to the parameters set forth in the 
DREIDING force field [21].  The protein was neutralized by adding counterions (Na+ 
and Cl-) to the charged residues (Asp, Arg, Glu and Lys) and subjected to a 
minimization of the potential energy by the conjugate gradient method using Surface 
Generalized Born continuum solvation method [22].  The RMS in coordinates 
(CRMS) of all atoms after minimization is 0.68Å and this structure is referred to as 
apo-MetRS(FF).  Using the same procedure the co-crystal structure of E.  coli MetRS 
(pdb code: 1F4L; resolution 1.85Å) was minimized and the CRMS for all atoms of 
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the minimized structure compared to the crystal is 0.57Å [23].  We refer to this 
structure as met/MetRS(FF).  The CRMS values for both the structures are well 
within experimental error that demonstrates the proficiency of the FF used in present 
studies.  The crystal waters and other bound molecules were removed for docking to 
maximize the searchable surface of the protein.  We have used continuum solvation 
method for all structure optimizations and energy scoring in this study with an 
internal protein dielectric constant of 2.5 was employed for all calculations.   
HierDock Protocol 
     We use the HierDock procedure, which has been applied successfully to study 
the binding of odorants to membrane-bound olfactory receptors [17, 24] for outer 
membrane protein A binding to sugars [15] and for Phenylalanine and its analogs 
binding to PheRS [25], [26].  The HierDock ligand screening protocol follows a 
hierarchical strategy for examining conformations, binding sites and binding energies.  
Such a hierarchical method has been shown to be necessary for docking algorithms 
[27].  The steps in HierDock involve using coarse grain docking methods to generate 
several conformations of protein/ligand complexes followed by molecular dynamics 
(MD) simulations including continuum solvation methods performed on a subset of 
good conformations generated from the coarse grain docking.  Methods combining 
docking and MD simulations have been tested [28] but the main drawback of these 
tests were that only a single protein/ligand complex structure was kept from the 
coarse grain docking methods for MD simulations.  This is risky considering that the 
coarse grain methods do not have reliable scoring functions that include solvation.   
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Free energy perturbation methods are generally regarded to lead to accurate free 
energies of binding but are computationally intensive and not readily applicable to a 
wide variety of ligands [29].  Our goal is to derive a fast hierarchical computational 
protocol that uses hierarchical conformation search methods along with different 
levels of scoring functions, which would allow screening of amino acid analogs for 
aaRSs.  The three major steps in HierDock procedure in this paper are: 
· First, a coarse grain docking procedure to generate a set of conformations for 
ligand binding.  In this paper we used DOCK 4.0 [30, 31] to generate and 
score 20000 configurations, of which 10% were ranked using the DOCK 
scoring function.   
· We then select the 20 best conformations for each ligand from DOCK and 
subject them to annealing molecular dynamics (MD) to further optimize the 
conformation in the local binding pocket, allowing the atoms of the ligand to 
move in the field of the protein.  In this step the system was heated and cooled 
from 50K to 600K in steps of 10K (0.05 ps at each temperature) for 1 cycle.  
At the end of annealing MD cycle, the best energy structure is retained.  
Annealing MD allows the ligand to readjust in the binding pocket to optimize 
its interaction with the protein.  This fine grain optimization was performed 
using MPSim [32] with DREIDING forcefield [21] and continuum solvation 
methods.  We use the SGB continuum solvent method to obtain forces and 
energies resulting from the polarization of the solvent by the charges of the 
ligand and protein.  This allows us to calculate the change in the ligand 
structure due to the solvent field and hence, obtain more realistic binding 
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energies that take into account the solvation effects on the ligand/protein 
structure.  The annealing MD procedure generated 20 protein/ligand 
complexes for each ligand.    
· For the 20 structures generated by annealing MD simulations for each ligand, 
we minimized the potential energy (conjugate gradients) of the full 
ligand/protein complex in aqueous solution using SGB.  This step of 
protein/ligand-complex optimization is critical to obtaining energetically good 
conformations for the complex (cavity + ligand).  Then we calculated binding 
energies as the difference between the total energy of the ligand-protein 
complex in solvent (DG(protein+ligand)) and the sum of the total energies of 
the protein (DG (protein)) and the ligand separately in solvent (DG(ligand)).  
The energies of the protein and the ligand in solvent were calculated after 
independent energy minimization of the protein and the ligand separately in 
water.  Solvation energies were calculated using Poisson-Boltzmann 
continuum solvation method available in the software Delphi [33].  The non-
bond interaction energies were calculated exactly using all pair interactions.  
Thus the binding energy is given by 
              )()()( ligandGproteinGligandproteinGGcalc D+D-+D=DD        (1) 
Since the structure optimizations included solvation forces using the SGB 
continuum solvent approximation with the experimental dielectric constant, we 
consider that the calculated energies are free energies [34].  This multi-step 
scanning procedure is based on docking via DOCK 4.0 coupled with fine-grain 
MM techniques.  The coarse grain docked complex structures generated are 
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scored with FF and differential solvation, which effectively filters the docked 
complexes to isolate the top contenders.  As demonstrated in Kekenes-Huskey 
2002, Dock 4.0 structures vary erratically with rank, whereas filtering with 
MPSim optimization brings the best structures to the top of the rank list.   
Scanning the entire apo-MetRS(FF) for predicting binding site of met: For the 
case of apo-MetRS(FF) we wanted to test the HierDock procedure for scanning 
the entire protein for the favorable binding site of met.  However, it has not been 
tested for a case where the protein undergoes a large conformational change in the 
binding site after the ligand binding starting from apo-protein structure.  The steps 
involved in the scanning procedure are: 
1. Mapping of possible binding regions.  A probe of 1.4 Å radius was used to 
trace a 4 dots/Å negative image of the protein molecular surface, 
according to Connolly’s method [35].  The resulting data was used to 
generate clusters of overlapping spheres with the SPHGEN  program.  
These spheres serve as the basis for the docking method.   
2. Definition of docking region.  The pockets of empty space of the receptor 
(apo-MetRS(FF)) surface represented by spheres were divided into 14 
possible 10 Å wide overlapping cubes, which covered the entire protein 
surface.  Each region was scanned to determine its suitability as a binding 
site.  The site that contains the greatest number of lowest energy docked 
conformations is designated as the putative binding region.   
3. Prediction of binding site:  Steps 1 to 3 of HierDock procedure was 
performed with methionine as the ligand in all the 14 possible binding 
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regions in the entire apo-MetRS(FF).  The orientations of the ligand in the 
receptor were generated by DOCK 4.0, using flexible docking with 
torsional minimization of the ligand, a continuum dielectric of 1.0 and a 
distance cutoff of 10 Å for the evaluation of energy.   
4. Selection of the most probable binding site and best configurations: The 
best conformation from each region was determined using the buried 
surface area cutoff criteria for the ligand along with the binding energy.  
Such a buried surface area cutoff is required for filtering at the coarse 
grain level.  An average of the most buried and the least buried conformer 
was calculated and all conformers whose buried surface area was lower 
than the average were eliminated from further analysis [36].  The 
conformations that passed the buried surface area filter were sorted by 
binding energies calculated using equation (1) and the conformation with 
the best binding energy in every region were compared between regions.  
All the complex energies were calculated.  The region with the lowest 
energy binding energy calculated using equation (1) was selected as the 
preferential binding region.   
Docking of ligand pool into the binding region and calculating relative 
binding energies:  Steps 1 to 3 of HierDock procedure was performed for all 
the ligands in the ligand pool in the putative binding region and the relative 
binding energies for the best ligand conformations were calculated using 
equation (1).  The ligands (20 natural amino acids and analogs of met) were 
ranked according to binding affinities to determine which ligands have the 
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highest affinity for the binding site.  The best energy conformation of 
methionine in optimized apo-MetRS(FF) structure is the predicted structure of 
methionine in apo-MetRS(FF).  We denote this predicted structure as 
met/apo-MetRS(FF).   
Prediction of binding site for met/MetRS(FF) co-crystal structure: For the 
case of met/MetRS(FF) structure, the receptor was prepared by removing the 
methionine from the met/MetRS(FF) structure.  The protein surface was 
mapped with spheres, as described above, and the binding regions was 
covered by a 12 Å ´ 12 Å ´ 12 Å box centered in the center of mass of 
methionine ligand.  Only this region was used in subsequent docking.  Steps 1 
to 3 of HierDock procedure were performed using the same set of control 
parameters but only in the known binding region.  The conformation with the 
best energy binding energy in this region calculated using equation (1), 
starting from the protein structure in met/MetRS (FF) is the predicted co-
crystal structure of met/MetRS.  We denote this predicted structure of 
methionine in MetRS co-crystal structure as met/MetRS (HierDock).   
Docking of ligand pool into the binding site and calculating relative binding 
energies in met/MetRS (HierDock) We performed steps 1 to 3 of HierDock 
procedure for all 20 natural amino acids and the methionine analogs in the 
12Å x 12Å x12Å binding region and the relative binding energies for the best 
ligand conformation for each ligand was calculated using equation (1).  The 
ligands (20 natural amino acids and analogs of met) can then be ranked 
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according to binding affinities to determine which ligands have the highest 
affinity for the binding site.   
Binding energy calculation of the 20 natural amino acids and methionine 
analogs in the  conformation that activates the protein: HierDock protocol 
predicts the best energy conformation for each ligand (20 natural amino acids 
and methionine analogs) in the defined 12Å x 12Å x 12Å binding region in 
Met/MetRS(FF) structure.  These predictions give rise to different preferred 
binding conformation for each ligand.  However, the orientation that 
methionine  adopts in the makes the necessary contacts required for the 
enzymatic activity is referred to as the “activation mode”.  To assess the 
relative binding energies of the twenty natural amino acids and their analogs 
in the activation mode perturbation calculations for all the ligands were 
performed as follows: 
· An amino acid rotamer library [37] was used to generate all the conformations 
of each amino acid in the binding site, and a similar library was generated for 
the five methionine analogs.   
· The best rotamer was chosen by matching each rotamer k in the binding site 
and evaluated with the following equation using the Dreiding force field: 
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where i and j sum over all atoms in the ligand and protein residue residues in the 
binding site, qi and qj are partial charges on atoms i and j, respectively.  rij is the 
distance between atoms i and j, and rm and De are van der Waals distance and well 
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depth of atoms i and j, rHB and DHB are hydrogen bond distance and well depth, 
respectively.  q is the hydrogen bond angle between atoms i, j and their bridging 
hydrogen atom.  The hydrogen bond term is only evaluated for hydrogen bond 
donor and acceptor atoms.  To avoid over penalizing clash, the van der Waals 
radii were reduced to 90% of the standard values in the Dreiding force field.   
· After the best rotamer was chosen for each ligand, the total energy was   
minimized in the presence of protein, and the binding energy was then 
calculated using equation (1) for each of the twenty natural amino acids in the 
“activation mode” and compared.   
Results and Discussion 
Prediction of Binding site of methionine in apo-MetRS(FF) and Met/MetRS(FF) 
 Figure IV-1 shows the location of region14 box in apo-MetRS(FF) which  was 
determined to be the binding region by  sifting through the 14 regions in apo-MetRS.  
The best conformation of methionine in this region shows methionine to be making 
electrostatic interactions with His301 and Asp52 (Figure IV-3c), the two amino acids 
that have been shown to play a significant role in methionine binding [38, 39].  His 
301 to alanine mutation results in loss of the affinity for methionine and D52A 
mutation reduces the Kcat of the adenylation reaction by 4 folds indicating that it has 
a major role on the catalytic step in the formation of methionyl adenylate.  Tyr15, 
another key amino acid determined by mutation analysis and has been structurally 
observed in the co-crystal structure to form the binding pocket for methionine [40], 
[23] is located within 5Å of the docked methionine.  The main component of the 
binding energy in our predicted binding orientation comes from the electrostatic 
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interactions tha t methionine makes with Asp52 and His 301 followed by its Van der 
Waals interactions in this binding region.   
 The docked orientation in the apo enzyme occupies the identical position in 
the binding pocket as seen in the co-crystal structure (Figure IV-3a).  However the 
orientation of methionine and the residues lining the binding pocket including parts of 
the protein backbone are very different in the two conformations of MetRS.  
Although methionine seems to be making electrostatic contact with Asp52 the 
anchoring residue, the side chain of methionine is not buried in the 7Å pocket.  The 
reason for this is that we have used the unbounded structure of the synthetase, which, 
on binding to the amino acids undergoes significant conformation change.  The co-
MetRS structure suggests that the large solvent exposed cavity become reduced in 
volume as it gets partially filled with methionine and Y15, W253, F300, W229, F304 
and Y251.  These residues are significantly displaced from their apo-enzyme 
orientation as they reorient to form a hydrophobic pocket for methionine.  In our 
predicted binding mode of methionine in the apo-enzyme, all these residues are 
within 5Å of methionine ligand.  We expect this to be the initial binding orientation 
of methionine.   
        Another interesting observation that substantiates that the predicted orientation 
of methionine could be the initial binding mode is that methionine has one of the best 
binding energies of all 20 natural amino acids in this region.  The specificity of this 
site further confirms that we have been able to find the correct binding region.  
Methionine has serine and cysteine as close competitors but they get eliminated as the 
protein undergoes conformation change.  In an attempt to force the side chain of 
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methionine to be buried in the pocket we did annealing dynamics of the entire 
complex with solvation and reduced VDW radii of the ligand atoms.  However, the 
orientation of methionine did not change.   
 Also, a number of residues within 5Å of methionine in this region are 
conserved among a large number of organisms.  In a sequence alignment among 59 
prokaryotes we find all the amino acids within 4Å of methionine in the predicted 
binding region are either strictly conserved or are conserved replacements.  Of the 12 
residues within 4Å of methionine, 7(Y15, D52, V252, W253, A256, Y260, H301) are 
strictly conserved and 5 (A12, L13, P14, P257, F300) are conserved replacements 
(Figure IV-3c).  This is interesting considering that there are only 21 positions in the 
entire alignment that are strictly conserved and we find a third of them in our 
predicted binding region without any prior knowledge of the binding site.  A binding 
search protocol for unliganded proteins followed by a sequence alignment analysis 
for the predicted binding region could provide more evidence on the accuracy of the 
predicted binding site and help in recognizing key amino acids lining binding pocket.  
Generally, one would expect to see conserved residues or conservative replacements 
in substrate binding sites in proteins across various species.   
 We also docked methionine in the binding region of the co-MetRS(FF).  This 
test was performed to check if we were able to predict the crystallographic binding 
orientation of methionine in the binding pocket.  This test was important to validate 
the accuracy of our docking protocol and the force field.  Our predicted structure had 
a CRMS deviation of 0.55Å from the crystal structure (Figure IV-3a).   
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IV b.    Specificity for methionine in 1QQT and 1FTM 
 We docked all 20 amino acids and calculated their binding energies in the 
predicted binding region in apo-MetRS(FF) and the crystallographic binding site in 
Met/MetRS(FF).  We also did perturbation studies of the natural amino acids in these 
two structures.  The perturbation studies were done to analyze the binding energies of 
the non-cognate amino acids if they oriented in a similar conformation in the binding 
site as methionine.   
Perturbation analysis : In the case of apo-MetRS(FF) closest competitors for 
methionine are serine and cysteine.  However, as the enzyme undergoes conformation 
change, its ability to discriminate against these non-cognate residues increases 
significantly.  It has been noticed that for most synthetases there is no absolute 
specificity for the cognate substrate in the sense of a “lock and key” model.  For 
example, Yeast IleRS is not able to distinguish between Trp and Ile in the first step of 
binding because of the higher hydrophobic interactions gained by the non-cognate 
substrate.  However, as the initial binding process is completed, the enzyme is able to 
discriminate against the non-cognate amino acids more easily [2, 5].   
In Met/MetRS(FF), methionine has the best binding energy, and it has an energy 
difference of more than 20 kcal/mol with its closest competitors, Asn and Arg.  The 
closest competitors from the first binding step (Leu, Glu and Gln) are discriminated 
against with a very high efficiency as the structure of the protein changes.   
Docking analysis: The docking study was done predominantly to recognize possible 
competitors of methionine.  It may be possible that a non-cognate amino acid binds at 
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the methionine binding pocket but does not make the critical interactions that 
methione makes in this binding pocket.  In such cases, the amino acid may not be able 
to react with ATP and charge the tRNA.  In apo-MetRS(FF), methionine has the best 
binding energy of –26.38 kcal/mol  with leucine glutamine and glutamate as the 
closest competitors.  In Met/MetRS(FF) methionine again has the best energy with 
glutamine and serine as the closest competitors.  Gln, in its preferred binding site in 
Met/MetRS(FF) has its zwitterions part and the ?1 torsional angle in the same 
orientation as methionine at this site.  Yet, its ?2 and ?3 angles are significantly 
different from that of methionine.  The Sd of methionine makes two hydrogen bonds – 
one with the terminal oxygen of Tyr260 and the other with the backbone amide of 
Leu13.  However, because of the difference in its binding mode, Gln is unable to 
make a hydrogen bond with Tyr260 and makes only a weak hydrogen bond with the 
backbone amide of Leu13 (O—H-N distance of 3.9Å).   
 
 One more observation is that the order of binding of the amino acids is 
identical in the docking analysis in apo-MetRS(FF) and the perturbation study in 
Met/MetRS(FF).  It indicates that when the enzyme undergoes structural change, if all 
the amino acids were to bind in the binding mode of methionine in the co crystal 
structure, their order of binding would remain the same as indicated by the apo 
enzyme.  However, the magnitudes of binding energies, which indicate the level of 
discrimination, would be very different.   
 
IV c.   Binding energies of analogs   
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 To test the sensitivity of our simulation procedure, we wanted to test if we 
could get good correlation between the computed binding energies for the methionine 
analogs with experimental binding energies.  We tested five methionine analogs of 
which four get incorporated into proteins with reasonable efficiency and for which the 
experimental binding energies are available.  Ccg, which is a cis- form of tcg (Figure 
IV-4a), has the lowest incorporation efficiency and hence, it was used as a negative 
control for which we hoped to get the worst binding energy for this analog.  Binding 
energy calculations of the methionine analogs were carried out in the conformation 
that activates the protein, i.  e.  , by perturbation analysis.   
     In the case of 1QQT, the binding energies of the analogs are all in the top 50% but 
are interspersed with the non-cognate natural amino acids This indicates that in this 
conformation, MetRS lack the capability to discriminate efficiently (Figure IV-4d).  
However, in the co-crystal structure, there is a clear preference for binding the 
analogs.  The analogs and methionine have a binding energy range of  -63.4 to -79.1 
kcal /mol (Figure IV-4b).  The closest competitor from the non-cognate set of natural 
amino acids has a binding energy of  -35.0 kcal/mol.  In this conformation, we also 
find a good correlation between experimentally observed binding energies and 
computed binding energies (Figure IV-4c).  As we had expected, ccg has the worst 
binding energy and gets incorporated with the lowest efficiency whereas myag has 
the best computed binding energy and has been tested to be the most best methionine 
analog.  This information could be useful for initial computational scanning of the 
analogs before experimental testing.  The binding energy of ccg in 
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Met/MetRS(FF)could be used as a cutoff for  designing new analogs and the ones that 
rank above the cut off could be experimentally tested for binding.   
 We analyzed the binding modes of ccg and tcg to understand what in 
particular about the cis-form of the ligand renders it to be an unfavorable ligand.  We 
analyzed the non-bond energies of these ligands with all the residues lining the 
binding pocket and have tabulated our findings as pairwise interactions in Table 1. 
Ccg has a VDW clash with Ala12, the terminal hydroxyl group of Tyr260 and 
His301.  At the same time, the cis orientation of terminal methyl group does not make 
the same favorable interactions with Ala 256 and Pro 267 as tcg (Figure IV-5).  Since 
Tyr 260 and His 301 have an important role in the binding process as indicated by 
experiments, mutating them to smaller residues may be deleterious.  On the other 
hand, it would be interesting to explore the effect of Ala to Gly mutation at position 
12 on the incorporation of cis forms of various analogs.   
 MetRS has been observed to be extremely promiscuous and is able to 
incorporate substrates that are up to 340000 folds poorer than methionine.  This could 
be attributed to the conformational flexibility of the active site of metRS that has not 
been modeled in our simulation.  The active site conformation could be different for 
different analogs.  However, we have performed our perturbation studies only on the 
co-metRS bound to the natural substrate.  The active site flexibility may be important 
in enabling MetRS to activate methionine analogs with varying side chain 
functionalities.  One more consideration is that we are comparing our simulated 
binding energies to experimentally derived binding energies that are further derived 
from ATP-PPi exchange studies.  ATP binding could have other structural effects on 
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the enzyme that were not modeled in our simulations.  However, it is interesting to 
note that we are able to get reasonably good correlation even with the limitations in 
the simulations.  One can expect to gain more insights into the mechanism of this 
system with advancements in the simulation procedures.   
 
Conclusions  
 We have studied the specificity of MetRS for methionine in the first two steps 
of the binding process.  We have demonstrated that its specificity increases in the 
second binding step where the enzyme undergoes a significant conformational 
change.  We speculate that methionine first anchors to residues Asp52 and His301 
with its side chain and as the protein undergoes conformation change due to substrate 
binding (either the amino acid, ATP, or both), the cavity opens up and methionine 
flips into the cavity.  Multi-step binding mechanisms where the ligand-protein 
complexes display “induced-fit” have been illustrated in other protein.  This has been 
attributed to the presence of energy gradients, or funnels, near the binding sites - the 
binding process initiates from a higher energy conformer and terminates in lower 
energy conformation [41].   
        When the structure to be docked is taken from the crystallized co-complex, 
predicting the fitted association is relatively straightforward as indicated by the 
docking study using met/metRS.  Our study with the apo-MetRS illustrates that 
although determining the final bound conformation starting with the “free”, 
“unbound” state of the enzyme is extremely difficult, a refined search method can be 
applied to predict the correct binding region for the ligand.  The predictions can be 
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used to indicate the important residues in the binding regions that can be further 
tested by mutations studies.  Therefore, for those enzyme crystal structures that are 
not co-crystallized with their substrates a powerful docking protocol, like HierDOCK 
can prove to be very useful in recognizing the binding region, even in cases where the 
protein is very flexible.  If the molecules are relatively rigid and have smooth binding 
funnels with single or few minima, there is a higher likelihood that the docked 
conformation of the ligand in the “free”, “unbound” state is the correct bound 
conformation since the conformational diversity of the protein is limited [42].  But in 
the case of proteins that undergo significant conformation changes on associating 
with the ligand, it is unlikely that the predicted ligand plus protein complex would be 
the correct structure.  In the case of a flexible protein, like MetRS, that has a larger 
conformational diversity, achieving a correct prediction bound conformation is 
complicated since the bound conformation could be very different from the free, 
unbound structure.  However, the complex predicted with the apo enzyme should be 
regarded as an important “recognition mode” for the system, a key step in its multi-
step binding process, since even at this stage of binding it could show some level of 
discrimination.  In apo-MetRS, both docking and perturbation analysis indicate that in 
this conformation the enzyme is able to eliminate more than 60% of the natural amino 
acids.  One could imagine that if the final bound complex after the change in 
conformation was the only filtering mechanism for an enzyme, each amino acid 
would first have to bind at this site, followed by the structural change in the enzyme 
and then get eliminated.  Such a process would be both time consuming and 
energetically expensive for the enzyme.  A first level of filter at the apo-enzyme 
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conformation certainly seems to be more efficient screening mechanism adopted by 
flexible enzymes.  It would be interesting to see how the procedure for binding site 
search performs in other apo-enzyme systems.  We have already tested it for the 
predicting the binding site of phe in thermus thermophillus PheRS by scanning the 
entire apo-crystal structure of PheRS and have been able to find the correct binding 
site (unpublished results).   
              Binding site dynamics in enzyme brings in the question of enzyme 
specificity.  An interesting observation about protein plasticity is that proteins 
displaying higher selectivity are also more rigid while those that more flexible can 
bind to a large number of substrates.  Considering the conformational flexibility in the 
MetRS, as indicated by the substantial structural change in the co-crystal, it is not 
surprising that it is one of the more permissive aminoacyl tRNA synthetases.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV-25 
References 
 
1. Ibba, M. and D. Soll, Aminoacyl-tRNA synthesis. Annu Rev Biochem, 2000. 
69: p. 617-50. 
 
2. Freist, W. Accuracy of protein biosynthesis: quasi-species nature of proteins 
and possibility of error catastrophes. J Theor Biol, 1998. 193(1): p. 19-38. 
 
3. Freist, W., H. Sternbach, and F. Cramer, Isoleucyl-tRNA synthetase from 
baker's yeast and from Escherichia coli MRE 600. Discrimination of 20 amino 
acids in aminoacylation of tRNA(Ile)-C-C-A(3'NH2). Eur J Biochem, 1987. 
169(1): p. 33-9. 
 
4. Freist, W., H. Sternbach, and F. Cramer, Isoleucyl-tRNA synthetase from 
baker's yeast and from Escherichia coli MRE 600. Discrimination of 20 amino 
acids in aminoacylation of tRNA(Ile)-C-C-A. Eur J Biochem, 1988. 173(1): p. 
27-34. 
 
5. Freist, W., H. Sternbach, and F. Cramer, Isoleucyl-tRNA synthetase from 
Escherichia coli MRE 600. Different pathways of the aminoacylation reaction 
depending on presence of pyrophosphatase, order of substrate addition in the 
pyrophosphate exchange, and substrate specificity with regard to ATP 
analogs. Eur J Biochem, 1982. 128(2-3): p. 315-29. 
 
6. Freist, W. and H. Sternbach, Tyrosyl-tRNA synthetase from baker's yeast. 
Order of substrate addition, discrimination of 20 amino acids in 
aminoacylation of tRNATyr- C-C-A and tRNATyr-C-C-A(3'NH2). Eur J 
Biochem, 1988. 177(2): p. 425-33. 
 
7. Deming, T.J., Fournier, M. J., Mason, T. L., & Tirrell, D. A., Biosynthetic  
Incorporation and Chemical Modification of Alkene Functionality in 
Genetically Engineered Polymers. J. Macromol. Sci. Pure Appl. Chem, 1997. 
A34: p. 2143-2150. 
 
8. van Hest, J.C. and D.A. Tirrell, Efficient introduction of alkene functionality 
into proteins in vivo. FEBS Lett, 1998. 428(1-2): p. 68-70. 
 
9. van Hest, J.C., Kiick, K. L., Tirrell D. A., Efficient Incorporation of 
Unsaturated Methionine Analogues into Proteins in Vivo. J Am Chem Soc, 
2000. 122: p. 1282-1288. 
 
10. Kothakota S, M.T., Tirrell DA, Fournier MJ, Biosynthesis Of A Periodic 
Protein Containing 3-Thienylalanine - A Step Toward Genetically-Engineered 
Conducting Polymers. Journal Of The American Chemical Society, 1995. 
117: p. 536-537. 
 
 IV-26 
11. Dougherty MJ, K.S., Mason TL, Tirrell DA, Fournier MJ, Synthesis Of A 
Genetically Engineered Repetitive Polypeptide Containing Periodic 
Selenomethionine Residues. Macromolecules, 1993. 26: p. 1779-1781. 
 
12. Budisa, N., Steipe, B., Demange, P. Eckerskorn, C., Kellermann, J., & Huber, 
R., High-Level Biosynthetic Substitution of Methionine in Proteins by its 
Analogs  2-Aminohexanoic Acid, Selenomethionine, Telluromethionine, and 
Ethionine in E. coli. Eur. J. Biochem, 1995. 230: p. 788-796. 
 
13. Duewel, H., Daub, E., Robinson, V., & Honek, J. F., Incorporation of 
Trifluoromethionine into a Phage Lysozyme: Implications and a New Marker 
for Use in Protein 19F NMR. Biochemistry, 1997. 36(3404-3416). 
 
14. Zhang, D., et al., Structure-based design of mutant Methanococcus jannaschii 
tyrosyl-tRNA synthetase for incorporation of O-methyl-L-tyrosine. Proc Natl 
Acad Sci U S A, 2002. 99(10): p. 6579-84. 
 
15. Datta, D., et al., A Designed Phenylalanyl-tRNA Synthetase Variant Allows 
Efficient in Vivo Incorporation of Aryl Ketone Functionality into Proteins. J 
Am Chem Soc, 2002. 124(20): p. 5652-3. 
 
16. Liu, D.R., et al., Engineering a tRNA and aminoacyl- tRNA synthetase for the 
site-specific incorporation of unnatural amino acids into proteins in vivo. Proc 
Natl Acad Sci U S A, 1997. 94(19): p. 10092-7. 
 
17. Floriano, W.B., Vaidehi, N., Goddard, W. A., Singer, M. S., Shepherd, G. M., 
Molecular mechanisms underlying differential odor responses of a mouse 
olfactory receptor. Proc Natl Acad Sci U S A, 2000. 97(20): p. 10712-6. 
 
18. Kiick, K.L., R. Weberskirch, and D.A. Tirrell, Identification of an expanded 
set of translationally active methionine analogues in Escherichia coli. FEBS 
Lett, 2001. 502(1-2): p. 25-30. 
 
19. Tannor, D.J., Marten B, Murphy R, Friesner RA, Sitkoff D, Nicholls A, 
Ringnalda M, Goddard WA, Honig B, Accurate First Principles Calculation 
Of Molecular Charge-Distributions And Solvation Energies From Ab-Initio 
Quantum-Mechanics And Continuum Dielectric Theory.     Journal Of The 
American Chemical Society, 1994. 116(26): p. 11875-11882. 
 
20. Mechulam, Y., et al., Crystal structure of Escherichia coli methionyl-tRNA 
synthetase highlights species-specific features. J Mol Biol, 1999. 294(5): p. 
1287-97. 
 
21. Mayo SL, O.B., Goddard WA, Dreiding - A Generic Force-Field For 
Molecular Simulations. Journal Of Physical Chemistry, 1990. 94(26): p. 8897-
8909. 
 IV-27 
22. Ghosh, A., Rapp, C. S., Friesner R. A., Generalized born model based on a 
surface integral formulation. Journal Of Physical Chemistry B, 1998. 102(52): 
p. 10983-10990. 
 
23. Serre, L., et al., How Methionyl-tRNA Synthetase Creates its Amino Acid 
Recognition Pocket upon l-Methionine Binding. J Mol Biol, 2001. 306(4): p. 
863-876. 
 
24. Vaidehi, N., et al., Prediction of structure and function of G protein-coupled 
receptors. Proc Natl Acad Sci U S A, 2002. 99(20): p. 12622-7. 
 
25. Wang, P., Vaidehi, N.,  Tirrell,  D. A,, and Goddard III, W. A., Virtual 
Screening for Binding of Phenylalanine Analogs to Phenylalanyl-tRNA 
Synthetase. J Am Chem Soc, 2002. (in press). 
 
26. Kekenes-Huskey, P., Vaidehi, N., Floriano,  W. B., Goddard III, W. A., 
Submitted. 2002. 
 
27. Halperin, I., Buyong, M., Wolfson, H., Nussinov, R., Principles of docking: 
An overview of search algorithms and a guide to scoring functions. Proteins : 
Structure, Function and Genetics, 2002. 47: p. 409-443. 
 
28. Wang, J.M., Morin, P., Wang, W., Kollman, P. A, Use of MM-PBSA in 
Reproducing the Binding Free Energies to HIV-1 RT of TIBO Derivatives 
and Predicting the Binding Mode to HIV-1 RT of Efavirenz by Docking and 
MM-PBSA. J. Am. Chem. Soc., 2001. 123: p. 5221-5230. 
 
29. Kollman, P.A., Free energy calculations: Applications to chemical and 
biochemical phenomena.  Chem. Rev., 1993. 93: p. 2395-2417. 
 
30. Ewing, J.A., Kuntz, I.D., Critical evaluation of search algorithms for 
automated molecular docking and database screening. J Comp Chem, 1997. 
18: p. 1175-1189. 
 
31. Ewing, T.J., Makino, S., Skillman, A.G., Kuntz, I.D., DOCK 4.0: search 
strategies for automated molecular docking of flexible molecule databases. J 
Comput Aided Mol Des, 2001. 15: p. 411-28. 
 
32. Lim, K.T., Brunett, S., Iotov, M., McClurg, R. B., Vaidehi, N., Dasgupta, S., 
Taylor, S., Goddard III, W. A.,   Molecular dynamics for very large systems 
on massively parallel computers: The MPSim program. Journal of 
Computational chemistry, 1997. 18: p. 501-521. 
 
33. Rocchia, W., Alexov, E., Honig, B., Extending the Applicability of the  
Nonlinear Poisson-Boltzmann Equation: Multiple Dielectric Constants and  
Multivalent Ions. J. Phys. Chem. B, 2001. 105: p. 6507-6514. 
 IV-28 
34. Hendsch, Z.S., Tidor, B., Electrostatic interactions in the GCN4 leucine 
zipper: substantial contributions arise from intramolecular interactions 
enhanced on binding. Protein Science, 1999. 8: p.  1381-1392. 
 
35. Connolly, M.L., Analytical Molecular-Surface Calculation. Journal Of 
Applied Crystallography, 1983. 16: p. 548-558. 
 
36. Stahl, M. and H.J. Bohm, Development of filter functions for protein- ligand 
docking. J Mol Graph Model, 1998. 16(3): p. 121-32. 
 
37. Bower, M.J., F.E. Cohen, and R.L. Dunbrack, Jr., Prediction of protein side-
chain rotamers from a backbone-dependent rotamer library: a new homology-
modeling tool. J Mol Biol, 1997. 267(5): p. 1268-82. 
 
38. Fourmy, D., et al., Identification of residues involved in the binding of 
methionine by Escherichia coli methionyl- tRNA synthetase. FEBS Lett, 1991. 
292(1-2): p. 259-63. 
 
39. Ghosh, G., et al., Activation of methionine by Escherichia coli methionyl-
tRNA synthetase. Biochemistry, 1991. 30(40): p. 9569-75. 
 
40. Kim, H.Y., et al., The relationship between synthetic and editing functions of 
the active site of an aminoacyl-tRNA synthetase. Proc Natl Acad Sci U S A, 
1993. 90(24): p. 11553-7. 
 
41. Zhang, C., Chen, J., DeLisi, C., Protein-protein recognition: Exploring the 
energy funnel near the binding sites. Proteins: Structure, Function and 
Genetics, 1999. 34: p. 255-267. 
 
42. Tsai, C.J., Kumar, S., Ma, B.,  Nussinov, R., Folding funnels, binding funnels, 
and protein function. Protein Sci, 1999. 8: p. 1181-1190. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV-29 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table IV-1.Energy analysis for CCG and TCG analogs 
 
                      CCG                          TCG 
Residue VDW Coulomb H-bond  VDW Coulomb H-bond 
ASP  52 
LEU  13 
TYR  15 
TRP 253 
ILE 297 
PRO  14 
HIS 301 
PRO 257 
ILE 293 
TYR 260 
ALA 256 
VAL 252 
ALA  12 
0.438 
-1.255 
-2.173 
-3.779 
-2.097 
-0.973 
-0.102 
-0.670 
-0.273 
-0.227 
-0.941 
-0.233 
-0.084 
-21.47 
-6.045 
-7.773 
-1.934 
-0.454 
-1.467 
-1.189 
-0.122 
-0.145 
-0.116 
0.616 
-0.025 
0.673 
-10.246 
-9.898 
-0.677 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
 0.364 
-1.762 
-3.282 
-3.779 
-0.967 
-1.931 
-1.216 
-1.486 
-1.110 
-1.780 
-1.414 
-0.227 
-0.144 
-21.427 
-6.142 
-6.162 
-1.879 
-1.585 
-0.526 
-1.074 
-0.080 
-0.232 
0.706 
0.601 
-0.047 
0.081 
-9.839 
-10.19 
-0.122 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
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Figure IV-1:  Sphere filled volume of MetRS representing the possible binding sites 
in the enzyme.The search volume was divided into 14 regions as indicated by the 
cubic boxes.The binding site was found in the box colored in red. 
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Figure IV-2: Binding energies of all 20 amino acids in the methionine binding site in 
Met/MetRS(FF) and apo-MetRS(FF).(a) shows binding energies of the 20 aminoacids 
when docked in the predicted methionine binding site in apo-MetRS(FF) and (b) 
shows the binding energies generated from perturbation analysis at the same site.(c) 
reports the binding energies generated from docking all 20 amino acids in the 
crystallographic methionine binding site in  Met/MetRS(FF) and (d) indicates binding 
energies calculated from perturbation analysis at the same site. 
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Figure IV-3(a) Binding site of methionine in apo-MetRS(FF) and 
Met/MetRS(FF).Amino acids lining the bind ing pocket are shown in purple for apo-
MetRS(FF) and in green for Met/MetRS(FF).Methionine orientation from 
perturbation analysis in Met/MetRS(FF) in shown in red and its conformation from 
docking in apo-MetRS(FF) is colored blue.Residues closest to methionine that 
undergo the largest conformation changes are labeled. 
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Figure IV-3(b) The Sd of methionine makes two hydrogen bonds – one with the 
terminal oxygen of Tyr260 and the other with the backbone amide of Leu13 in the 
docked conformation in Met/MetRS(FF).The crystal structure orientation on 
methionine is shown in blue.The CRMS between the two conformations is 0.55 Å. 
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Figure IV-3(c) The predicted binding site for methionine in apo-MetRS(FF).The 
conserved residues within 4 Å are labeled in gold and the conserved replacements are 
labeled in aqua. 
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Figure IV-4: (a) Structures of methionine and its analogs used in this study.L-
methionine (met), homoallylglycine (mhag), homopropargylglycine (myag), 
norleucine (nleu), trans-crotglycine (tcg) and  cis-crotglycine (ccg). 
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Figure IV-4 (b) Binding energies of the analogs in the binding site of Met/MetRS(FF) 
calculated using perturbation method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV-43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
myag
tcg mhag
nleu
ccg
-20
-10
0
10
20
30
D
D
G
 k
ca
l/m
ol
 
 IV-44 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV-4(c) shows the correlation between the calcula ted binding energies and the 
experimentally observed ??G with respect to methionine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV-45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                           
R2 = 0.8604
3.5
4
4.5
5
5.5
6
6.5
7
-80 -75 -70 -65 -60
MYAG
CCG
MHAG
NLEU
TCG
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ex
pe
rim
en
ta
l  
D
D
G
  k
ca
l/m
ol
 
Computed DG kcal/mol 
 IV-46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV-4(d) Binding energies of analogs along with the natural amino acids in the 
binding site of apo-MetRS (FF).Analogs are represented in shades of pink. 
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Figure IV-5: The binding modes of tcg and ccg, shown in the binding pocket of 
Met/MetRS(FF), were predicted by perturbation analysis at this site.Ccg (orange) has 
VDW clashes with Ala12, His301 and Tyr 260 and at the same time, cis orientation 
of the terminal methyl group created a void near Ala 256 and Pro 257.Tcg (Pink) is 
shown to fill that void and also avoid the unfavorable VDW interactions. 
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 One of the goals in computational protein design is to develop algorithms for 
predicting amino acid sequences that would adopt a specified three-dimensional 
structure. It is an extremely progressive area of research and has been successfully 
applied to engineer proteins with improved stabilities and activities [refer to [1]for a 
recent review]. Developments in this field are beginning to have an impact on 
biotechnology and further advancements in improving design strategies are expected to 
expand the range of applicability of computational protein design to larger and more 
complex biological systems. Besides providing as a suitable tool for designing proteins 
for medicinal and industrial purposes, the development of protein design tools should 
also confer a deeper insight into the principles that underlie protein sequence-structure 
relationship. 
There are three primary aspects of computational protein design that, although 
quite distinct from one another, are significantly interdependent. The progress achieved 
by several groups in this field shows that improvements in design techniques have been 
made possible through refinements in these areas. The first aspect concerns the energy 
expression used to assess and score the relative fitness of different amino acid sequences 
with respect to the desired protein fold. The second area deals with the way in which the 
protein design problem, the model, is represented. The model provides a framework for 
describing the target fold and its flexibility, the amino acids allowed for design positions, 
and the rotamer library used to represent the possible side chain conformations. The third 
area of enhancement is the search strategy used to scan the enormous combinatorial 
complexity of possible sequences and selecting those that are optimal for a given fold. 
 Since the inception of computational protein design, elements of a suitable energy 
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expression or force field to rank the desirability of an amino acid sequence for a 
particular backbone structure have been suggested and evaluated. Alterations and 
additions to the energy terms to improve the correlation between computed and 
experimentally observed properties are usually achieved by iterating between theory and 
experiment [2].  The force-field terms describing the non-bond interactions are usually 
explored for improvement, while the bonded energies are taken from commonly used 
molecular mechanics force fields [3]. Since the rotamers derived from protein databases 
generally have good internal energies, and for most design schemes, rigid backbone 
structures are used, the usefulness of improving “bonded” energies has not been 
rigorously demonstrated in protein design.  
For protein cores, a force field that models packing specificity is usually sufficient 
to design a well- folded protein [2, 4]. For designing protein surfaces however, energy 
terms that properly balance non-bonded polar interactions also need to be included in the 
potential function. Chapter 7 describes an approach used to derive a potential function for 
designing ß-sheet surfaces. This method was used to create a plastocyanin variant with 
enhanced thermostability. The derived potential placed more importance on electrostatic 
interactions that led to the selection of charged residues on protein surfaces. An important 
next step in understanding b-sheet stability was to define the role of side-chain ionic 
interactions. Chapter 8 outlines a study that evaluates the interaction energy of a three-
residue ionic network constructed on the ß-sheet surface of protein G. 
Except for a few notable exceptions, the models used to represent protein design 
problems in most cases, do not allow for backbone flexibility; side-chain flexibility is 
incorporated by selecting amino acid rotamers from a library of discrete conformations 
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[5-9].  If necessary, one may use rotamer libraries with different levels of resolution. 
However, because the size of the design problem grows exponentially with the increase 
in the number of rotamers, using a finely descretized rotamer library is often unfeasible.  
The rigidity of such a framework ignores the possibility of backbone shifts to 
accommodate mutations and an incomprehensive rotamer library could lead to the 
selection of incorrect side chain conformations. These limitations of the design procedure 
are highlighted in Appendix 1. This section reports a study on the redesign of the core 
residues in T-4 lysozyme where a significant shift in the protein backbone is observed in 
the crystal structure of a designed variant.  
  The third area of thrust in computational protein design deals with refinements in 
the search strategy. Searches for the optimal sequence for a target protein fold are 
achieved using various deterministic and stochastic combinatorial optimization 
algorithms. However, as structural targets get larger, it has become necessary to find 
more powerful methods to address the increased combinatorial complexities. Efficient 
algorithms that take into account the limitations of computing power and computational 
time are being developed and applied to numerous design problems. 
The ultimate goal of automated protein design is not only to be able to generate 
amino acid sequences that are compatible with the given backbones, but also to ensure 
that the selected sequences are able to perform specific functions. Intermolecular 
interactions lie at the core of protein function in a wide range of fundamental biochemical 
processes. Proteins function through their interactions with ligands, other proteins, or 
surfaces and these interactions are controlled by a complex array of intermolecular 
forces.  In many instances, binding to ligands induces structural changes that allow, for 
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example, signal transduction across large distances. Designing ligand binding sites and 
engineering ligand- induced conformation changes in proteins are very important 
applications of computational protein design.   
Chapters 9 and 10 delve into the application of computational techniques in the 
area of ligand-protein interactions. Chapter 9 describes the applicability of protein design 
to alter the specificity of a known binding site to enable it to bind to alternate ligands. An 
aminoacyl tRNA synthetase with altered ligand specificity was designed and was 
subsequently shown to be capable of incorporating an artificial amino acid in vivo.  
Chapter 10 explores the possibility of using computational methods to manipulate 
ligand- induced conformational change. The methodology in this study combines 
computational protein design with techniques from mean-field theory to generate 
sequences that undergo substantial conformational changes upon ligand binding.  The 
design approach and the results in this study will provide important insights and 
information that will aid future design efforts in this direction. 
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Abstract 
Plastocyanin, like many other metalloproteins, does not undergo reversible 
folding, which is thought to be due to an irreversible conformational change in the 
copper-binding site.  Moreover, apoplastocyanin’s ability to adopt native tertiary 
structure is highly salt-dependent, and even in high salt it has an irreversible thermal 
denaturation.  Here we report a designed apoplastocyanin variant, PCV, that is well-
folded and has reversible folding in both high and low salt conditions.  This variant 
provides a tractable model for understanding and designing protein ß-sheets. 
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Introduction 
Plastocyanins are small (97-104 amino acids) copper-binding proteins that 
function in photosynthesis to catalyze electron transfer from cytochrome-f of the 
membrane-associated cytochrome-b6f complex to P700+ in photosystem-I.  Like all 
plastocyanins, the poplar plastocyanin used in this study is a small Greek key ß-
sandwich protein (10,500 Da) with eight ß-strands, a single turn of a-helix, and a 
copper site coordinated by two histidines, a cysteine, and a methionine in a distorted 
tetrahedral geometry (1, 2) (Fig 7.1). 
Plastocyanin has been used to assess the role of ß-turns in dictating protein 
structure (3) and to elucidate folding mechanisms in ß-sheet proteins (4).  It has also 
been a useful model for studying electron transport in Type 1 copper proteins and in 
plants (5).  However, plastocyanin has a major drawback as a model for understanding 
protein thermodynamics.  The thermal denaturation of plastocyanin occurs at 61 °C and 
is irreversible (6).  It has been suggested that the overall protein denaturation occurs 
after the disruption of the copper-binding site and that during the thermal transition the 
geometry of this site changes from tetrahedral, in the native form, to square planar, in 
the denatured state (7).   
The apo form of plastocyanin in low salt conditions has an altered circular 
dichroism (CD) spectrum compared to the holo protein, suggesting that the apo protein 
has a significantly reduced ß-sheet content and is unstable in solution (8). 
Apoplastocyanin (apoPC) adopts the folded conformation only in the presence of high 
salt concentrations (1 M NaCl or 0.5 M Na2SO4), and under these conditions, its CD 
spectrum is almost identical to that of holo PC (4).  In order to address both the 
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irreversibility of folding and the salt dependency, we used the ORBIT (Optimization of 
Rotamers By Iterative Techniques) protein design software to redesign the copper-
binding site of poplar apoPC. The design resulted in a variant in which two metal 
coordinating residues, Cys84 and His37, were replaced with an alanine and a valine, 
respectively. The designed mutant, PCV, adopts the folded conformation in both high 
and low salt concentrations and has a completely reversible denaturation under high salt 
conditions.  
 
Results and Discussion  
In the process of redesigning the copper-binding site, calculations were run 
using different van der Waals scale factors. A scale factor of 0.9 has typically been used 
for protein core design (9). In order to replace the metal binding site in plastocyanin, 
van der Waals scale factors smaller than 0.9 were explored (10).  PCV was generated 
using a scale factor of 0.85 where His37 and Cys84 are mutated to a valine and an 
alanine, respectively.  
PCV and apoPC were compared for their thermal stability and reversibility of 
folding in high and low salt conditions.  PCV appears folded in both high and low salt 
concentrations while apoPC lacks the native conformation in low salt conditions. 
ApoPC can only adopt its folded conformation in high salt concentrations or when 
reconstituted with copper to yield holoplastocyanin.  PCV has a completely reversible 
two-state thermal transition in high salt and is almost completely reversible in low salt 
conditions (Fig VI-2a).  Also, thermal denaturation results show that PCV is marginally 
stabilized compared to apoPC (Fig VI-2b). 
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PCV is a salt- independent, metal- free variant of plastocyanin that expresses well 
and is easy to purify. It should therefore be an excellent model system for protein 
studies. We have already found it to be useful in understanding and designing ß-sheet 
surfaces (11).  
 
Experimental Methods 
Computational design:  Simulations were performed using coordinates from the X-ray 
structure of apoplastocyanin (PDB code: 2pcy). The metal binding site residues (Fig 
VI-1) were classified as core and boundary using the RESCLASS residue classification 
program as described previously (9). Cys84, His37 and Met92 were classified as core 
residues and His87 as a boundary residue.  Eight hydrophobic amino acid types (Ala, 
Val, Leu, Ile, Phe, Tyr, Met, and Trp) were considered at the three core positions.  All 
other residues as well as the backbone were held fixed.  To maximize core packing, the 
radius scale factor for van der Waal’s interactions was varied from 0.9 to 0.7 in steps of 
0.5.  Computational details, potential functions and parameters for van der Waals 
interactions, solvation and hydrogen bonding are described in our previous work (12).  
Gene synthesis, mutagenesis and protein purification: The wild type (PC) 
plastocyanin gene (13) was constructed using recursive PCR technique (14) and was 
cloned into the pET-11a expression vector (Novagen).  PCV was obtained by site 
directed mutagenesis (15) on the constructed plastocyanin gene using inverse PCR.   
Protein expression was carried out in E. coli strain BL21(DE3). The cells were grown 
in 2?YT at 37 °C.  Recombinant protein expression was induced by adding IPTG to 
cells at an OD600 of 0.75.  Cells were then incubated at 30 °C for an additional five 
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hours.  To isolate apoPC, cells were sonicated in the presence of 10 mM DTT 
(dithiothrietol) to prevent intermolecular disulfide bond formation. Purification was 
accomplished by reverse phase high performance liquid chromatography.  Two peaks 
corresponding to a 99-residue form (lacking an N-terminal methionine) and a 100-
residue form (including the N-terminal methionine) were observed.  The 100-residue 
form was used for all analysis. 
CD analysis: Circular Dichroism (CD) data were collected on an Aviv 62 DS 
spectrometer equipped with a thermoelectric cell holder using a 1 mm path length cell.    
Protein samples were at a concentration of 70 mM in 50 mM potassium phosphate 
buffer at pH 7.0 (low salt) and potassium phospha te buffer containing 0.5 M sodium 
sulfate (high salt).   Wavelength scans were carried out from 200 nm to 260 nm using 
increments of 2 nm.   Thermal melts were monitored at 210 nm and data were collected 
every 2 °C with an equilibration time of 2 min and an averaging time of 40 seconds.  
The melting temperatures were determined by evaluating the maximum of a d?/dT 
versus T plot. 
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Figure VI-1: Ribbon diagram of the X-ray crystal structure of wild type poplar 
apoplastocyanin illustrating residues in the copper-binding site. This figure was created 
using MOLSCRIPT (16). 
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Figure VI-2: (a) Wavelength scans of PCV in high salt conditions at 1 ºC before 
thermal denaturation (? ) and after refolding (?).  (b) Thermal unfolding curves 
monitored at 210 nm for apoPC in high salt (?), PCV in high salt (? ), and PCV in low 
salt conditions (?).  
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Chapter  7 
Designing Protein b -Sheet Surfaces by Z-Score Optimization 
 
 
 
 
 
 
 
 
 
Adapted from Street AG, Datta D, Gordon DB, Mayo SL. Phys Rev Lett 2000 May 22; 
84(21): 5010-3 
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Abstract 
Studies of lattice models of proteins have suggested that the appropriate energy 
expression for protein design may include non-thermodynamic terms in order to accommodate 
negative design concerns. A method has been developed to improve protein design in lattice 
model studies where enumeration of all possible sequences, and their ground state structures, is 
possible. The method maximizes a quantity known as the "Z-score," which compares the lowest 
energy sequence whose ground state structure is the target structure to an ensemble of random 
sequences. Here we show that, in certain circumstances, the technique can be applied to real 
proteins. The energy expression is then optimized using the assumption that the wildtype 
sequence is a low energy sequence (and its ground state is known to be the target structure). 
The new energy expression is used to design the b-sheet surfaces of two real proteins. We find 
experimentally that the resulting proteins are stable and well folded, and in one case, is even 
more thermostable than the wildtype. 
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Introduction 
Much effort in the field of computational protein design is directed towards developing a 
potential function to rank the compatibility of amino acid rotamer sequences with a target 
structure (Gordon et al., 1999). In a "protein design cycle" (Dahiyat & Mayo, 1996; Street & 
Mayo, 1999), the potential function is developed by cycling between experiment and simulation, 
so that the computational potential ideally approaches nature's "true" potential. This technique 
has had some remarkable recent successes (Dahiyat & Mayo, 1997a; Malakauskas & Mayo, 
1998). 
The approach nevertheless rests on a controversial assumption. Rotamer sequences are 
threaded onto the target structure, and the sequence with the lowest energy (as determined by 
the potential function) is reported as the best sequence for that structure. It is conceivable, 
though, that in some circumstances this sequence will not adopt the desired ground-state 
structure. An extreme example is provided by imagining that the true potential function is one 
that only benefits hydrophobic contacts (and hydrophobic-polar and polar-polar interactions 
contribute zero energy) (Lau & Dill, 1989). Then, for any target structure, an all-hydrophobic 
sequence must be one of the best sequences. This sequence, of course, is not likely to fold 
specifically to the target structure — some polar residues ought to be included to characterize 
the surface of the molecule. Overcoming this problem involves introducing non-thermodynamic 
considerations to the design procedure, collectively known as "negative design" (Hellinga, 
1997). 
There are a number of schemes proposed to implement negative design, often 
specifically to solve the problem of the example in the last paragraph (or variations on it based 
on the Ising model of ferromagnetism). Perhaps the simplest is to use a fixed sequence 
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composition, that is, to hold the total number of hydrophobic and polar residues constant 
(Shakhnovich & Gutin, 1993). Even with this constraint, however, designed sequences are 
frequently found to fold to alternative structures of lower energy than the target structure 
(Shakhnovich, 1994; Yue et al., 1995). Alternatively, instead of minimizing the potential 
function, it is possible to choose a sequence to maximize the occupation probability of the target 
structure (Micheletti et al., 1998b; Seno et al., 1998).  
Other approaches employed in lattice model studies involve adding non-thermodynamic 
terms to the potential function. One method is to introduce a "clamping potential" to force the 
molecule into the target structure, and then to minimize the difference between the clamping 
potential and the "true" potential (Kurosky & Deutsch, 1995; Deutsch & Kurosky, 1996). 
Another approach involves the addition of a penalty for exposing hydrophobic surface area 
(Sun et al., 1995). 
Negative design is thus clearly important, at least in lattice model studies with simple 
potential functions and a limited set of amino acids (Crippen, 1996; Micheletti et al., 1998a). 
For real proteins and more physical potential functions, negative design can be necessary to 
guarantee the correct multimeric state of designed proteins (Harbury et al., 1993). A penalty for 
exposing hydrophobic surface area has also been shown to improve the designability of real 
proteins (Dahiyat & Mayo, 1997b; Malakauskas & Mayo, 1998). 
We have taken yet another approach to determining the optimal potential function for 
protein design, in which we maximize the energy gap between a low energy sequence known to 
fold to the target structure, and the average energy of an ensemble of random sequences 
threaded onto a target structure (Chiu & Goldstein, 1998). In a cubic 3x3x3 lattice simulation, 
the desired "true" potential can be selected manually and the protein folding problem can be 
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solved. Thus a sequence S, whose ground state structure is the target structure, can be 
determined and its energy calculated. If the distribution of energies of the random sequences is 
assumed to be Gaussian, the success of the test potential for protein design is measured by the 
energy gap between the mean of the distribution and the energy of sequence S, normalized by 
the standard deviation of the distribution (Figure VII-1). This quantity is known as the Z-score 
of the sequence S on the target structure. The test potential is then adjusted to maximize the Z-
score. 
Chiu and Goldstein applied the method to a 3x3x3 lattice model, using statistically-
derived pair potentials (Miyazawa & Jernigan, 1985) as the "true" potential. They found that the 
potential generated by maximizing the Z-score across many structures led to significantly better 
success at solving the protein design problem than the true potential. Here we show that the 
technique does not transfer readily to real proteins in their entirety. Nevertheless, we show that 
the technique can be applied to certain subsections of proteins. In particular we use it to design 
the b-sheet surfaces of the B1 immunoglobulin-binding domain of streptococcal protein G 
(GB1) and of a variant of poplar apoplastocyanin with the metal-binding site removed (PCV). 
 
The Z-Score Applied to Real Proteins  
One of the key assumptions of the lattice model method of Chiu and Goldstein (Chiu & 
Goldstein, 1998) is that the energies of random sequences threaded onto the target structure 
form a Gaussian distribution. It would be surprising if this assumption were to hold for real 
proteins. In particular, one would expect that placing random amino acid side chains in the core 
of a protein would typically lead to unresolvable steric clashes, especially since the modeled 
backbone of the target structure is held rigid. Indeed, Figure VII-2a shows the distribution of 
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potential energies of random sequences threaded onto the core of GB1. The distribution is 
clearly not Gaussian, with most sequences yielding enormous energies. A Gaussian distribution 
may be achievable by using a statistically-derived pair potential instead of an atomistic van der 
Waals potential, but designs using pair potentials have not yielded uniquely characterizable 
folded states (Isogai et al., 1999). 
When only surface residues are considered, the situation is improved. For a-helix and 
b-sheet surface residues of GB1, the distribution of energies of random sequences is close to 
Gaussian, as shown in Figure VII-2b. Thus it appears that on the surface, even randomly 
selected amino acids are always able to find suitable rotamers that avoid severe steric 
interference. The Z-score analysis may therefore provide some insight into the appropriate 
potential function for a-helix and b-sheet surface design, provided one can find an appropriate 
sequence with which to calculate the Z-score. In lattice models, one knows the true potential 
function and can exhaustively search all conformations to solve the protein folding problem 
(Shakhnovich & Gutin, 1993). Hence the Z-score of a structure could be calculated using the 
lowest-energy sequence whose ground state is the target structure. 
In contrast, in the lattice model study of Chiu and Goldstein (Chiu & Goldstein, 1998), 
the Z-score is actually calculated without knowledge of this lowest-energy sequence. One 
thousand 27-residue random amino acid sequences are constructed, which are found to 
correspond to 992 unique ground state structures. Eight sequences are discarded to yield a 
one-to-one correspondence between structures and sequences. The Z-score is calculated for 
each sequence in its ground state structure, using the 992 sequences to determine the energy 
distribution. The potential function is then modified to maximize an appropriately formed average 
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of the Z-scores. Thus, the reference sequence used to calculated the Z-score is not necessarily 
the lowest-energy sequence whose ground state structure is the target structure, but instead an 
arbitrary sequence whose ground state structure is the target structure. Nevertheless, the 
resulting potential function is significantly better for protein design than the "true" potential. 
In our application of the theory to real proteins, we therefore expect that any arbitrary 
sequence known to fold to a target structure will suffice for calculating the Z-score of that 
structure. Given an experimentally determined structure, we can thus use the protein's wildtype 
sequence to calculate its Z-score. In essence, the method then chooses the potential function 
which locates the protein's wildtype sequence as far as possible down the tail of the distribution 
of energies. 
Since a number of successful computational redesigns of a-helical surfaces have been 
reported (Dahiyat et al., 1997; Morgan, 2000), we chose to examine the Z-score technique on 
the b-sheet surface, where there have been few successful computational protein design efforts. 
Negative design issues are also expected to play a larger role in b-sheet design (Hecht, 1994). 
Rather than maximizing the Z-score of a large number of structures, as a first step we consider 
just one structure, so that the resulting potential function is optimized for protein design on that 
structure. This method should increase the possibility of the technique being successful for at 
least the one selected structure. The resulting potential function may then be applied to other 
proteins to test its generality, or a new potential function may be calculated by considering more 
protein structures. In particular, we chose to apply the technique to the eight b-sheet surface 
residues of GB1 which are not involved in stabilizing interactions with neighboring turns (Figure 
VII-3a), and to the seven b-sheet surface residues on one face of PCV (Figure VII-3c). 
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The computational potential function, E, included van der Waals interactions, EvdW 
(Mayo et al., 1990; Dahiyat & Mayo, 1997b), electrostatics, Eelec, and a hydrogen bonding 
potential, EHB (Dahiyat, et al., 1997), a bias for secondary structure propensity, ESS (Dahiyat, 
et al., 1997), and solvation energies. The solvation energies were a benefit for burial of 
hydrophobic surface area,   Anp
buried , a penalty for burial of polar surface area,   Apolar
buried , and a 
penalty for exposure of hydrophobic surface area,   Anp
exposed  (Street & Mayo, 1998), and a 
further penalty for polar hydrogen burial, Ephb (Dahiyat, et al., 1997).  
 
  
E = vEvdW - snp Anp
buried + xnpAnp
exposed + spApolar
buried +
1
e
Eelec + DEHB + PEphb + ESS N( )
 (1) 
The magnitude of the van der Waals interactions, v, was held fixed and the relative 
magnitudes of the other seven energy terms (s np, s np, s p, e, D, P, and N as shown, where ESS 
is an exponential function of N) were allowed to vary individually until the Z-score was 
maximized. 
 
Results and Discussion 
The resulting potential functions are shown in Table 1. For GB1, the maximum Z-score 
is 2.6, i.e., the wildtype sequence is assigned an energy lower than 99.5% of all possible 
sequences. For PCV, the maximum Z-score is 2.2. Also shown in Table VII-1 is the potential 
function built up over many experiments using the protein design cycle, which has been 
successful in particular for core design and a-helix surface design (Street & Mayo, 1999). The 
Z-score optimized potential functions exhibit some interesting common features. The 
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hydrophobic burial benefit, which is the main embodiment of the hydrophobic effect (Wesson & 
Eisenberg, 1992), has disappeared. This reflects the relative lack of importance of hydrophobic 
burial on the surface of proteins (although there may be some role for small hydrophobic 
clusters on the surface of b-sheets (Tisi & Evans, 1995)). The other solvation parameters are 
broadly similar to the experimental potential function.  
The most dramatic difference from the protein design cycle potential is the increased 
importance of electrostatic interactions. The value of the dielectric constant used in the protein 
design cycle is similar to that of water, and leads to electrostatic interactions being de-
emphasized. This value was never experimentally tested, however. Although saltbridges are not 
encouraged, the hydrogen bonding potential from the protein design cycle is quite strong (an 
ideal hydrogen bond receives a benefit of 8.0 kcal/mol). The Z-score optimized dielectric 
constant is an order of magnitude smaller, closer to unity. This is justifiable because we are 
considering effects at the molecular level, where the assumptions behind the use of the dielectric 
constant break down. The screening effect of solvent is also approximated by using a distance 
attenuated Coulomb potential (Mayo, et al., 1990). 
To determine if the Z-score technique may be useful, this potential function must be 
used for real protein design. We used a combination of dead-end elimination (Desmet et al., 
1992; Gordon & Mayo, 1998) and branch-and-terminate (Gordon & Mayo, 1999) to find the 
lowest energy sequence for each b-sheet surface, using the new potential functions. (These 
minimization algorithms are guaranteed to produce the absolute lowest energy sequence, unlike 
stochastic algorithms such as Monte Carlo.) 
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The resulting GB1 variant, GB1-Z1, is a five-fold mutant of the wildtype protein. One 
can clearly see the impact of the electrostatic term in the potential function. The modeled side 
chain configurations are shown in Figure VII-3b, alongside those of the wildtype crystal 
structures (Gallagher et al., 1994). A cluster of threonines and an isoleucine have been replaced 
by two cross-strand saltbridges, Asp42 to Arg55, and Arg6 to Glu53. The wildtype saltbridge 
formed by Lys4 and Glu15 is maintained. Such cross-strand saltbridges might be expected to 
contribute to b-sheet formation and stability, and surface networks of saltbridges are postulated 
to be a stabilizing factor in hyperthermophilic proteins (Elcock, 1998; de Bakker et al., 1999). 
The resulting PCV variant, PCV-Z1, is a three-fold mutant of the wildtype protein. The 
modeled side chain configurations are shown in Figure VII-3d, alongside those of the 
apoplastocyanin wildtype crystal structure (Garrett et al., 1984). Again, the impact of the 
electrostatic term is clear, with a saltbridge network formed by Glu18, Lys95, Lys97 and 
Glu79.  
The designed proteins were made experimentally using standard molecular biology 
techniques and their properties measured. Their far UV circular dichroism spectra overlay those 
of the wildtype proteins. The melting temperature of GB1-Z1 was determined to be 71 °C 
(Figure VII-4a). The melting temperature of GB1 is 86 °C. Although the designed protein is not 
as stable as the wildtype protein, it appears to fold to the correct structure. Although the 
literature contains many examples of alterations to the b-sheet surface of GB1, we know of no 
instances resulting in greater than wildtype stability. This is the first example of a well formed, 
many-stranded b-sheet designed through purely computational means. 
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The results for PCV-Z1 were even more impressive. The melting temperature of PCV-
Z1 was determined to be 64 °C, compared to the melting temperature of PCV of 56 °C (Figure 
VII-4b). The designed protein is thus even more stable than the natural one. To our knowledge, 
this is the first time a natural protein's stability has been increased by redesigning its b-sheet 
surface. 
 
Materials and Methods  
Simulation: The core residues of GB1 are positions 3, 5, 7, 20, 26, 30, 34, 39, 52, and 54. 
The eight b-sheet surface positions of GB1 considered here are 4, 6, 15, 17, 42, 44, 53, and 
55. The a-helix surface positions of GB1 are 24, 27, 28, 31, 32, 35, and 36. The seven b-
sheet surface positions of PCV considered here are 18, 20, 79, 81, 93, 95, and 97. These 
follow from our residue classification algorithm (Dahiyat & Mayo, 1997a). The potential 
function used in Figure VII-1 is derived from the protein design cycle, shown in Table 1. 
The Z-score maximization algorithm searched along each potential function basis vector 
(that is, varying the scale factor for each energy term in Eq. 1) individually to maximize the Z-
score. The search was initiated at the potential function derived from the protein design cycle, 
from the van der Waals potential alone, and from other random potentials, and always 
converged to the same result. Further, the ordering of the search through basis vectors had no 
effect on the result. It was found that this optimization algorithm was sufficient to find the 
maximum Z-score. 
The Z-score was calculated using 4000 random sequences to determine the energy 
distribution of the potential function on the structure, resulting in an uncertainty in the Z-score of 
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±0.04. The random sequences were composed of the polar amino acids Ser, Thr, Asp, Asn, 
Glu, Gln, Lys and Arg, as well as the hydrophobic amino acids Ala, Val and Ile. The results 
were surprisingly robust to changes in the set of amino acids considered. In particular, the 
results were not significantly different if Ala was removed from consideration, or if His, Met and 
Gly were included. 
In contrast to the case in lattice models, real amino acids may adopt many different 
conformations, or rotamers. The energy of a given amino acid sequence on a structure is thus 
calculated by minimizing the energy across all possible rotamer configurations, using dead-end 
elimination. For this procedure a backbone-dependent rotamer library was used (Dunbrack & 
Karplus, 1993), in which the c1 angles of all hydrophobic amino acid rotamers were expanded 
±1 standard deviation about the mean value (Dahiyat, et al., 1997). 
Experimental: A synthetic GB1 gene (Minor & Kim, 1994) was cloned into a pET11a vector 
(Novagen) and used as the template for QuikChange mutagenesis (Qiagen). A synthetic PCV 
gene was constructed by recursive PCR (Prodromou, et. al., 1994) The genes were confirmed 
by DNA sequencing. The expression and purification of the protein followed published 
procedures, and was verified by mass spectrometry. The 56-residue form of GB1 (with N-
terminal methionine processed) and the 100-residue form of PCV (including the N-terminal 
methionine) were used. PCV was derived from wildtype poplar apoplastocyanin (Garrett, et al., 
1984) by removing its metal-binding site through the mutations His37 to Val and Cys84 to Ala. 
These mutations are in the core of the molecule and are not expected to interact with changes to 
the surface of the protein. The melting temperature of PCV was observed to be 56 °C 
compared to 51 °C for unmodified apoplastocyanin.  
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Far UV circular dichroism spectra were measured on an Aviv 62DS spectrometer. The 
spectra of GB1 and GB1-Z1 were measured at pH 5.5, in 50 mM phosphate and 50 µM 
protein, using a 1 mm path length, with thermal melts performed at 218 nm using 2 °C 
temperature steps with an averaging time of 30 s and an equilibration time of 2 min. The spectra 
of PCV and PCV-Z1 were measured at pH 7.0, in 50 mM potassium phosphate, 0.5 M 
sodium sulfate, and 70 µM protein, with thermal melts performed at 210 nm. The melting 
temperatures were derived by evaluating the maximum of a dq/dT versus T plot. Protein 
concentration was determined by UV spectrophotometry. 
Conclusion 
It is interesting that we have designed two stable protein b-sheet surfaces using different 
potential functions. Indeed, further application of the technique to other proteins suggests yet 
different potentials may be appropriate. This supports the belief that there may be alternative 
routes taken by nature to stabilize protein surfaces, and which may be taken in de novo design 
too (Cordes et al., 1996). Of course, one test of this proposal is to use the potential derived 
from one protein to design the b-sheet surface of another, and preliminary results in this regard 
appear promising (unpublished data). The potential derived for plastocyanin was applied to 
protein G and the mutant (PGPC) was 7 °C more stable than GB1-Z1. A further advantage of 
the approach outlined in this Letter is that it could lead to a faster turn-around time for protein 
design, since it optimizes the potential function with less frequent recourse to experiment.
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Energy term Design cycle PCV Range GB1 Range 
van der Waals v 1.0 1.0 n.a. 1.0 n.a. 
np burial snp 
(kcal/mol/Å2) 
0.05 0.0 0.0 – 0.01 0.0 0.0 – 0.02 
np exposure snp 
(kcal/mol/Å2) 
0.05 0.10 0.04 – 0.16 0.06 0.02 – 0.08 
polar burial sp 
(kcal/mol/Å2) 
0.0 0.0 0.0 – 0.04 0.03 0.01 – 0.06 
dielectric e 40.0 4.0 2.0 – 6.0 4.0 2.0 – 6.0 
H-bond D  8.0 1.0 1.0 – 8.0 6.0 1.0 – 8.0 
polar H burial P  2.0 9.0 6.0 – 15.0 3.0 1.0 – 7.0 
 
secondary structure bias 
N 
n.a. 1.0 0.0 – 1.4 1.4 0.8 – 1.6 
 
 
Table VII-1. Potential functions determined through different methods. The energy terms considered are 
shown in Eq. 1. The van der Waals energy scale factor v was held fixed. A potential function has been 
developed using the protein design cycle (Street & Mayo, 1999), and has been successful for core and a-
helix surface design in particular. The Z-score method applied to the b-sheet surface of PCV and of GB1 
yield new potential functions. Also shown are the ranges over which each parameter may be changed while 
keeping the Z-score within 5% of its maximum (when the other parameters are kept fixed). 
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Figure VII-1. The assumed distribution of energies of sequences threaded onto the target 
structure. Sequence S0 is the lowest energy sequence whose ground state structure is the target 
structure. Note that there may be sequences of lower energy that do not fold to the target 
structure. By altering the energy function non-thermodynamically, negative design seeks to move 
these sequences above S0. 
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Figure VII-2. The actual distribution of energies of various subsets of the real protein GB1, 
using the potential function derived from the protein design cycle (Table 1). a) The core (only 
the 2.5% lowest-energy sequences are shown), b) the b-sheet surface. 
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Figure VII-3. Views of the eight designed positions on the b-sheet surface of GB1 and PCV. 
a) the crystographically-determined wildtype GB1 side chain orientations. b) the orientations 
modeled using the Z-score-derived potential function on GB1. c) the crystographically-
determined PCV wildtype side chain orientations. d) the orientations modeled using the Z-
score-derived potential function on PCV. 
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Figure VII-4. Thermal denaturation data. a) Circular dichroism measurements of PCV (black) 
and PCV-Z1 (red) with temperature at 210 nm. b) Circular dichroism measurements of GB1 
(blue), GB1-Z1 (red) and PGPC (black) with temperature at 218 nm. 
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Chapter 8 
Evaluation of the Energetic Contribution of an Ionic 
Network to Beta-Sheet Stability 
 
 
 
 
 
 
 
 
Adapted from Kirsten S. Lassila, Deepshikha Datta, and Stephen L. Mayo. Protein 
Sci. 2002 Mar;11(3):688-90. 
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Abstract 
We have evaluated the interaction energy of a three residue ionic network 
constructed on the beta-sheet surface of protein G using double mutant cycles.  
Although the two individual ion pairs were each stabilizing by around 0.6 kcal/mol, 
the excess gain in stability for the triad was small (0.06 kcal/mol).   
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Introduction 
The b-sheet surface of the protein G immunoglobulin-binding domain B1 
(GB1) has been used as a model system for evaluating the b-sheet forming 
propensities of amino acids (Minor & Kim, 1994; Smith et al., 1994).  These studies, 
in combination with statistical surveys of known structures and theoretical models of 
b-sheet propensity provide some general guidelines for amino acid selection in b-
sheet design (Munoz & Serrano, 1994; Street & Mayo, 1999).   
An important next step in understanding b-sheet stability is to define the role 
of side chain interactions such as hydrogen bonding and ionic interactions.  In 
particular, the energetic effects of surface ionic interactions have been debated.  
Solvent exposed ion pairs have been found to stabilize folded proteins in a number of 
cases (Lyu et al., 1992; Horovitz et al, 1990; Spek et al, 1998; Takano et al, 2000; 
Serrano et al, 1990).  In the context of the b-sheet surface environment, ion pairs have 
been reported to stabilize folded proteins by 0.4 – 1 kcal/mol (Merkel et al, 1999; 
Blasie & Berg, 1997; Smith & Regan, 1995).  However, some surface ion pairs 
exhibit neutral or destabilizing effects (Strop & Mayo, 2000; Dao-pin et al, 1991).  
The high dielectric of the aqueous environment and the loss of side chain 
conformational freedom have been invoked to explain the marginal stabilizing effects 
of some pairwise electrostatic interactions.   
Networks of charged surface residues have been observed in 
hyperthermophile proteins and have been proposed to offer an energetic advantage 
over single ion pairs due to the reduced entropic cost of fixing a third residue (Yip et 
al, 1995; Dao-pin et al, 1991).  Indeed, two analyses of solvent exposed ionic triads in 
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a-helical regions have shown that three-residue networks offer a stabilizing effect 
greater than would be observed for the sum of the two individual pairwise 
interactions (Horovitz et al, 1990; Spek et al, 1998). 
To test the effect of an ionic triad in the context of the b-sheet surface, we 
have evaluated the energetic contribution of a three residue triad constructed on the b-
sheet surface of GB1.  The network consists of Arg 6, Glu 53, and Arg 44, residues 
which lie on three adjacent strands of the b-sheet surface (Figure 1a).  Double mutant 
cycle analysis was used to isolate the interaction energy of the triad (Horovitz & 
Fersht, 1990).  Eight GB1 variants were constructed which represent all permutations 
of Arg or Ile at position 6, Glu or Ala at position 53, and Arg or Ala at position 44.  In 
this three-residue thermodynamic cycle, the interaction energy of the ionic network is 
calculated as in equation 1. 
 
? ? ? GRERinteraction= {(?GRER-? GRAA)-[(? GREA-?GRAA)+(?GRAR-?GRAA)]}-                           
[1] 
                            {(?GIER-?GIAA)- [(? GIEA-?GIAA)+(?GIAR-?GIAA)]} 
 
?GXYZ is the free energy of unfolding for the GB1 mutant with amino acids X, Y, and 
Z at positions 6, 53, and 44, respectively.  The interaction energy of an Arg-Glu ion 
pair in the presence of another residue X is calculated as in equation 2.  
 
? ? GXERinteraction= (?GXER-?GXAA)-[(? GXEA-?GXAA)+(?GXAR-?GXAA)]                                
[2] 
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Free energies of unfolding (?G) were evaluated by two-state analysis of thermal 
denaturation curves monitored by circular dichroism (CD) (Figure 1b).   
 The variant containing both a single ion pair and isoleucine, I6E53R44, had the 
highest Tm and ?G of unfolding (Table 1) while the variant with the ionic triad, 
R6E53R44 was only slightly less stable.  It is interesting to note that the addition of the 
third charged residue almost fully compensates for the loss of the beta-branched (and 
therefore b–sheet stabilizing) amino acid. 
Interaction energies of the Arg6-Glu53 pair were 0.58 kcal/mol in the 
presence of Ala44 and  0.64 kcal/mol in the presence of Arg44 (Table 2).  The Arg44-
Glu53 pair had interaction energies of 0.51 kcal/mol (in the presence of Ile6) and 0.57 
kcal/mol (with Arg6).  This level of stabilization is consistent with other surface 
electrostatic interactions studied by double mutant cycles (Spek et al, 1998; Serrano 
et al, 1990; Merkel et al, 1999). 
Although the pairwise electrostatic interactions are clearly favorable, the ionic 
network does not appear to significantly enhance GB1 stability any more than the 
simple sum of the individual pairs.  As shown in Table 2, the interaction energy of 
unfolding for the ionic network, ? ? ? Ginteraction, determined at 75 °C (approximately 
the average Tm for the eight variants) was 0.06 kcal/mol.  This very low interaction 
energy suggests that the contributions of the ion pairs are additive; there is no 
additional stabilization of one ion pair in the presence of a third charged residue.  In 
contrast, previous studies of charged networks on a-helices using the double mutant 
cycle method showed stabilizing interaction energies of 0.77 kcal/mol for an Asp-
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Arg-Asp triad (Horovitz et al, 1990) and 0.65 kcal/mol for an Arg-Glu-Arg triad 
(Spek et al, 1998).  
The lack of a significant stabilizing interaction energy of the Arg6-Glu53-
Arg44 triad may be due to a variety of factors.  Previously reported factors such as 
desolvation, side chain entropy loss, and conformational strain may counteract the 
electrostatic benefits of the network.  However, the local environment of the triad, 
including secondary structure and neighboring residues, may also affect the 
magnitude of the interaction energy of the triad.  Further studies on b-sheet surface 
electrostatic interactions may help to clarify whether or not secondary structure 
influences the stabilizing effect of ionic networks.   
 
Methods 
Mutagenesis and protein expression 
GB1 variants were constructed by inverse PCR mutagenesis and expressed 
using the T7 promoter system as previously described (Su & Mayo, 1997).  
Purification of 57-residue GB1 variants containing an N-terminal methionine was 
accomplished by reverse phase HPLC and verified by mass spectrometry.  
 
Thermal denaturation 
The increase in CD signal at 218 nm was followed during thermal unfolding 
from 1 °C to 99 °C using 50 mM protein in 50 mM sodium phosphate, pH 5.5.  The 
midpoint of the thermal denaturation (Tm) and the enthalpy of unfolding (?H) were 
determined from a two-state analysis of each denaturation curve (Minor & Kim, 
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1994; Smith et al, 1994).  The change in heat capacity upon unfolding (? Cp) was held 
constant at 0.621 kcal/K•mol, a value previously reported for wild-type GB1 
(Alexander et al, 1992).  ?G values were assigned using the Gibbs-Helmholtz relation 
with ? Cp = 0.621 kcal/K•mol (Minor & Kim, 1994; Smith et al, 1994).  The average 
error in calculating ?G (as determined from curve fitting) was 0.06 kcal/mol.
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Table VIII-1  Stability data for GB1 variants 
 
                                      Tm1                           ?HTm2              ?G (75 °C)3 
Variant                         (°C)                        (kcal/mol)           (kcal/mol) 
R6E53R44                    79.1 ± 0.5                  53.5 ± 2.0                 0.61 
R6E53A44                     76.1 ± 0.4                    52.3 ± 2.0                 
 0.16 
R6A53R44                     69.6 ± 0.3                   45.0 ± 1.6                
 -0.74 
R6A53A44                    70.6 ± 0.3                   46.6 ± 1.5                -0.62 
I6E53R44                      80.1 ± 0.6                    56.1 ± 2.5                 0.79 
I6E53A44                      77.2 ± 0.4                    54.1 ± 1.9                  0.34 
I6A53R44                      75.5 ± 0.3                   50.1 ± 1.5                 
 0.08 
I6A53A44                      76.0 ± 0.3                   51.4 ± 1.6                 
 0.14 
1Tm, midpoint of thermal denaturation transition  
2?HTm, enthalpy of unfolding at Tm  
3?G (75 °C), free energy of unfolding calculated at 75 °C  
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Table VIII-2.  Interaction energies for ion pairs and the three-residue network.  
 
                                                 ??G (75 °C)4                ???G (75 °C)5 
Interaction                                 Kcal/mol                       Kcal/mol 
R6E53   (A44)                                     0.58 
R6E53   (R44)                                      0.64 
E53R44   (I6)                                       0.51 
E53R44   (R6)                                      0.57 
R6E53R44                                                                                  0.06 
4??G (75 °C) interaction energy (calculated at 75 °C) of the ion pair in the presence 
of the residue indicated in parentheses  
5???G (75 °C) interaction energy (calculated at 75 °C) of the triad as described in the 
text 
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Figure 1.   The b-sheet surface of GB1 showing possible orientations for side chains 
Arg 6, Glu 53, and Arg 44.  In the positions shown, nitrogen-oxygen distances are 
2.92 Å  and 2.85 Å for residue pairs 6-53 and 44-53, respectively.  Side chains were 
positioned with a dead-end elimination algorithm (Voigt et al, 2000) and the figure 
was created with MOLSCRIPT (Kraulis, 1991).   
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Figure VIII-2  Thermal denaturation curves for GB1 variants.  From left to right (at 
50% unfolded):  R6A53R44, R6A53A44, I6A53R44, I6A53A44, R6E53A44, I6E53A44, 
R6E53R44, and I6E53R44. 
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Chapter 9 
 
 
Redesigning Aminoacyl-tRNA Synthetases for in vivo Incorporation of 
Non-natural Amino Acids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from Datta D, Wang P, Carrico IS, Mayo SL, Tirrell DA. J Am Chem Soc 2002; 
124:5652-3 
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ABSTRACT 
 
We present here a computationally designed new mutant E. coli phenylalanyl-tRNA 
synthetase, which allows efficient incorporation of aryl ketone functionality into protein in 
vivo.   We demonstrate chemoselective modification of ketone-containing protein as a new 
means for selective modification of recombinant proteins.  Given the mild reaction 
conditions, we envision that this chemoselective formation of hydrazone linkage can be 
widely utilized to in vivo label proteins of interest and post-translational protein 
engineering.   
 This study also demonstrates the usefulness of computational protein design in 
manipulating tRNA synthetases for incorporation of non-natural aminoacids. It can be 
potentially used to design both the synthetase for the incorporation amino acid analog and 
also the protein in which we would like to incorporate the analog to enhance or modify its 
structural, catalytic and binding properties. This dual design approach, in which we are not 
limited to the 20 natural amino acids, could be used as a very powerful protein-engineering 
tool to design biomolecules with novel structures and functions. 
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Introduction 
Protein engineering, a powerful tool for structural and functional modification of 
proteins, relies on an efficient recognition mechanism for incorporating mutant amino acids 
in the desired protein sequences. Though this process has been very useful for designing 
new macromolecules with precise control of composition and architecture, a major 
limitation is that the mutagenesis is restricted to the 20 naturally occurring amino acids.  
For many applications of designed macromolecules, it would be desirable to develop 
methods for incorporating amino acids that have novel chemical functionality not 
possessed by the 20 natural amino acids. For example, the ability to synthesize large 
quantities of proteins containing heavy atoms would facilitate protein structure 
determination, and the ability to site specifically substitute fluorophores or photocleavable 
groups into proteins in living cells would provide powerful tools for studying protein 
functions in vivo. One might be able to enhance the properties of proteins by providing 
building blocks with new functional groups, such as an amino acid containing a keto-group. 
Incorporation of novel amino acids in macromolecules has been successful to an 
extent. Biosynthetic assimilation of non-canonical amino acids into proteins has been 
achieved largely by exploiting the capacity of the wild type synthesis apparatus to utilize 
analogs of naturally occurring amino acids [1-5]. Nevertheless, the number of amino acids 
shown conclusively to exhibit translational activity in vivo is small, and the chemical 
functionality that has been accessed by this method remains modest. In designing 
macromolecules with desired properties, this poses a limitation since such designs may 
require incorporation of complex analogs that differ significantly from the natural 
substrates in terms of both size and chemical properties and hence, are unable to 
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circumvent the specificity of the synthetases. To further expand the range of non-natural 
amino acids that can be incorporated, the activity of the aminoacyl tRNA synthetases 
(AARS) needs to be manipulated. 
The importance of the aminoacyl-tRNA synthetases (aaRS) in determining the 
success or failure of analogue incorporation has been recognized for decades. [5-16] Here, 
we report a computationally designed new variant of the E. coli phenylalanyl-tRNA 
synthetase (ePheRS), which allows efficient incorporation of aryl ketone functionality into 
protein in vivo.  In this study we demonstrate computational protein design to an extremely 
useful tool in predicting mutations in synthetases that will allow incorporation of new 
analogs that do not get incorporated by the natural synthetases.  
In 1991, Kast and coworkers [8, 10, 11] introduced a variant of ePheRS (termed 
ePheRS*), which bears an Ala294Gly mutation and which thereby acquires relaxed 
substrate specificity.  We have recently shown that ove r-expression of ePheRS* can be 
exploited to effect efficient incorporation of p-bromo-, p- iodo-, p-ethynyl-, p-cyano- and p-
azidophenylalanines into recombinant proteins in E. coli hosts[5, 7]. But similar 
experiments with p-acetylphenylalanine (DPA) failed (Figure IX-4); even in a host in 
which ePheRS* was over-expressed, phenylalanine-depleted cultures supplemented with 
DPA did not produce detectable yields of protein (Figure IX-5).  Our interest in DPA arises 
from the chemical versatility of the side-chain ketone function, which can be 
chemoselectively ligated with hydrazide, hydroxylamino, and thiosemicarbazide group 
under physiological conditions[17-22]. Cornish and coworkers have accomplished site-
specific incorporation of ketone functionality into recombinant proteins via in vitro 
translation; however, we are unaware of previous reports of in vivo methods of introducing 
 IX - 5 
  
ketone functionality, Bertozzi and coworkers have reported that N-levulinoylmannosamine 
can be incorporated into cell surface oligosaccharides and that the associated ketone 
functionality can be captured through reaction with nitrogen nucleophiles [20, 22]. 
 
Methods 
Computational Modeling 
Model System 
Phenylalanine –tRNA synthetase (PheRS): We have selected the PheRS as our model for 
this study. PheRS is an (aß)2 enzyme with 350 amino acids in the a subunit and 785 in the 
ß subunit [23, 24].  The binding site for phenylalanine (Phe) is in the a subunit (Figure IX-
2).  There are a number of reasons for selecting this system. Although the crystal structure 
of E.coli PheRS is unavailable, the crystal structure of Thermus aquaticus PheRS (tPheRS) 
complexed with Phe is available [23]and there is 43% identity between ePheRS and 
tPheRS (Figure IX-1). An accurate description of the binding pocket is critical for the 
computational design approach since it depends on the crystal structure for the protein 
backbone descriptions. The crystal structure also defines the orientation of Phe in the 
binding pocket of the synthetase. The aromatic ring of Phe is buried in the hydrophobic 
pocket while the carbonyl and the amide groups of the backbone make extensive 
electrostatic contacts with the charged and polar residues at the mouth of the pocket. We 
attempted to design the binding pocket for the analogs so that they bind to PheRS in the 
same orientation as Phe since this orientation may be important for the adenylation step.   
Another reason for using this system is that the structure of PheRS does not 
undergo any significant structural rearrangement on substrate binding as indicated by the 
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crystal structures of free PheRS and the PheRS-Phe complex.  This makes the system well 
suited for our protein design algorithm which uses a fixed-backbone structure for side-
chain selection. PheRS is an extensively studied system for the assimilation of artificial 
amino acids and has been used successfully in incorporation of a few Phe analogs.  In fact, 
limited mutation analysis has also been done on this system to alter substrate specificity 
(Kast and Hennecke,1991). Moreover, molecular dynamics (MD) simulations have been 
performed in an effort to understand the binding behavior of PheRS towards various 
analogs. 
Analogs: The Phe analogs selected for the study are shown in Figure IX-4. These analogs 
have been experimentally tested to check if they are readily incorporated in proteins by the 
natural PheRS. MD simulations were performed using these analogs and significant 
correlation was achieved between the predicted binding energies and the in vivo 
incorporation rates exhibited by these analogs (Wang et al., 2001).  
Binding Site Design 
We used a protein design algorithm [25, 26], ORBIT, to predict the optimal amino 
acid sequences of the binding pocket for binding to the different analogs. Selection of 
amino acids is performed using a very efficient search algorithm that relies on a discrete set 
of allowed conformations for each side chain and empirical potential energy functions that 
are used to calculate pairwise interactions between side chains and the between the side 
chains and backbone.  
Surveys of protein structure database have shown that side chains exhibit marked 
conformational preferences, and that most side chains are limited to a small number of 
torsional angles. Thus, the torsional flexibility of most amino acids can be represented with 
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a discrete set of allowed conformations called rotamers. Rotameric preferences in side 
chains are observed that depend on the main-chain conformations. ORBIT accounts for the 
torsional flexibilities of side chains by providing rotamer libraries that are based on those 
developed by Dunbrack and Karplus [27, 28].  
  In our design, we performed optimization calculations by varying the torsional 
angles of the analogs and the side chains lining the pocket simultaneously.  This required 
generating rotamer libraries for the analogs, since they are not included in our standard 
rotamer libraries. For all the natural amino acids, the possible ?1 and ?2 angles are derived 
from database analysis. Since this was not feasible in the case of artificial amino acids, the 
closest approximation for ?1 and ?2 angles for Phe analogs were taken to be the same as 
those for Phe. Moreover, our goal was to select for conformations that were as close as 
possible to the orientation of Phe in the binding pocket. So allowing similar torsional 
angles for the analogs as of Phe seems logical.  
Since the residues in the pocket are buried in the protein structure, we used force 
field parameters similar to those used in previous protein core design calculations. The 
design algorithm uses energy terms based on a force field that includes van der Waals 
interactions, electrostatic interactions, hydrogen bonding, and solvation effects [29].  
We generated backbone independent rotamer libraries for all the analogs shown in 
Figure IX-4. Both the ?1 and ?2 torsional angles were varied to match those of Phe 
rotamers in our standard backbone independent rotamer library.  The torsional angles of 
Phe in the crystal structure  (?1: –101º, ?2: –104º) were also included in the new rotamer 
libraries for both Phe and the analogs. Charges were assigned only to the heavy atoms of 
the analogs to be consistent with the way charges for the natural amino acids are 
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represented in ORBIT.  The first analog selected for design was acetylphenylalanine 
(DPA).   
Design calculations were run by fixing the identity of the substrate to be DPA and 
varying 11 other positions on PheRS (137, 184, 187, 222, 258, 260, 261, 286, 290, 294, 
314). Positions 137, 184, 258, 260, 261, 286, 290, 294, 314 were allowed to be any of the 
20 natural amino acids except proline, methionine and cysteine.  Methionine was allowed 
at position 187 because its wild-type identity is Met and only hydrophobic amino acids 
were allowed at position 222. Most of these positions are buried in the core and a number 
of them pack against Phe in the crystal structure.  Mutation analysis at position 294 has 
been shown to alter substrate specificity.  The anchor residues (Glu 128, Glu 130, Trp 149, 
His 178, Ser 180, Gln 183, Arg 204) were held fixed both in identity and conformation in 
all the calculations. These make very important electrostatic interactions with the substrate 
and this interaction is probably equally critical for the analogs.  From the crystal structure it 
appears that the anchor residues hold the Phe zwitterion in a way that the carbonyl group of 
the zwitterion is close to the ATP binding site. This proximity may be important for the 
aminoadenylation reaction. The aminoadenylation step is required for the incorporation of 
all the amino acids and hence, it seems important to make sure that the carbonyl and the 
amide groups of the analog zwitterions are also anchored the same way as the natural 
substrate at this site. 
In the first design attempt we allowed all the DPA rotamers that were generated in 
the rotamer library. The DPA rotamer selected in the structure generated was not buried in 
the binding pocket and most of it is solvent-exposed. A second calculation was run 
allowing only those DPA rotamers that would pack into the binding pocket.  These are the 
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rotamers with all possible combinations of ?1 of  –101 (±20°) and ?2 of  -104  (±20°) in 
increments of 5°. The structure generated in this calculation has the aromatic ring of DPA 
buried in the pocket and is almost completely superimposable with the Phe in the PheRS 
crystal structure.  
Gene construction, protein expression and analysis of designed PheRS activity 
E. coli PheRS* was amplified by the polymerase chain reaction (PCR) from vector 
pQE-FS [5] The amplified ePheRS* was subjected to PCR mutagenesis to create the  
desired Thr251Gly mutant, which we designate ePheRS**.  To allow constitutive 
expression of the synthetase, a tac promoter with an abolished lac repressor binding site 
was inserted upstream of the start codon of the ePheRS** gene[30]. The constitutive 
expression cassette was then cloned into pQE15 (Qiagen), which encodes the marker 
protein mouse dihydrofolate reductase (mDHFR).  The resulting plasmid was designated 
pQE-FS**.   As a control, plasmid pQE-FS* containing ePheRS* under control of tac 
constitutive promoter was constructed similarly.  AF-IQ, a phenylalanine auxotrophic cell 
strain carrying the repressor plasmid pLysS-IQ[5], was transformed with pQE15, pQE-FS*, 
or pQE-FS** to generate expression systems AF-IQ[pQE15], AF-IQ[pQE-FS*], and AF-
IQ[pQE-FS**], respectively.  The capacity of DPA to support protein synthesis in each 
expression system was determined by induction of mDHFR expression in phenylalanine-
free minimal media supplemented with DPA.  The histidine-tagged protein isolated from 
the latter culture (mDHFR-DPA) was purified by nickel-affinity chromatography. The 
isolated protein yield was about 20 mg/L, approximately 60% of that obtained from 
cultures supplemented with Phe.  Incorporation of DPA was confirmed by MALDI-TOF 
mass spectrometry analysis and tryptic peptide digestion analysis of purified mDHFR  
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With ketone-modified mDHFR, we also investigated the reactivity of hydrazide 
with this protein.   Purified mDHFR-wt and mDHFR-2 was dissoved in PBS buffer 
(pH=6.0) and treated with 5 mM biotin hydrazide (BH) or PBS buffer alone as a negative 
control.  The reaction products were analyzed by western blot after being seperated by 
SDS-PAGE and stained with streptavidin HRP conjugate (Figure IX-7).  The products were 
also examined for the presence of 6xHis tag of mDHFR to ensure existence of proteins and 
no degradation occuring after reaction.   
Results and Discussion 
The structure generated in the design calculation has the aromatic ring of DPA 
buried in the pocket and is almost completely superimposable with the Phe in the PheRS 
crystal structure. We also ran a control calculation where we fixed Phe as the substrate.  In 
all calculations, with DPA, position 258 is mutated from Phe to Tyr. This position is 
slightly exposed and is not in direct contact with DPA. Position 258 is very close to the 
anchor residues so mutating it may affect the transfer of the amino acid to its RNA and 
therefore, we did not include this mutation. We also ignored mutations V184I (this position 
is far enough from the substrate binding site and therefore, may not affect binding) and 
L222A  (this mutation was predicted because of a potential clash between methionine 
rotamer at 187 and leucine at 184 in the calculation). 
We compared the sequence predicted for Phe and DPA and observed that most 
significant difference between the two sequences was the prediction of two important 
cavity-forming mutations in the case of DPA: Val261 (Thr251 in E. coli) to Gly and 
Ala314 (Ala294 in E. coli) to Gly (Figure IX-3).  
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These predictions are consistent with the findings of Reshetnikova and coworkers 
[23] who pointed out that Ala314 and Val261 provide steric hindrance to the binding of 
larger amino acids (e.g., tyrosine) into the active site of tPheRS. Further confidence in the 
prediction was engendered by the fact that Ala294Gly allows incorporation of an 
interesting set of para-substituted analogues of Phe.  We were encouraged to test whether 
the additional Thr251Gly mutation would relax the specificity of ePheRS sufficiently to 
allow incorporation of DPA into protein in vivo.  
As shown in SDS-PAGE analysis of whole cell lysates (Figure IX-5), neither AF-
IQ[pQE15] nor AF-IQ[pQE-FS*] yields mDHFR in the negative control cultures (-phe) or 
in the cultures containing DPA.  On the other hand, expression of mDHFR is evident in the 
AF-IQ[pQE-FS**] culture supplemented with DPA.  
MALDI-TOF mass spectrometry analysis showed that molecular weight of 
mDHFR-2 was increased 307.65 kDa, indicating 81.4% substitution of Phe residues by 
DPA (mDHFR contains 9 Phe residues).  Incorporation of DPA was also confirmed by 
tryptic peptide digestion analysis of purified mDHFR (Figure IX-6).  For mDHFR-wt, two 
peptides within mass range from 1550 to 1750 Da was observed, which can be assigned to 
residues 34-47 and 93-106, respectively (Figure IX-6a, both fragments contain 1 phe 
residue).  The corresponding peptides containing analogue 2 (Figure IX-6b) showed 
additional mass of 42 Da, which is consistent to increased mass of DPA relative to Phe.   
The chemoselective ligation of hydrazide with ketone-containing protein proceeded 
sucessfully and western blot using anti-His antibody confirmed that no side reactions 
occured (Figure IX-7b).    
RBIAS – for enhancing protein-substrate interactions 
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The sequence generated in the first calculation has two important cavity forming 
mutations which are Val261 to glycine and Ala314 to glycine. Mutation to glycine at 
position 314 has been previously reported to have enhanced the incorporation of larger Phe 
analogs that are not incorporated by the wild type synthetase. All the mutations predicted in 
this calculation gear towards making enough space in the binding pocket for 
accommodating DPA, but besides van der Waals interactions, we do not see any specific 
interaction between DPA and the protein.  
In an attempt to design specificity in protein-substrate interaction, we developed a 
program, RBIAS, which enhances the interactions between the substrate and the protein 
positions. This was achieved by scaling up the pairwise energies between the substrate and 
the amino acids allowed at the design positions on the protein in the energy calculations. In 
an optimization calculation where the protein-substrate interactions are scaled up compared 
to the intra-protein interactions, sequence selection will be biased toward selecting amino 
acids to be those that have favorable interaction with the substrate.  
We performed multiple calculations by scaling up the substrate-protein interactions 
by factors of 2.0 to 20.0 in increments of 2.0. A scale factor of 4.0 generated an interesting 
mutation, Val 286 to Gln, which makes a hydrogen bond with the acetyl group at the distal 
end of DPA. The interaction between DPA and the PheRS in this sequence was enhanced 
by 2.12 kcal/mol although the complex is destabilized by 12.96 kcal/mol as indicated by 
the total energy. A bias scale factor of 18.0 generated a new mutation, Val 290 to lysine. 
We believe this mutation is not important for specificity since lysine at this position is not 
making significant interactions with DPA. Moreover, polar groups in the core, especially 
those that are not involved in a salt-bridge or a hydrogen bond may significantly destabilize 
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proteins. Therefore, we can trade off only some amount of overall protein stability in order 
to gain specificity between the protein and the substrate. 
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       Sequence 128 130 137 149 178 180 183 184 187 204 222 258 260 261 286 290 294 314 
    Ligand    
E  Energy 
 
Total 
Energy 
WT_phe E E L W H S Q V M R L F F V V V V A -16.91 -240.71 
No bias_phe E E L W H S Q I M R A Y F V L I I A -16.87 -242.14 
WT_dpa E E L W H S Q V M R L F F V V V V A -103314 51669.81 
No bias_dpa E E L W H S Q I M R L Y F G L I V G -21.40 -225.13 
Bias2.0 E E L W H S Q I M R L Y F G L I V G -21.40 -225.13 
Bias4.0 E E L W H S Q I M R A Y F G Q L V G -23.52 -212.17 
Bias6.0 E E L W H S Q I M R A Y F G Q L V G -23.52 -212.17 
Bias8.0 E E L W H S Q I M R A Y F G Q L V G -23.52 -212.17 
Bias10.0 E E L W H S Q I M R A Y F G Q L V G -23.52 -212.17 
Bias12.0 E E L W H S Q I M R A Y F G Q L V G -23.52 -212.17 
Bias14.0 E E L W H S Q I M R L Y F G Q L V G -23.63 -209.34 
Bias16.0 E E L W H S Q I M R L Y F G Q L V G -23.63 -209.34 
Bias18.0 E E L W H S Q I M R A Y F G Q K V G -23.96 -198.83 
Bias20.0 E E L W H S Q I M R A Y F G Q K V G -23.96 -198.83 
Table IX-1. RBIAS calculations for DPA. A big energy clash between DPA and the binding pocket in the wild type sequence (WT_dpa) 
indicates why DPA is not incorporated by the wild type synthetase 
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Figure IX-1. Sequence alignment between E.coli and T. thermophilus PheRS a 
subunits. Conserved residues are colored in red and conservative 
replacements are indicated by blue + symbol. 
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Query:    61 
XXXXXXXXXXXXXXXXXXXXXXXXXVDVSLPGASLFSGGLHPITLMERELVEIFRALGYQ 120 
                         +DVSLPG  + +GGLHP+T     +   F  LG+  
Sbjct:    71 
VQQALNAAKAELESAALNARLAAETIDVSLPGRRIENGGLHPVTRTIDRIESFFGELGFT 130 
 
Query:   121 
AVEGPEVESEFFNFDALNIPEHHPARDMWDTFWLTGEGFXXXXXXXXXXXXXXXXXTHTS 180 
   GPE+E ++ NFDALNIP HHPAR   DTFW                       T TS 
Sbjct:   131  
VATGPEIEDDYHNFDALNIPGHHPARADHDTFWFD---------------TTRLLRTQTS 175 
 
Query:   181 
PMQVRYMVAHTPPFRIVVPGRVFRFEQTDATHEAVFHQLEGLVVGEGIAMAHLKGAIYEL 240 
 +Q+R M A  PP RI+ PGRV+R +  D TH  +FHQ+EGL+V   I+  +LKG +++  
Sbjct:   176 
GVQIRTMKAQQPPIRIIAPGRVYRNDYDQTHTPMFHQMEGLIVDTNISFTNLKGTLHDF 234 
 
Query:   241 AQALFGPDSKVRFQPVYFPFVEPGAQFAVWWPEG 274 
              +  F  D ++RF+P YFPF EP A+  V    G 
Sbjct:   235 LRNFFEEDLQIRFRPSYFPFTEPSAEVDVMGKNG 268 
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Figure IX-2.  Residues involved in the binding site of PheRS. Phenylalanine in 
shown in magenta and the anchor residues are labeled in bold. 
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Figure IX-3. The redesigned binding site of PheRS showing the orientation of 
DPA in bound conformations and the two cavity forming mutations. 
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Figure IX-4. Phenylalanine analogs considered as interesting because of their 
unique  chemical functionalities. 
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Figure IX-5.  SDS-PAGE of cell lysates of different expression systems with 4 hr 
post-induction with 1 mM IPTG demonstrated ePheRS** allows incorporation of 
2 into protein in vivo.  Concentration of Phe(1)=20mg/l; DPA(2)=250mg/l. 
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Figure IX-6. MALDI TOF mass spectra of tryptic peptides digested from 
mDHFR expressed in media supplemented with Phe (a) or DPA (b).  
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Figure IX-7.  Western blot for the detection of chemoselective formation of hydrazone linkage. (a) 
Modified protein was treated with biotin hydrazide (BH), stained with HRP conjugated streptavidin 
and analyzed by western blot. (b) Western blot analysis of the products. Lane 1: mDHFR-wt + 
buffer; Lane 2: mDHFR-DPA + buffer; Lane 3: mDHFR-wt + BH; Lane 4: mDHFR-DPA + BH. 
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Chapter 10 
 
An Experimental and Computational Approach for Designing 
          a Conformation Switch in Proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The entropy profile calculations in this study were generated by Christopher 
Voigt.  
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Abstract 
In this study we have combined methods from mean-field theory (derived from statistical 
mechanics) and computational protein design to understand protein sequence space and 
eventually design a protein sequence capable of switching between two completely 
different protein folds – a ß-sheet fold to an a-helical fold.  It has been suggested that 
switch sequences are evolutionary bridges that serve as intermediates in the pathway for 
the evolution of new folds, as evolutionary end points in the development of allosteric 
systems, or as hazardous dead ends, as in protein misfolding diseases. An important 
determinant for switching conformation in proteins/peptides is the external perturbation 
that induces the switch. In our study, we are attempting to achieve this by using metal 
binding as an external force to direct the sequence towards the a-helical conformation 
over the ß-sheet conformation. To design an amino acid sequence capable of adopting 
both the conformations, we have used a strategy of first determining positions on both the 
proteins (protein G and engrailed homeodomain) that are highly tolerant to substitutions 
to common residues.  This was done by using a mean-field approach to identify the 
conserved and mutable amino acids on the two proteins. In the next step, the mutable 
positions on both the folds were designed using a protein design algorithm to select for 
identical amino acids and consequently, to bring the two conformations closer in 
sequence space.  
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Introduction 
Localized conformation changes in secondary structure are physiologically 
important for the correct functioning of many proteins.  The native forms of such proteins 
are metastable and this property is often critical to their biological function.  Mutational 
analysis and structural examination of metastable proteins have revealed unusual 
interactions, such as side-chain over-packing, buried polar groups, and cavities (Bullough 
et al., 1994; Chen et al,. 1998).  These structural defects are likely to be the design 
principle of metastable native proteins to regulate conformation changes.  Some examples 
of such metastable proteins are the plasma serpins (serine protease inhibitors) (Huber et 
al., 1989), the spring- loaded structure of the membrane fusion protein of influenza virus 
(Bullough et al., 1994; Carr et al., 1993), heat shock transcription factors (Orosz et al., 
1996), and G-protein EF-Tu complex (Abel et al., 1996).  It has been suggested that the 
conformational switches exhibited by these structures may represent a general 
mechanism to mediate activation in metastable proteins.   
An important determinant for switching conformation in proteins/peptides is the 
external environment that induces the switch.  For example, up to heptapeptide long 
sequences have been identified that adopt either a a-helical or ß-sheet conformation, 
depending on the protein in which they are found (Mezei et al., 1998).  The secondary 
structure of such chameleon sequences is determined by their tertiary environment.  The 
dual nature of an 11-residue switch peptide was experimentally demonstrated (Minor and 
Kim, 1996) by placing it in two different regions within a small molecule, the ß1 domain 
of Protein G (Gronenborn et al., 1991).  This indicated that context is an important factor 
governing the secondary structures of stretches of amino acid sequences in a protein.   
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The structure adopted by peptides and proteins also depends on external 
environmental conditions such as pH, temperature, and the ionic strength of the solvent.  
Two 17-residue peptides display switching between a-helix and ß-sheet conformations 
when these solvent conditions are varied (Cerpa et al., 1996).  In another example, a 
designed variant of Rop protein converts from a-helical to a fibrillar ß-sheet form when 
the pH of the solution is changed (Dalal and Regan, 2000). 
Conformation changes in proteins are also seen when proteins bind to other 
molecules.  A segment of MATa2, a DNA binding protein, converts from a-helical to ß-
sheet conformation when it binds to DNA (Tan and Richmond, 1998).  The folding state 
of an artificially designed peptide has been shown to be regulated by cofactor binding.  A 
17-amino acid peptide can be prevented from forming ß-sheet aggregates by binding 
heme to it, which facilitates the formation of an a-helix tetramer (Sakamoto et al., 1999).  
In calmodulin, a peptide binding protein, the structural flexibility of the central a-helical 
tether is believed to be an essential element in the calcium-dependent recognition of 
target peptides (Yap et al., 1999).  An interesting example of a designed conformation 
switch has been demonstrated by introducing a single mutation on a surface position of 
the arc repressor protein (Cordes et al., 2000).  The designed arc repressor protein is able 
to adopt both the ß-sheet and a-helical folds with the ß-sheet form being stabilized by 
DNA binding.   
Conformation switching has been proposed to occur during protein folding.  A 
transient population of a non-native a-helical intermediate has been observed in the 
folding pathway of a predominantly ß-sheet protein, ß- lactalbumin (Hamada et al., 1996).  
A number of protein misfolding diseases are associated with protein conformation 
change.  In amyloid diseases, fibril formation is a result of the conversion of soluble 
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protein into regular ß-sheet aggregates (Cohen et al., 1999; Harrison et al., 1997).  It has 
been proposed that all proteins have the potential to convert to such misfolded and 
aggregated assemblies under appropriate conditions (Chiti et al., 1999; Gross et al., 
1999). 
It has been suggested that switch sequences are evolutionary bridges that serve as 
intermediates in the pathway for the evolution of new folds, as evolutionary end points in 
the development of allosteric systems, or as hazardous dead ends, as in protein 
misfolding diseases.  Predictions of such bridges have also emerged from theoretical 
lattice models of protein folding (Bornberg-Bauer et al., 1997; Bornberg-Bauer and 
Chan, 1999).  Besides providing an insight into some fundamental protein evolution 
questions and sequence-structure relationships, understanding and designing a protein 
conformation switch can have a tremendous impact in the biotechnology industry for 
creating genetically engineered protein biosensors. 
In this study, we have attempted to design a sequence capable of switching 
conformation between two completely different structures – the fold adopted by protein 
G (PG) and that seen in engrailed homeodomain.  We have tried to achieve this by using 
metal binding as the external perturbation to direct the sequence towards the a-helical 
(engrailed homeodomain) conformation over the ß-sheet (PG) conformation.  To design 
an amino acid sequence capable of adopting both the conformations, we have used a 
strategy of first determining positions on both the proteins that are highly tolerant to 
substitutions to common residues.  Using a mean-field approach, the conserved and 
mutable amino acids on the two proteins were identified.  Several positions on the 
proteins were mutated to histidines; these were selected such that they would collectively 
coordinate a metal ligand in the engrailed structure but not in the PG structure. The 
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mutable positions were designed using our protein design algorithm, ORBIT, to select for 
common amino acids and consequently, to bring the two conformations closer in 
sequence space.   The design strategy is based on the assumption that if a designed 
protein sequence that folds spontaneously into PG is close in energy to the engrailed 
structure, then addition of metal could facilitate a conformation switch to the engrailed 
fold. 
Results and Discussion 
Model system 
The two proteins that we have chosen for this study are the ß1 domain of PG and 
a variant of engrailed homeodomain, SC1.  SC1 is a redesigned variant of engrailed 
homeodomain with 29 core and surface positions mutated from the wild type protein 
(Morgan, 2000).  Both are compact globular proteins and are small enough to attempt 
experimental characterization of a number of hybrid sequences and to monitor the change 
in the structural properties of the sequences as they diverge from their native sequences 
towards a mutual sequence.  Both proteins follow a simple two-state folding transition 
and are easy to express in vivo.  The sizes of the proteins are comparable ?  PG has 56 
amino acids, while the engrailed homeodomain variant (SC1) has 51 amino acids.  SC1 
has a Tm of 91 ºC that is in the same range as that of PG  (86 °C).  Regardless of these 
similarities, the conformations of the two proteins are very different.  SC1 is an all-helical 
protein, while PG has a well-structured ß-sheet with a central helix packed against it.  
The circular dichroism (CD) signals of both the structures are very distinct and changes 
in the structures can be easily followed by observing the changes in their CD signals.    
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Designing metal binding sites 
Metal binding sites are often formed from amino acids that are distant in the 
primary sequence but are brought into spatial proximity in the folded protein structure.  
Identifying key features for metal recognition and modeling the scaffold provided by the 
protein for metal site design is difficult and complicated.  Instead, we have adopted a 
simpler approach where protein secondary structure provides the rigid framework 
necessary for metal recognition.  This approach has been used in constructing metal 
binding sites by placing two histidines as His-X3-His on exposed positions on the helices 
(Todd et al., 1991).  This motif forms part of the metal coordination site in a number of 
metalloproteins, including zinc-finger proteins (Berg, 1988), thermolysin (Holmes and  
Matthews, 1982), and hemocyanin (Volbeda and Hol, 1989).  The His-X3-His metal-
binding site engineered into the surface of the protein confers a unique affinity for 
forming complexes of metals bound to solid supports or soluble polymers (Suh et al., 
1991).  In this orientation, the e-nitrogens of the imidazole groups from both histidines 
can coordinate a single metal.  Using this simple geometric consideration, surface i, i+4 
positions of the helices on SC1 can be selected to study the effect of metal binding.   
Six metal binding sites were designed on SC1 on the surface positions of the 
C-terminal and the N-terminal helices.  Histidines were substituted on the surface 
residues in i and i+4 positions to get His-X3-His geometry that is capable of chelating 
metal.  Three such sites were created on the C-terminal helix (SCCH1, SCCH2, SCCH3) 
and three more on the N-terminal helix (SCNH1, SCNH2, SCNH3) (Figure X-1).  A total 
of six proteins were created and tested for a change in stability in the presence of NiCl2 
(Figure X-2).  SC1 was used as a control since it does not have a His-X3-His designed 
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site.  Five of the six His-X3-His proteins showed a gain in stability in the presence of 
metal (Table X-1).  Variants that showed the maximum gain in stability are SCNH1 and 
SCCH3 with a stabilization of greater than 1.0 kcal mol-1 in the presence of nickel.  This 
result can be explained by the fact that in these two proteins the metal binding occurs 
near the C and N termini of the protein.  The termini of proteins are generally more 
disordered than the internal positions.  Metal binding increases the stability of these 
molecules by stabilizing the frayed ends of the protein to a well-defined helical structure.  
We selected positions 5 and 9 (SCNH1 metal-binding site) and positions 46 and 50 
(SCCH3 metal-binding site) to be the sites that we expected would trigger the 
conformation switch on chelating metal. 
 
Sequence alignment 
To make the design strategy simpler, we aligned the sequences of the two 
molecules so that their existing similarities were maximized.  The simplest similarities to 
look for are sequence identity and binary pattern.  There are six possible ungapped 
alignments between SC1 and PG.  Selection of the best frame can be determined by 
minimizing binary pattern mismatches and maximizing identical residues.  Binary pattern 
is an important consideration because it is a key determinant in defining the topology of a 
protein fold (Dill et al., 1995).  Based on the best alignment, positions on PG that 
correspond to the selected histidine positions of SC1 need to be analyzed.  This analysis 
is important because the corresponding histidine positions on the PG structure must be 
solvent accessible and mutating them to histidines should not significantly destabilize 
PG.   
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SC1 has 51 residues while PG has 56.  Hence, there are six possible ways SC1 and PG 
can be aligned with each other in an ungapped manual alignment (Figure X-3a).  Every 
position on both the proteins was classified as core, surface or boundary using a residue 
classification program as described previously (Dahiyat and Mayo, 1997).  The boundary 
positions were further reclassified as core and surface.  The wild type binary pattern was 
used to reclassify PG and the binary pattern of the B7 molecule (a boundary redesigned 
variant of SC1) was used to reclassify SC1 (Marshall and Mayo, 2001).  The number of 
identical residues and the number of binary pattern mismatches between the two 
sequences were noted for each alignment.  Alignment 1 was selected as the best 
alignment since it has the least number of binary pattern mismatches and the highest 
number of identical residues (Figure X-3a).  In this alignment, the histidine positions of 
SCNH1 and SCCH3 correspond to positions 10 and 14, and positions 51 and 55, 
respectively, on the PG sequence.  All four positions are solvent-accessible surface 
positions.  Positions 14, 51 and 55 are on the ß-strands and position 10 is on the ß-turn 
between strand 1 and strand 2 (Figure X-4).  In this alignment, the central helix of PG can 
be almost completely aligned with the central helix of SC1 so that the conformation 
switch is designed primarily to occur in the ß-sheet region, converting the two ß-hairpins 
(two anti-parallel ß-strands connected by a turn) to two a-helices (Figure X-3b). 
Position 10 is a glycine in the native sequence of PG and we were concerned that 
replacing it with a histidine may be highly unfavorable for the molecule because a 
histidine may not be compatible with the torsional angles of the backbone at this site (phi 
177.87º, psi 178.41º).  A point mutant, G14H, shows that replacing glycine with a 
histidine is a neutral mutation and the mutant has the same thermal stability as the wild 
type (Figure X-5).  A PG variant (PG4H) was made that has histidines at positions 10, 14, 
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51 and 55, and this molecule was tested for thermal stability (Figure X-5).  Another 
molecule (SC4H) that has the histidine mutations of both SCCH3 and SCNH1 was also 
created and tested for stability.  CD analysis indicates that SC4H is a well- folded and 
stable molecule (experimental data not shown). 
SC4H and PG4H became our starting molecules that we have used to generate the 
first two entropy profiles.  In both calculations, the identities of positions 10, 14, 51 and 
55 on PG, and, positions 5, 9, 46 and 50 on SC1, are fixed to be histidines.  The identities 
of five other residues that are identical in alignment1 (positions 12, 13, 19, 42 and 47 on 
PG and positions 7, 8, 14, 37, and 42 on SC1) were held fixed to wild type identities in 
further calculations.  Residues 1 to 5 in PG were also fixed as wild type identities since 
there are no corresponding amino acids for them in SC1 in alignment 1.   
 
Selecting mutable paired positions on PG and SC1 
Many proteins maintain their native structures while undergoing single and 
double mutations at many different sites.  The sequences that fold into a particular native 
fold form neutral networks that percolate through the sequence space.  A neutral net is 
defined as a collection of unique sequences that are interconnected by single-point 
mutants and encode for the same native structure (Bornberg-Bauer and Chan, 1999).  An 
important question asked in understanding sequence-structure relationships is how close 
do the neutral networks of the two structures come towards each other.  In other words, 
how similar can sequences be that fold into different structures?  As a “rule of thumb”, if 
two natural proteins have 30% or greater sequence identity, one has confidence that they 
share the same fold (Sander and Schneider, 1991).  On the other hand, this assumption is 
challenged in designed proteins, where it has been shown that two sequences with 50% 
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sequence identity fold to two completely different structures (Dalal et al., 1997).  
Computational simulations support an even stronger claim that sequences that fold into 
two completely different native structures need not differ by more than a few crucial 
amino acids (Babajide et al., 2001).  This indicates that neutral sets form extensive 
neutral networks that make them suitable for efficient protein evolution.  Empirical 
evidence for functional neutrality in protein space is indeed observed (Martinez et al., 
1996).  In some cases seemingly unrelated sequences have essentially the same fold 
(Holm and Sander, 1997; Murzin et al., 1996).  In fact, it is proposed that only some 
information in a protein sequence is necessary to specify a fold, with the rest just 
stabilizing that specified structure (Lattman and Rose, 1993; Rose and Creamer, 1994).   
In this study, we have tried to explore the possibility of to designing a single 
sequence to have more than one conformation.  It has been proposed that a sequence 
folds to a single unique conformation if there exists an energy gap between the native 
state and any other possible conformation, including the unfolded state (Karplus and Sali 
et al., 1995); (Bryngelson et al., 1995).  This theory suggests that a particular sequence 
specifies a single fold.  However, examples of sequences that can adopt multiple 
conformations described earlier indicate that distinct protein folds need not be isolated 
islands in a sequence space but can be linked by evolutionary bridges where multiple 
native conformations coexist (Cordes et al., 2000).   
In designing a sequence that can convert from PG to the SC1 conformation on 
binding to metal, we attempted to converge the sequences as much as possible towards a 
common sequence. At the same time, we wanted make sure that the native structures of 
both the proteins were maintained.  This is possible if we design only the positions that 
are tolerant to mutations while keeping the critical residues the same as the starting 
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sequence.  The critical residues are expected to maintain the correct fold of the protein.  
The rationale for our design is that if we have a sequence that is highly biased towards a 
metal binding variant of SC1, but folds to the PG structure due to the presence of only a 
few conserved residues that maintain the PG structure, the molecule is going to be 
unstable enough that in the presence of metal it will change to the SC1 structure.  We 
expect that metal binding will increase the propensity of the sequence to adopt a helical 
conformation since metal bound SC1 variants have been shown to stabilize the helical 
structure (described later in the chapter).  Our design strategy includes the following 
steps:  
1. Identifying the two sets of  positions: those that are highly mutable and those 
that are highly conserved on both structures. 
2. Redesigning as many positions as possible on both structures, starting with the 
most mutable positions and changing  to mutually acceptable amino acids, 
while making sure that the redesigned proteins fold to their native structures. 
The tolerance of protein structures to mutations can be calculated using a 
mean-field approach for recognizing the high entropy positions or sites (Voigt et al., 
2001).  These sites are classified as highly tolerant to amino acid substitutions.  The site 
entropy is determined by the variability of the amino acid identity at a given site among 
the sequences that fold to the native conformation.  The amino acid probabilities are 
calculated as the sum of the amino acid’s rotamer probabilities, as determined by the 
mean-field theory.  The probabilities of the existence of all allowed amino acids at all 
positions are tabulated and condensed into site entropy.  Therefore, site entropy is a 
measure of the number of amino acid substitutions that can be made at each position 
without disrupting the overall protein structure.  Sites with low entropy are intolerant to 
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mutations and are classified as conserved residues, whereas the positions with high 
entropy are tolerant to mutations and are selected for design.  A tabulation of the entropy 
at each position produces an entropy profile for the protein.  By comparing the entropy 
profiles of PG and SC1, we can determine the positions that can be selected for design.  
We are using the entropy profiles as a guide for designing the switch sequence.  The 
entropy profile is dependent on the force field used for energy calculations and the amino 
acids allowed at each site.   
 
 Generating entropy profiles 
Entropy profile I.  To select high entropy positions for design, we generated entropy 
profiles of PG and SC1.  In our first try, we generated profiles by allowing only two 
amino acids at each position on both the molecules, one from the PG sequence and one 
from the SC1 sequence.  The positions showing the highest entropy on both the structures 
were the common surface positions.  The positions with the lowest entropy were the 
positions that showed binary pattern mismatches in the sequence alignment.  Since we 
wanted to bias the sequence as much as possible towards SC1, we selected only the high 
entropy positions on PG and mutated them to amino acids on the SC1 sequence in two 
sets; these were SW2 and SW4 (Figure X-6).   
We were unable to express both SW2 and SW4.  Looking at the structures 
closely, it was obvious why these molecules were probably destabilized to a point that 
they could not be expressed.  The sites on PG that show the highest entropy are 
predominantly the ß-sheet surface positions and the helix capping positions (Figure X-7).  
The force field used to generate the entropy profile does not capture helix capping unless 
we set it to do so.  This can be achieved by scaling up a term in the force field that selects 
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for hydrogen bonds between the side chain and the backbone.  Also, the force field does 
not take secondary structure propensity of the amino acids into consideration unless this 
term is turned on.  As a result, all the ß-sheet surface positions on PG that are 
predominantly made of high ß-sheet propensity residues were selected as high entropy 
positions, indicating that these residues could be substituted by the corresponding 
residues from SC1.   
Entropy profile II – using secondary structure propensity and scaling up the remote 
backbone H-bond scale factor. To overcome the problems in the first entropy profile, a 
new profile was generated by including a secondary structure propensity term and a term 
to accentuate hydrogen bonds between the side chain and the backbone in the force field.  
Some of the helix capping positions and ß sheet surface positions were now calculated to 
be low entropy positions (Figure X-8). 
Entropy profile III – allowing more than two amino acids.  One of the biggest concerns in 
designing the two structures towards a mutual sequence is that allowing only two amino 
acids at a given position is an extremely limited search of the sequence space between the 
two structures.  And, as a result, we may not be able to capture the “switch” sequence.  
An easy way to overcome this would be to allow all amino acids at each position to 
generate the entropy profile.  However, a simple entropy profile generated by allowing all 
amino acids at each position will give us the high entropy positions on both molecules 
but will not give any information on the possibility that the two linked positions can be 
mutated to a common amino acid (Figure X-9a and X-9b).  Also, some corresponding 
positions that have high entropies may have tolerance for very different sets of amino 
acids.  For example, a high entropy core position in one molecule corresponding to a high 
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entropy surface position on the other molecule will have a very low probability of 
tolerating common amino acids.   
  The tolerance of the paired positions on the two structures to substitution by common 
amino acids can be extracted from the probabilities calculated using mean-field theory.  
The probabilities of all amino acids, except for histidine, proline and cysteine, at each 
paired position were calculated and tabulated (Figure X-11).  This tabulation along with 
the joint entropy profile (Figure X-10) provides us with the essential information we need 
to run the design calculations.  First, it gives us information on which positions have high 
entropy in both structures.  Second, we can now choose from paired positions on both 
structures that not only have high entropy, but more specifically, a higher probability for 
tolerating a common amino acid mutation (Figure X-10).  Third, it gives us a set of amino 
acids that are allowed at each paired position.  This information is ve ry useful for 
subsequent design calculations because reducing the number of allowed amino acids at 
each linked position will make the calculations run much faster.   
Experimental analysis of the designed SC1 and PG variants:  Using the information from 
the joint entropy profile four variants of PG (PG50, PG45, PG40 and PG35) and four 
variants of SC1 (SC50, SC45, SC40 and SC35) were designed using ORBIT. They were 
tested for secondary structure content and stability in the presence and absence of NiCl2 
and copper iminodiacetic acid (Cu(II)IDA).  Metals with vacant coordination sites bind to 
ligating atoms exposed on protein surfaces. However, since nickel has six vacant 
coordination sites and the nickel binding sites on the proteins are designed as di-histidine 
binding sites, NiCl2 in the solution caused most of the variants to aggregate because of 
non-specific chelation of the metal. To address this issue, we used Cu(II)IDA as the 
chelating agent.  We expected it to limit non-specific binding since it has only two vacant 
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coordination sites. Moreover, it is a five-membered ring that has been shown to have a 
very large chelating effect mainly attributed to a low entropic cost on bi-dentate binding 
(Kellis, 1991; Suh, 1991).  
While none of the engrailed mutants (SC50, SC45, SC40 andSC35) showed a 
significant change in structure on binding to Cu(II)IDA as indicated by their wavelength 
spectra,  dramatic changes were observed in the spectra of the PG mutants (PG50, PG45, 
PG40 and PG35) in the presence of metal (Figures X-15 to X-18).  Moreover, binding to 
Cu(II)IDA also increased the thermal stabilities of the engrailed mutants, while it appears 
to have  to destabilized the PG mutants. PGWT and SC1, the starting structures, do not 
have any designed histidines and therefore, did not show a change in structure or stability 
in the presence of metal (Figure X-13).  However, when the divalent histidine sites were 
engineered into these structures to form PG4H and SC4H56, binding to copper increased 
the stability of one (SC4H56) and decrease the stability of the other (PG4H). These 
changes are marginal, and based on the wavelength spectra, indicate that metal binding 
does not cause a structural change in either molecule. This implies that designing the 
divalent histidines on the ß-sheet surface of PG is not sufficient to cause a structural 
change. The striking changes that we observe in the PG variants are because these 
sequences are designed to be closer in sequence space to SC1 fold.  
PG50 shows reduced ß-sheet content in the presence of copper; however, it still 
appears folded. Conversely, PG45 and PG35 both appear to unfold on adding copper. 
PG40 is unfolded without the metal, but on adding copper, it appears to be partially 
folded.  PG35 has a 41% sequence identity with SC35 (Table X-2). At such high 
sequence identities, one would expect them to have the same structure. But their response 
metal binding indicates otherwise. PG35 completely unfolds on binding to metal, while 
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SC35 gains stability.  Further characterization of these molecules with NMR could be 
useful in understanding these characteristics better.  
1D NMR spectra of PG50, PG45, PG35, SC50, SC45, SC40, and SC35 were 
obtained without metal at pH 7.6 and at  a temperature of 5° C.  PG35 is folded but 
indicates molten globule-like features.  This is not surprising since, as we link more 
positions on both the molecules to be identical, we are moving them closer in sequence 
space and thereby, moving them further away from their own global minima. 
Materials and Method 
Gene construction, protein expression, and purification: Genes for the metal binding variants 
of SC1 (SCCH1, SCCH2, SCCH3, SCNH1, SCNH2, SCNH3, SC4H) were constructed by 
inverse PCR on the SC1 gene, which was cloned in the pET-11a (Novagen) vector.  The two 
PG variants (G14H and PG4H) were also made by inverse PCR on the wild type PG gene, 
which was also cloned into the pET-11a vector.  SW2, SW4, SC50, SC45, SC40, SC35, 
PG50, PG45, PG40 and PG35 genes were synthetically constructed using recursive PCR and 
cloned into a pET-11a variant.  Sequences for all constructs were confirmed by DNA 
sequencing.  All proteins were expressed in E. coli BL21 (DE3) hosts (Stratagene) by IPTG 
induction and proteins were isolated from the cells using a freeze-thaw protocol followed by 
purification by HPLC on a reverse phase column.  Protein masses were determined by mass 
spectrometry. 
 
Circular dichroism (CD): CD data were obtained on an Aviv 62A DS spectropolarimeter 
equipped with a thermoelectric cell holder and an autotitrator.  Gain in stability (??G) on 
metal binding was experimentally measured for SC1 and all the mutants of SC1 
containing the His-X3-His site by measuring the difference in the free energy of 
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unfolding (?Gu) of the proteins in the presence and absence of NiCl2.  ? Gu was measured 
by guanidinium chloride denaturation of protein samples at pH 7.5 at 25 °C (Figure X-2 
2).  The protein concentrations were 5 µM in 10 mM HEPES buffer.  A 1:100 ratio of 
protein to NiCl2 was used for denaturations done in the presence of metal.  Data was 
acquired at a wavelength of 222 nm every 0.2 M from 0.0 M to 6.0 M GdmCl using a 
mixing time of nine minutes and averaging time of 100 seconds.  ?Gu was obtained from 
the chemical denaturation data assuming a two-state transition and using the linear 
extrapolation model.  Wavelength scans and thermal denaturation data for the PG and 
SC1 variants were also obtained in the presence of 1 mM copper(II)iminodiacetic acid 
(Cu(II)IDA). Cu(II)IDA crystals were obtained by following a procedure decribed by 
Roman-Alpiste and coworkers. (Roman-Alpiste et al., 1999). 
Thermal denaturation data for G14H and PG4H mutants were obtained using 
samples containing 50 µM protein in 50 mM potassium phosphate buffer at pH 5.5.  
Thermal denaturations were performed by increasing the temperature from 1 °C to 99 °C 
with a step size of 2 °C, an equilibration time of 90 seconds, and an averaging time of 30 
seconds.  Melting temperatures were calculated by evaluating the maximum of a d?/dT 
versus T plot. 
Nuclear magnetic resonance studies: 
1D 1H NMR spectra were obtained on a Varian 600 MHz spectrometer using a Varian 
triple resonance probe.  All samples except PG35 and SC35 contained 250 µM protein and 
50 mM sodium phosphate in a 10% 2H2O buffer at pH 7.6.  PG35 and SC35 were not 
soluble at high concentrations; therefore, lower protein concentrations were used for their 
analysis. 
 
 X-19 
      
 
Structural entropy calculations:   
Force field and rotamer library:  The energy term used in ORBIT consists of two 
contributions – the rotamer-backbone energies e(ir) and the rotamer-rotamer energies 
e(ir,js),                      
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where N is the number of residues and ir is rotamer r at position i.  The total energy for a 
rotamer is the sum of the van der Waals, hydrogen bonding, electrostatic, secondary 
structure propensity and atomic solvation energies (Dahiyat and Mayo, 1996,1997).  The 
parameters for these potentials are described in previous work.  We use Dreiding force 
field parameters for the atomic radii and internal coordinate parameters (Mayo et al., 
1990).  The van der Waals energies are modeled using a 6-12 Leonard-Jones potential 
with an additional 0.9 scale factor applied to the atomic radii to soften the lack of 
flexibility implied by using a fixed backbone model.  All rotamer-rotamer and rotamer-
backbone energies are calculated and stored prior to mean-field calculations. 
The rotamer library used in mean field calculations is our expanded version of the 
backbone dependant library described by Dunbrack and Karplus (1993, 1994).  Rotamers 
that interact with the backbone with energies greater than 20 kcal mol-1 are eliminated 
from the calculation.   
Mean-field theory: The mean field solution for equation (1) is  
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where emf(ir) is the mean-field energy felt by rotamer r at position i and Kj is the total 
number of rotamers at residue j (Koehl and Delarue, 1994, 1996; Lee et al., 1994).  The 
probability vector p(js) is calculated at some temperature T using Gibbs equation 
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where ß = 1/kBT, where kB is the Boltzmann constant.  The algorithm iterates between 
equations (2) and (3) until self-consistency is achieved. 
Entropy profiles: The entropy can be calculated from the probability distribution of 
allowed amino acid substitutions (Voigt et al., 2001).  The site entropy is calculated by 
determining the variability of amino acid identity among sequences consistent with an 
energy.  It is calculated from the probability pi(a) that an amino acid identity ia exists at 
site i, 
å-=
A
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where A is the total number of amino acids and kb is chosen to be 1.  The amino acid 
probability, pi(a) is calculated as the sum of amino acid’s rotamer probabilities as 
determined by the mean-field theory. 
Design calculations using ORBIT based on joint entropy profile:  The joint entropy 
profile was used to select positions for design on both PG and SC1. We used cutoffs   
(0.5, 0.45, 0.40 and 0.35) as indicated by the dotted lines in Figure X-10 to select for 
design positions. All the positions that are above the cutoff were selected on both the 
molecules and were forced in the design protocol to be identical amino acids. The 
positions that were not designed were allowed to maintain their wild type identities but 
were varied in their rotameric conformations. The designed histidine sites, positions 10, 
(3) 
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14, 51 and 55 on SC4H56 and PG4H were fixed to be histidine in all calculations. The 
amino acids allowed at the paired design positions were based on the combined amino 
acids probabilities calculated for those positions. As the cutoff was lowered from 0.5 to 
0.35, the number of identical amino acids on both the structures increased. The SC1 
variants made by this method were SC50, SC45, SC40 and SC35 and the PG variants 
were PG50, PG45, PG40 and PG35.  
Selecting common amino acids at the high entropy positions: Design calculations were 
run so that the corresponding high entropy positions on the two structures are forced to 
have the same amino acid identity.  This is achieved by specifying these positions and 
linking them in our protein design algorithm, ORBIT.  As the optimization calculation 
runs, the linked positions can be forced to maintain amino acid symmetry by setting a 
high penalty energy for pairs of amino acid combinations that break the symmetry at the 
linked positions.  Typically, the penalty energy is set at 100 kcal/mol.  If this penalty 
energy is set to zero, the design calculation will run as two independent calculations on 
the two structures.   
When the two positions are linked in a calculation, the selection of a common 
amino acid is based on the sum of the interaction energies for the amino acids at these 
two sites.  If position A on SC1 is linked to position B on PG, the linked energy of having 
a residue i at these two positions (EiAB) is given by the sum of the total ene rgy of residue 
i in the SC1 structure at position A (EiSC1A) and the total energy of residue i in the PG 
structure at position B (EiPG B):  
EiAB = EiSC1A  +  EiPG B 
If there exists another amino acid, j, that has a more favorable linked energy at these two 
positions than residue i, i.e., if 
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     EjAB < EiAB  
j will be selected as the common amino acid.   
 
Conclusions  
We have developed a procedure that is potentially useful in characterizing protein 
sequence-structure relationships.  Using this method we are able to generate PG variants 
that showed significant changes in structure on binding to metal. Most of the 
conformation changes were from folded to unfolded structures and vice versa. However, 
none of the changes caused a complete switch to a a-helical fold from the ß-sheet fold, as 
we had hoped. The primary reason for not obtaining a distinct structural switch could be 
that the model systems we selected for this study are not close enough in sequence space 
to allow it. It is also possible that the energy contributed through binding Cu(II)IDA is 
not enough to completely tip the energy balance towards the helical structure. Future 
efforts using this procedure with more appropriate model systems and a more effective 
external perturbation to facilitate the switch could be potentially useful understanding and 
designing ligand- induced conformation changes in proteins. 
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Mutants ?Gu   
(kcal mol-1)a 
m value b 
(kcal mol-1 M-1) 
??G 
(kcal mol-1)c 
SCCH1 (-) 2.471 1.455 
SCCH1 (+) 2.537 1.289 
0.07 
    
SCCH2(-) 3.088 1.575 
SCCH2(+) 3.816 1.259 
0.728 
    
SCCH3(-) 2.580 1.530 
SCCH3(+) 4.130 1.481 
1.55 
    
SNH1(-) 2.814 1.670 
SNCH1(+) 3.920 1.807 
1.106 
    
SNH2(-) 3.596 1.885 
SNH2(+) 2.934 1.7164 
-0.662 
    
SNH3(-) 2.820 1.587 
SNH3+) 3.292 1.619 
0.472 
    
SC1(-) 3.428 1.749 
SC1(+) 3.628 1.739 
0.20 
          aFree energy of unfolding at 25 °C 
          bSlope of ?Gu   versus denaturant concentration. 
          cChange in ?Gu in the presence of 500 µM NiCl2 
 
 
 
 
 
Table X-1. Guanidinium chloride denaturation data. (+) indicates that chemical 
denaturation was performed in the presence of 500µM NiCl2, and (-) indicates the 
absence of NiCl2.   
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Protein Tm Without 
Cu(II)IDA (° C) 
Tm 1mM 
Cu(II)IDA (° C) 
Sequence 
Identity (%) 
SC1 87 85 
PGWT 81 79 
8.9 
 
SC4H 
 
71 
 
83 
 
 
SC4H56 
 
79 
 
91 
PG4H 57 47 
25 
 
PG50 
 
49 
 
31 
SC50 65 77 
31 
 
PG45 
 
41 
 
Unfolded 
SC45 67 79 
33 
 
PG40 
 
Unfolded 
 
33 
SC40 77 85 
37.5 
 
PG35 
 
25 
 
Unfolded 
SC35 61 71 
41 
 
 
 
 
Table X-2:  Thermal denaturation data of all the relevant protein G and engrailed 
homeodomain mutants constructed using joint entropy profiles. For comparison, the 
stabilities of the starting sequences of both the structures, PGWT and SC1, were also 
measured in the presence and absence of Cu(II)IDA. Sequence identities between pairs 
of molecules are also noted. 
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Figure X-1: SC1 structure showing the designed metal binding sites.  The amino acids 
labeled represent the helical surface positions that were considered for metal site design.  
i, i+4  combinations of these positions were tested for gain in stability on chelating 
nickel.  SCCH1, SCCH2, and SCCH3 were three such combinations for the C-terminal 
helix, and SCNH1, SCNH2 and SCNH3 were the combinations for the N-terminal helix. 
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Figure X-2: Chemical denaturation curves monitored at 222 nm to study the effect of 
metal binding in metal site designed mutants of SC1. Guanidinium chloride denaturation 
was performed at 25 °C in the presence (shown in red) and absence of nickel (shown in 
blue).  Maximum gain in stability is seen for SCCH3 and SCNH1.  SC1 was used as a 
control since it does not have histidines on the helix surface positions that can chelate 
metals.  The denaturation curves show that its stability is not affected by the presence of 
metal.   
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Figure X-3: Sequence alignment between PG and SC1.  (a) There are six possible 
alignment frames.  “s” indicates surface positions and “c” indicates the core positions.  
Alignment 1 was selected as the most favorable because this has the least number of 
binary pattern mismatches and has five residues with common identities.  (b) The 
secondary structure alignment corresponding to Alignment1 shows that the Helix2 of 
SC1 overlaps with the central helix of PG. 
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1   5   10   15   20   25   30   35   40   45   50   55  
TTYKLILNGKTLKGETTTEAVDAATAEKVFKQYANDNGVDGEWTYDDATKTFTVTE   
sscscscscsscssssssscssbsscssccssccsssscscscscsssssscscss 
     sscssscssscssccssssscssscsssccsscscsssccssccsscssss 
       TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI 23   5 Alignment1 
    sscssscssscssccssssscssscsssccsscscsssccssccsscssss 
    TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI  20 3 Alignment2 
   sscssscssscssccssssscssscsssccsscscsssccssccsscssss 
   TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI   28 2 Alignment3 
  sscssscssscssccssssscssscsssccsscscsssccssccsscssss 
  TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI    22 2 Alignment4 
 sscssscssscssccssssscssscsssccsscscsssccssccsscssss 
 TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI     19 4 Alignment5 
sscssscssscssccssssscssscsssccsscscsssccssccsscssss  
TKFDEQLKRRLEEEFKRDRRLTNQRRHDLSQKLGINEELIEDWFRRKEQQI      17 3 Alignment6 
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Figure X-4: The four histidine mutations on the surface of SC1 and PG are shown. The 
positions on PG correspond to the i, i+4 histidine positions of SCCH3 and SCNH1 metal 
chelating mutants of SC1. 
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Figure X-5:  Thermal denaturation of PG mutants monitored by CD at 218 nm.  G14H 
mutant is represented by red closed circles and PG4H by blue triangles.   
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Figure X-6: Entropy profile I.  A comparison of site entropies is based on allowing 
only the two corresponding amino acids from Alignment 1 (Figure X-3a) at each 
position.  The dotted lines represent the mean of the distribution for the entropies of both 
the molecules and the solid lines represent the standard deviations.  Positions close to the 
Y-axis have a low tolerance for substitution in the SC1 structure and those close to the 
X-axis have a low mutability in the PG structure.  The positions on the upper right 
quadrant of the graph have high entropies on both the molecules and can be substituted 
with each other’s corresponding amino acids.  The sequences at the bottom are of 
mutants constructed based on this profile. Molecule SW2 is a PG mutant that has 
mutations presented in the graph (in blue) up to the standard deviation line of the PG 
distribution.  SW4 has additional mutations, marked in green in the graph, that are 
between the average line and the standard deviation line of PG entropy distribution in the 
graph. 
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Figure X-7:  Mutation distribution of SW2 and SW4 on PG.  (a) SW2 mutations are 
predominantly clustered on the ß-sheet surface.  (b) The additional mutations of SW4 are 
clustered on the helical surface. 
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Figure X-8: Entropy profile II:  Some of the high entropy positions from entropy 
profile I are now reclassified as low entropy positions. 
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Figure X-9: Entropy profile III. (a) Comparison of the site entropies of all the positions on 
the two structures when all 20 amino acids are considered in the entropy profile calculations.  
(b) The entropy profiles of SC1 (red) and PG (black).   
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Figure X-10: Joint entropy profile of both the molecules derived from the 
combined probabilities of having common amino acids at the corresponding 
positions. The amino acid probabilities, pi(a) are the combined probabilities 
calculated as the sum of the amino acids rotamer probabilities at the paired 
positions on PG and SC.                  
 pi(a) = pi(a) PG pi(a) SC 
The dotted lines represent the cutoffs used to select for design positions. 
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Figure X-11:  Probability grid for determining common amino acids at the linked positions.  
The rows are the linked positions on the two structures and the columns are the 17 amino 
acids used in the study.  An “X” in a box indicates that it may be possible to substitute the 
linked positions with the amino acid corresponding to that box. Positions considered for 
design upto a cutoff of 0.35 are highlighted 
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1 6                X  
2 7                  
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Figure X-12:  Structure of  copper(II)iminodiacetic acid is shown with a di-histidine site 
chelating the copper center. The geometry of i, i+4 positions on a helix is ideal for maximum 
chelating effect. 
 
 
 
 
 
 
 
 
 
 
 
 X-52 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
O
N
N
N
O
N
N
Cu
O
O
NH
O
O
OH2
 X-53 
  
 
 
 
 
 
 
 
 
 
 
Figure X-13: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PGWT and SC1. In all plots, red indicates measurements taken in the 
absence of Cu(II)IDA, and blue represents those taken in the presence on Cu(II)IDA. The 
wavelength scans indicate that the structures of the molecules do not undergo any significant 
conformational change in the presence of metal. These molecules do not have designed di-
histidine sites and are not able to chelate metal ions. 
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Figure X-14: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PG4H and S4H56. In all plots red indicates measurements taken in the 
absence in Cu(II)IDA and blue indicates those taken in the presence on Cu(II)IDA. 
Wavelength scans indicate no significant structural changes. PG4H destabilizes by 10 °C in 
the presence of copper while SC4H56 gains 12 °C in thermostability. 
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Figure X-15: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PG50 and SC50. In all plots, red indicates measurements taken in the 
absence of Cu(II)IDA and blue indicates those taken in the presence of Cu(II)IDA.  PG50 
shows a significant shift in wavelength spectrum in the presence of Cu(II)IDA and also a loss 
in thermostability of 18 °C. Wavelength spectra of SC50 in the presence and absence of 
metal are identical, but a 12 °C gain in thermostability is observed on binding to metal. (e) 
represents the amino acid sequences of the two molecules. The identical amino acids are 
colored in red. 
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Figure X-16: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PG45 and SC45. In all plots, red indicates measurements taken in the 
absence of Cu(II)IDA and blue indicates those taken in the presence of Cu(II)IDA.  In the 
presence of copper PG45, undergoes a structural change from a folded to an unfolded 
protein. (e) represents the amino acid sequences of the two molecules. The identical amino 
acids are colored in red. 
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Figure X-17: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PG40 and SC40. In all plots, red indicates measurements taken in the 
absence of Cu(II)IDA and blue indicates those taken in the presence of Cu(II)IDA.  In the 
absence of copper, PG40 is unfolded but gets partially folded in the presence of copper. (e) 
represents the amino acid sequences of the two molecules. The identical amino acids are 
colored in red. 
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Figure X-18: (a) and (c) are the wavelength scans and (b) and (d) are the thermal 
denaturation plots of PG40 and SC40. In all plots, red indicates measurements taken in the 
absence of Cu(II)IDA and blue indicates those taken in the presence of Cu(II)IDA.  In the 
presence of copper, PG35 undergoes a structural change from a folded to an unfolded 
protein. (e) represents the amino acid sequences of the two molecules. The identical amino 
acids are colored in red. 
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Figure X-19: 1-D NMR spectra of engrailed homeodomain mutants. Spectra of all variants 
except SC35 indicate folded structures. 
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            Figure X-20: 1-D NMR spectra of Protien G variants. PG50 and PG45 are folded 
proteins while PG35 appears more like a molten globule.  
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Appendix A 
 
Repacking the Core of T4 Lysozyme by Automated Design 
 
 
 
 
 
 
 
 
This appendix is adapted from an unpublished manuscript that was coauthored with Blaine 
H. M. Mooers, Walter A. Baase, Professor Stephen L. Mayo and Professor Brian W. 
Matthews.  This was a collaborative effort between Caltech and University of Oregon. D. 
D. did the computational part of this study. 
 
 
   
 A-2 
ABSTRACT 
Automated protein redesign, as implemented in the program ORBIT, was used to 
redesign the core of T4 lysozyme.  Twenty-six buried or partially buried sites in the C-
terminal domain were allowed to vary both their sequence and side-chain conformation 
while the backbone and non-selected side-chains remained fixed.  A variant with seven 
substitutions ("Core-7") was identified as having the most favorable energy.  The redesign 
experiment was repeated with a penalty for the presence of methionines.  In this case the 
redesigned protein ("Core-10") had ten amino acid changes.  The two designed proteins, as 
well as the constituent single mutants, and several single-site revertants were over-
expressed in E. coli, purified, and subjected to crystallographic and thermal analyses.  The 
thermodynamic and structural data show that some repacking was achieved although 
neither redesigned protein was more stable than the wildtype protein.  The use of the 
methionine penalty was shown to be effective.  Several of the side-chain rotamers in the 
predicted structure of Core-10 differ from those observed.  Rather than changing to new 
rotamers predicted by the design process, side-chains tend to maintain conformations 
similar to those seen in the native molecule.  In contrast, parts of the backbone change by 
up to 2.8 Å relative to both the designed structure and wildtype. 
 Water molecules that are present within the lysozyme molecule were removed during the 
design process.  In the redesigned protein the resultant cavities were, to some degree, 
reoccupied by side-chain atoms.  In the observed structure, however, water molecules were 
still bound at or near their original sites.  This suggests that it may be preferable to leave 
such water molecules in place during the design procedure.  The results emphasize the 
specificity of the packing that occurs within the core of a typical protein.  While point 
substitutions within the core are tolerated they almost always result in a loss of stability.  
Likewise, combinations of substitutions may also be tolerated but usually destabilize the 
protein.  Experience with T4 lysozyme suggests that genuine core repacking with retention 
or enhancement of stability is difficult if not impossible to achieve without provision for 
   
 A-3 
shifts in the backbone. 
 
INTRODUCTION 
 The cores of proteins are generally well-packed (Richards, 1986; Richards & Lim, 1994).  
They have shown a remarkable ability to accommodate changes in buried hydrophobic 
residues although generally with some loss of stability (Baldwin et al., 1993, 1996; Gassner 
et al., 1996).  It has been suggested that protein core packing is not like a jigsaw puzzle.  
Rather, it is more like nuts and bolts in a jar (Liang & Dill, 2001).  If this is the case there 
may be opportunities to improve the stability of native proteins by optimizing the packing 
of buried amino acids.  An early test with T4 lysozyme showed that the effectiveness of 
doing so by single amino acid substitutions seemed limited (Karpusas et al., 1989).  A more 
general and possibly more powerful approach is by using automated design procedures that 
permit the consideration of multiple substitutions with alternative side-chain packing 
arrangements.   
 Several side-chain packing algorithms have been developed in which core redesign has 
been simplified by placing the side-chains on a rigid template.  The side-chain 
conformations are usually varied by selecting from a library of rotamers, which are defined 
as statistically significant combinations of dihedral angles of a side-chain (Janin et al., 
1978).  One of the earliest attempts at automated side-chain repacking was implemented in 
the program, known as propack, developed by Ponder and Richards (1987).  Hurley et al. 
(1992) used a modification of this program to redesign the C-terminal domain of T4 
lysozyme.  They considered several hundred promising sequences and energy minimized 
the best candidates.  These redesigned proteins folded into native- like structures, but their 
stabilities were lower than that of the wildtype protein.   
 Programs such as propack make a direct attack on the combinatorial problem of 
finding the globally optimal arrangement of side-chains on a fixed template.  The 
astronomical number of possible rotamer combinations limits the size of the rotamer library 
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and the number of positions that are allowed to vary in sequence.  In addition, these 
algorithms have no guarantee of finding the structure with the lowest energy. 
 A different approach that has been developed recently is to iteratively eliminate the so-
called dead-ending rotamers, i.e. those rotamers that cannot be part of the lowest energy 
structure (Desmet et al., 1992; Goldstein, 1994).  This improvement allowed the extremely 
rapid testing of the 1040 to 1060 possible rotamer sequences in a reasonable amount of time, 
thereby permitting the use of more detailed rotamer libraries and the consideration of larger 
numbers of sites for repacking. 
 The ORBIT (Optimization of Rotamers By Iterative Techniques) protein redesign 
program allows use of several alternative versions of the dead end elimination theorem 
(Dahiyat & Mayo, 1996, 1997a, 1997b; Dahiyat et al., 1997).  Several optional terms in the 
forcefield and alternative design strategies were developed using feedback from the 
redesign of two small proteins:  the 56 residue b1 domain of streptococcal protein G 
(Dahiyat & Mayo, 1997a, 1997b; Su & Mayo, 1997) and 33 residue peptides that form 
homodimeric coiled-coils based on GCN4-p1 (Dahiyat & Mayo, 1996).  By implementing 
these strategies, the b1 domain of streptococcal protein G was successfully redesigned with 
substantially enhanced thermal stability.  One variant had a melting temperature in excess 
of 100 °C and an increase in thermal stability of 4.3 kcal mol-1 at 50 °C (Malakauskas & 
Mayo, 1998).   
 For several reasons, it was unclear whether the success of ORBIT with small proteins 
would be directly transferable to larger ones.  For example, the change in exposed surface 
area on unfolding, as well as the change in heat capacity on unfolding both increase 
essentially linearly with protein size (Myers et al., 1995).  Thus a given number of 
substitutions is likely to have a larger effect on stability when the total number of residues 
is small.  Also, a larger proportion of residues are buried in larger proteins compared to 
smaller ones (Janin, 1979; Miller et al., 1987).  This may require the design process to be 
more stringent.  
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 To test the applicability of ORBIT to a larger protein, we used it to redesign the C-
terminal domain of T4 lysozyme.  Two designs were developed:  one without and one with 
a penalty for the incorporation of methionine.  The proteins were constructed, their thermal 
stabilities measured and their crystal structures determined.  To determine the contributions 
made by individual substitutions, we studied proteins with constituent single mutations as 
well as proteins with the designed sequences but with a single site changed back to the 
wildtype sequence. 
 
RESULTS 
Redesigned T4-Lysozyme 
 The coordinates of the starting model were from the atomic resolution crystal structure of 
the cysteine-free pseudo-wildtype T4 lysozyme, referred to as WT* (Matsumura & 
Matthews, 1989).  To obtain the highest possible accuracy the X-ray diffraction data were 
collected to 1.05Å resolution at 100K (Eriksson et al., 1993; B.H.M.M. & B.W.M., 
unpublished).  After removal from the coordinate file of the solvent molecules and the 
alternative side-chain conformations, the crystal structure was energy minimized to relieve 
possible van der Waals clashes and steric strain before its use as the starting model in the 
redesign exercise.  The discrepancy between the backbone atom positions in the crystal 
structure and in the energy minimized structure was 0.21 Å which is less than that between 
the 100K and 293K crystal structures (0.30 Å) (data not shown).  Thus the energy 
minimization resulted in only small changes in the crystal structure.   
 T4 lysozyme has a N-terminal and a C-terminal domain.  The latter is composed of a 
tightly packed a-helical bundle and includes residues 1-11 plus 70-164.  It includes the 
most extensive and well-defined hydrophobic core and the redesign was in this part of the 
molecule.  Twenty-six buried or largely buried residues were selected as contributing to the  
core (Figure A-1(a)).  The amino acids at these positions were allowed to vary with regard 
to both their amino acid identity and their side-chain conformation while the remaining 
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residues were held fixed.  The amino acids allowed at each site were those with 
hydrophobic side-chains, namely alanine, isoleucine, leucine, methionine, phenylalanine, 
tyrosine, tryptophan, and valine.  Proline, glycine and cysteine were omitted from 
consideration to avoid possible disruption of secondary structure and the formation of 
disulfide bonds.  This resulted in about 6 x 1026 amino acid sequences.  By also allowing 
for different side-chain conformations the overall number of possible combinations 
increased to about 4 x 1059.  Based on the most favorable calculated energy the optimal 
design selected by ORBIT had seven substitutions (I78V, V87M, L118I, M120Y, V149I 
and T152V).  It is referred to as Core-7. 
 This design protocol has been found to lead to an over-representation of methionines 
compared to the occurrence of methionine in natural protein cores [unpublished results].  
The larger number of possible rotameric states for methionine leads to a proportionately 
over-representation of methionine in the rotamer library in comparison to other amino 
acids.  It is also known that methionine-to- leucine substitutions at geometrically 
appropriate sites can enhance stability (Lipscomb et al., 1998).  To take these factors into 
account, the design procedure was repeated with a penalty of 10 kcal/mol for each 
methionine included.  With this penalty in place, ORBIT selected the ten-fold mutant 
("Core-10") which has the mutations shown in Figure A-1(b).  In the present instance the 
effect of the penalty was to both prevent the selection of new methionines and eliminate 
methionines present in the wildtype protein. 
 In order to obtain calculated energies for the various single, double and other mutants that 
had been constructed, the same procedure was applied without allowing amino acid 
sequence variation at the 26 sites.  Energies were determined in the presence and absence 
of the methionine penalty (Table A-1). 
 
Thermal Stability 
 Table A-1 includes the thermodynamic data for Core-7, Core-10, and the other variants.  
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Neither Core-7, Core-10, nor any of the revertants is as stable as WT*.  The pH of 
maximum stability for both Core-7 and Core-10 is between pH 5 and 5.5 (data not shown).  
This is similar to WT* (Anderson et al., 1990) and suggests that the strong salt bridges, 
especially that between His31 and Asp70, are not significantly perturbed by either set of 
mutations. 
 
Crystal Structures 
 Structures were determined for almost all of the proteins that had not been analyzed 
previously (Table A-2).  Most crystallized isomorphously with WT* in space group P3221.  
Diffraction data were generally to high resolution with an estimated uncertainty in the 
main-chain atom positions of 0.1 Å.  Although the diffraction data were collected at 100K, 
the crystal structures are assumed to be accurate representations of the structure at room 
temperature.  This is supported by comparisons of pairs of 100K and 293K crystal 
structures for the wildtype protein, WT*, and several mutants not included in this study 
(B.H.M.M. & B.W.M., unpublished results).   
 Core-7 crystallized in space group F222 with two or three molecules in the 
asymmetric unit and diffracted to 2.4 Å resolution, but it has not been possible to use 
molecular replacement to solve the structure.  Crystals of M87V/Core-7 were also non-
isomorphous with WT*.  In this case there were three molecules per asymmetric unit and it 
was possible to determine the structure to 1.56 Å resolution.  Crystals of the single-site 
revertant I118L/Core-7 were isomorphous with WT* and the structure was determined to 
high resolution (Table A-2).  As will be apparent from the behavior of Core-10 revertants, 
however, the structure of M87V/Core-7 and I118L/Core-7 cannot be reliably used to infer 
the structure of Core-7 itself. 
 The redesigned protein Core-10 crystallized isomorphously with WT* and its structure 
was determined to 1.65 Å resolution.  The structure is generally similar to WT* but also 
has some distinct differences in both the backbone structure and the side-chain 
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conformations (Figure A-2(a)).  The average discrepancy between the main-chain atoms of 
residues 81-161 in Core-10 and WT* is 0.49 Å (Table A-4) which is about three times the 
combined uncertainty in the positions of the backbone atoms in each structure.  When sites 
106-123 are excluded from the least-squares superimposition to avoid incorporating the 
effect of the shifts in helices F and G, the discrepancy is 0.21 Å (Table A-3).  This shows 
that the backbone structure of most of the C-terminal domain is well conserved, but within 
helices F and G some atoms move substantially (up to about 2.8 Å) (Figure A-3 (a)).  The 
shift in helix F is associated with the breaking of the hydrogen bond between Thr109 O and 
Gly113 N.  This distance increases from 3.0 Å to 4.2 Å.  The breaking of this hydrogen 
bond was also observed in the crystal structure of the single mutant Val1116Ile (Hurley et 
al., 1992).  The outward shift of helix F creates a cavity to which a water, HOH310, binds 
and is within hydrogen bonding distance of Ala111 O (2.9 Å with a C—O...HOH angle of 
100°). 
 The temperature factors for the side-chain atoms at the ten sites of mutation in the crystal 
structures of Core-10 and of WT* are quite similar, indicating that these side-chains are not 
disordered; nor is there any indication of a molten globular state (Table A-4). 
 Comparison of the crystal structures of WT* and Core-10 reveals that the side-chain 
rotameric states are completely conserved at all of the non-substituted sites (Table A-5).  
Conservation also occurred at all but one of the substitution sites, the single exception 
being Met1026Leu, where both c1 and c2 changed (Table A-5; Figure A-5(a)). 
 
DISCUSSION 
The overall objective of the present experiments was to use ORBIT to identify 
variants of T4 lysozyme that had repacked cores and were more stable than wildtype.  The 
most promising variant identified by the design process, Core-7, was found to be a 
functional lysozyme but with melting temperature reduced by 9.8°C, which corresponds to 
a destabilization of 3.5 kcal/mol relative to WT*.  Change of the design procedure to 
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include a penalty for methionine residues led to a modified design, Core-10, which was 1.1 
kcal/mol more stable than Core-10 but still not equal to WT*.  In the following sections we 
discuss these findings in more detail with their implications for future design initiatives. 
 
Energetics of the Designed Variants 
 As noted above, neither of the designed variants was as stable as wildtype lysozyme.  This 
is at variance with the success of ORBIT in predicting stabilized variants of the b1 domain 
of protein G and coiled-coils based on GCN4 (Dahiyat & Mayo, 1996, 1997a, 1997b; Su & 
Mayo, 1997).  It is, however, in agreement with earlier experiments on T4 lysozyme.  
Hurley et al. (1992) used a computational procedure to identify combinations of amino 
acids that would repack the core.  Some possible combinations were suggested but their 
stability was, at best, slightly less than the native molecule.  Also Baldwin et al. (1993) 
used a genetic approach to select variants that had repacked cores.  Again, a large number 
of variants were identified, but none had stability greater than that of WT*. 
 One possible inference of these results is that it may be energetically more costly to 
repack larger proteins than smaller ones.  In a very small protein most side-chains may be 
at least partly in contact with solvent.  This may allow them freedom to be substituted, or to 
adjust their positions in response to substitutions at nearby sites.  Within the core of a 
larger protein the side-chains tend to be tightly packed by their neighbors and it is more 
difficult for the structure to relax in response to introduced changes. 
 
Calculated and Observed Stabilities 
 The stabilities of the various T4 lysozymes predicted by ORBIT are compared with those 
determined experimentally in Table A-1 and Figure A-4.  These two energy terms do not 
have the same definition, but they are expected to correlate.  For T4 lysozyme the 
experimental DDG is traditionally defined to be the free energy of unfolding relative to the 
WT* protein (Elwell & Schellman, 1975; Grütter et al., 1987).  DDG refers to the free 
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energy of unfolding and a positive value indicates that the protein is more stable than WT*.  
The ORBIT score is the sum of the calculated energies of interactions for the side-chains 
that are allowed to vary.  The energetically more favorable ORBIT scores are in the 
negative direction.  For the individual mutations, excluding sites 102 and 103, there is a 
possible correlation between the calculated and observed energies (Figs. 4(c), 4(d)).  This is 
equally apparent whether or not the ORBIT score includes the methionine penalty.  
However, when all sites and all constructs are considered no clear-cut correlation emerges 
(Figs. 4(a), 4(b)).  This lack of agreement between the experimental and the predicted 
energies could be due to a number of factors including the following.  (1) Some of the 
mutant proteins experience significant changes in the main-chain (see below).  These may 
invalidate the rigid template assumption.  (2) The rotameric states of some of the side-
chains in the calculated structures (in particular, in Core-10) do not agree with those in the 
actual proteins leading to inaccurate energies.  (3) The forcefield, which was based in part 
on experience with smaller proteins, may not be appropriate for proteins of the size of T4 
lysozyme. 
 
Predicted and Observed Structure of Core -10 
 Figure A-2(b) compares the backbone of the predicted and observed structure of Core-10.  
For residues 81-105 plus 124-161 the backbone agreement is generally good but in the 
remaining region there are shifts up to 2.8 Å.  Likewise, some but not all of the side-chain 
conformations are correctly predicted.  Eight of the ten modified side-chains adopt the 
rotameric state that was predicted (Table A-5).  The two exceptions are Ile87 and Ile149 in 
which cases the differences are restricted to the c2 torsion angle.  At another site 
(Val1036Ile) the c2 angle differs from the predicted structure more than 30°.  Of the ten 
non-alanine residues that were included in the design process but did not change identity 
nine had correctly-predicted rotamers.  The three incorrect predictions plus the prediction 
that is somewhat in error are discussed briefly below. 
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(a) Val876Ile (Dc1 = 25°, Dc2 = -96°) 
 With reference to the crystal structure of WT*, the introduction of the CD1 carbon atom 
of Ile87 is associated with the outward movement of the side-chains of Leu118 and Glu122 
as well as other shifts (Figure A-5(a)).  Notwithstanding these shifts, potential steric 
clashes appear to cause the CD1 methyl of Ile87 to adopt a rotameric state that is fairly 
uncommon (frequency of 14%; Blaber et al., 1994).  Before the design process, the starting 
model was energy minimized.  Comparison of the design to the crystal structure of WT* 
shows that the distal part of the side-chain of Gln122 has moved outward in the designed 
structure.  At least in part this suggested that an isoleucine in a common rotameric state 
could be accommodated at this site.  (Gln122 is a surface residue that was held fixed during 
the design process.  Thus, its outward movement is the result of the energy minimization 
step and not the rotamer selection step.) 
 
(b) Leu91 (Dc1 = 24°, Dc2 = 139°) 
 Leu91 was included in the design process but its identity remained unchanged.  It was 
predicted, however, that the two methyl groups at the end of the leucine side-chain would 
flip by about 180°.  This change is not observed.  Rather, the conformation of Leu91 in 
Core-10 is essentia lly identical to WT*.  The change in conformation in the designed 
structure presumably occurs in concert with the introduction of an isoleucine at site 87.  As 
mentioned above, Ile87 is predicted to have an altered conformation in Core-10.  To avoid 
close contact with this residue Leu91 in the designed structure Ile87 adopts a different 
rotamer.  Thus the error in prediction at the two sites seems to be coupled. 
 
(c) Val1036Ile (Dc1 = 1°, Dc2 = -32°)  
 The side-chain of Ile103 adopts a rotameric state which has a frequency of only 3% 
among proteins in general.  This is essentially as predicted although the observed c2 is 32° 
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from that anticipated.  The distal methyl groups of the side-chain adopt positions that are 
close to those predicted (Figure A-5(b)).  This coincidence occurs in spite of the change in 
the side-chain torsion angle and extensive shifts in several of the surrounding residues 
(especially 106-111).  The superimposition of the crystal structure of WT* on the crystal 
structure of Core-10 suggests that these shifts may be caused in part by the need for Val111 
to avoid a close contact with the CD atom of Ile103.  Since the design process assumes a 
rigid framework such backbone shifts are not anticipated. 
 
(d) Val1496Ile (Dc1 = -2°, Dc2 = 111°) 
 Ile149 was predicted to adopt the most common rotameric state for leucine which has a 
frequency of 57%.  Instead, it adopts a rotameric state which has a frequency of 14%.  The 
design procedure deleted the four water molecules that are bound within the T4 lysozyme 
molecule (Weaver & Matthews, 1987).  The removal of one of these resulted in a cavity 
into which the CD methyl group of Ile149 was predicted to occupy.  In actuality, the water 
molecule remains bound to Core-10 and forces the isoleucine to adopt an alternative 
rotamer.  [The water HOH197 shifts by 0.7 Å but retains its hydrogen bonding partners 
(Figure A-5(c)).] 
 
Internal Water Molecules 
Four buried waters occupy three cavities in WT* (Weaver & Matthews, 1987; Xu et al., 
2001).  These four waters were removed from the coordinate file during the design process.  
Two of the cavities are in the C-terminal domain and were therefore available for repacking 
by side-chain atoms.  The first of these two cavities is next to site 149 and has already been 
discussed.  The second cavity decreases slightly in the designed structure following the 
replacement of Thr152 with a valine.  In the crystal structure, however, the water molecule 
(HOH173) still appears in the cavity although it is displaced towards the surface of the 
protein by about 1 Å. 
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Core-10 Revertants 
Selected single-site revertants were constructed to address, both energetically and 
structurally, how the different sites interact with each other.  The sites chosen for reversion 
were those where the point mutant had the largest effect on the stability of WT* (Table A-
1).  The single-site revertants of Core-10 are discussed briefly below. 
 
 (a) Leucine1026Methionine/Core-10 
 In the revertant L102M/Core-10, the leucine at site 102 in Core-10 was changed back to a 
methionine as in the wild-type sequence.  The structure, however, remains very similar to 
that of Core-10 (rmsd of 0.14 Å).  Thus, the amino acid change at site 102 back to that of 
the wildtype sequence does not recover the backbone atoms positions of the WT* structure.  
Met102 in the revertant adopts a side-chain conformation that is very similar to that of 
Met102 in WT* but that differs from that of Leu102 in Core-10 by a rotation of 85° about 
the c1 torsion angle. 
In the L102M/Core-10 revertant the sum of the DDG's of the remaining nine 
constituent mutants is essentially the same as the measured DDG for the revertant (Table A-
1, Figure A-6).  This suggests that each of these nine sites is acting independently and that 
there is no interaction between them. 
 
 (b) Isoleucine1036Valine/Core-10 
 The discrepancy between revertant I103V/Core-10 and Core-10 for the main-chain atoms 
from sites 81-161 is 0.47 Å while it is only 0.22 Å relative to WT*.  Thus the change of 
this single site back to the wildtype sequence is sufficient to revert the Ca positions in 
Core-10 essentially back to those of WT* (Figure A-3(b)).  [It should be noted that the 
discrepancy between Core-10 and V103I is 0.68 Å, showing that the introduction of this 
single mutation is not sufficient to cause all the structural changes seen in Core-10.  At the 
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same time, the single mutant V103I crystallized in a different space group and has a hinge-
bending motion relative to WT*.  This results in shifts in the C-terminus of helix C which 
makes detailed structure comparison more difficult.] 
The change back to a valine from an isoleucine at site 103 removes a buried methyl 
group.  This is correlated with Ala111 moving into a position similar to that occupied by 
Val111 in WT* and with helix F reverting to its wildtype conformation.  It appears that the 
potential clash between the Ile103 CD1 methyl group and the CB methyl of Ala111 causes 
helix F to move outwards.  The I103V revertant resulted in an 0.8 kcal/mol increase in 
stability relative to Core-10.  This is notwithstanding the decrease in hydrophobicity 
resulting from the Ile6Val substitution and clearly suggests that the original V103I 
replacement introduces strain in the Core-10 structure. 
The I103V/Core-10 revertant shows the largest non-additivity in DDG of all the variants 
studied (Figure A-6).  This also suggests that the remaining nine sites have the greatest 
degree of repacking and synergistic interaction. 
 
 (c) Revertant Protein, Alanine1116Valine/Core-10 
 In the Core-10 revertant A111V/Core-10, the alanine at position 111 in the Core-10 
background is changed back to a valine as in the wildtype sequence.  If the vicinity of site 
111 in Core-10 was tightly packed, it would be expected that the introduction of two 
methyl groups would result in large structural changes.  This, however, is not the case.  The 
observed changes are actually modest.  Val111 moves closer to the core by about 0.3 Å 
compared to Ala111 in Core-10, and atoms surrounding the reintroduced valine side-chain 
move by at most a few tenths of an Angstrom (Figure A-7(a)).  The two methyl groups of 
the valine essentially refill the cavity that was created by the Val1116Ala substitution in 
Core-10.  The most dramatic change in atomic position in the revertant is a 2 Å movement 
of the CD1 atom in the side-chain of Ile103.  This movement occurs largely by a rotation of 
about the c2 angle to an energetically unfavorable rotameric state which places the CD1 
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atom at a distance of 2.7 Å from Ile103 CG2 atom (as opposed to 3.8 Å in Core-10). 
The A111V reversion increases the stability of Core-10 by 0.6 kcal/mol (Table A-
1).  The fact that this is an increase rather than a decrease also suggests that the valine side-
chain occupies a preformed cavity and does not introduce any serious steric clashes. 
 
Evidence for Synergy Between the Mutation Sites 
One can ask whether the ORBIT procedure results in genuine repacking of the core 
or, conversely, the individual substitutions act independently.  In the case of Core-10 none 
of the constituent point mutations causes a large change in stability.  Six of the ten 
mutations change the melting temperature by less than 1.0°C and the largest effect is for 
V111A for which the change is 2.9°C (Table A-1).  If there were to be large synergistic 
effects one would anticipate that at least some of the point mutations would be quite 
destabilizing and that these effects would be compensated in the multiple mutant.  This is 
not obviously the case.  The hallmark of synergistic interaction is non-additivity of the 
DDG's.  If each of the substitutions acts independently of the others the change in stability 
of the multiple mutant should equal the sum of the DDG's of its single-site constituents.  As 
can be seen in Table A-1 and Figure A-6, the sum of the DDG's for Core-10 is numerically 
1.0 kcal/mol greater than the observed DDG.  This shows that there is some favorable 
interaction among the redesigned sites, although the effect is modest.  By way of 
comparison, in the "size switch" mutant in which the sizes of adjacent residues were 
switched by the substitutions Leu216Ala and Ala1296Leu, the thermodynamic 
compensation was substantially larger (2.5 kcal/mol) (Baldwin et al., 1996). 
Cooperativity between substitutions at different sites can also be evaluated 
structurally.  Using a cut-off distance of 4.0 Å the average number of residues among the 
26-residue set that are in contact or almost in contact with any given residue is 2.4 (or 1.4 
residue-residue contacts if the threshold is reduced to 3.5 Å).  Thus, even though the 26 
residues are all within the most pronounced hydrophobic core of T4 lysozyme there do not 
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tend to be multiple close contacts between each residue and a multitude of neighbors.  This 
separation of the sites may make cooperativity difficult to achieve.  In the present case the 
design algorithm assumes that selected variants will retain the same backbone structure as 
the parent molecule.  As noted above this is true for much of the C-terminal domain of 
Core-10, but not in the vicinity of the F and G helices. 
In this context it is instructive to contrast the behavior of the Core-10 revertant 
L102M/Core-10 with that of I103V/Core-10.  When the single-site reversion I103V is 
made in Core-10 the structure reverts much closer to that of WT* (Figure A-3(b)).  Also 
the stability of the protein is increased by 0.8 kcal/mol and, in addition, the non-additivity 
of the DDG's increases by 0.3 kcal/mol (Table A-1, Figure A-A-6).  Thus, the I103V/Core-
10 revertant is, in all respects, a more superior design than Core-10 itself (it is more stable, 
more synergistic and has a structure more like WT*).  When the V103I mutation is 
included in the full Core-10 construct, the addition of the CD1 methyl group introduces a 
steric clash which is not compensated by the other replacements and, therefore, leads to a 
relatively large change in the structure. 
In contrast, the behavior of the L102M/Core-10 revertant is quite different.  Here 
the reversion of Leu102 to Met causes almost no change in the Core-10 structure.  At the 
same time (as judged by the equivalence of the DDG's; Figure A-6), it eliminates any 
synergistic interaction between the remaining nine sites.  The L102M/Core-10 structure 
seems "poised" to accept the M102L substitution without structural perturbation, and, in so 
doing, the Leu102 side-chain contributes to the synergistic interaction that is observed in 
Core-10. 
Since the L102M revertant in Core-10 eliminates synergistic interaction between 
the remaining nine sites it implies that the M102L substitution does contribute to 
cooperativity in Core-10.  There is some structural evidence for this.  When the M102L 
mutation is made in WT* it results in a rotation of the side-chain of Phe114 by almost 70° 
into a strained conformation.  (This rotation appears to be mediated indirectly via Trp138 
   
 A-17 
and possibly other residues as well) In Core-10 (and in M102L/Core-10), however, the 
combination of substitutions allows the side-chain of Phe114 to revert to the angle seen in 
WT* (Figure A-7(b)), relaxing the strain that had been introduced. 
 
Success of the Methionine Penalty 
Because of their conformational adaptability methionine side-chains tend to be 
more readily accommodated within a designed protein.  At the same time incorporation of 
multiple methionines can result in a loss of stability (Gassner et al., 1996).  Conversely, 
under favorable circumstances substitutions from methionine to leucine can increase 
stability (Lipscomb et al. 1998).  For these reasons it would seem desirable to avoid the 
introduction of methionines into the designed protein. 
In the present case the imposition of a methionine penalty resulted in four positions in 
Core-7 being retained in Core-10 while I78V and I118L were lost and V87M was replaced 
with V87I.  Meanwhile, five new positions were added, resulting in the loss of two 
methionines:  I100V, M102L, V103I, M106I, and V111A.  In total, Core-10 has three 
fewer methionines than Core-7.  The M102L substitution is known to introduce steric 
clashes (Hurley et al., 1992) and it could be that the additional sites of substitution in Core-
10 arise from the need to minimize this steric interference.  In any event, the incorporation 
of the methionine penalty did increase the stability of the protein by 1.1 kcal/mol. 
 
Conclusions  
One of the main findings of this work is that the introduction of the designed core-
repacking mutations resulted in changes of the backbone up to 2.8 Å.  Also both of the 
designed variants were less stable than the wildtype protein.  Taken together these results 
suggest that genuine core repacking with retention or enhancement of stability may be 
difficult if not impossible to achieve without provision for shifts in the backbone. 
A second finding is that the rotamer angles that occur in WT* are strongly conserved in the 
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mutant.  For the substituted and non-substituted sites in Core-10 there is only one case 
(Met102 -> Leu) where there is a change of rotamer (Table A-5, Figures A-2(a), A-5(c)).  
Conservation of rotamers was also observed in genetically selected core-repacking variants 
of T4 lysozyme (Baldwin et al., 1993).  This suggests that core redesign might be improved 
by favoring models that maintain the side-chain rotamers present in the reference structure. 
If, as was the case with the Core-10 design, a total of 26 sites were allowed to vary, 
the overall number of possibilities is astronomical.  At a given site, however, the packing is 
typically determined by the side-chain itself plus two or three neighbors.  Here the number 
of choices is more limited.  Also since the number of hydrophobic amino acids is fairly 
small, and each amino acid is restricted to distinct rotamers, the choice of substitutions is 
"quantized" (Karpusas et al., 1989).  On the other hand, if the backbone were allowed to 
move it would allow a wider range of substitutions to be considered. 
 
MATERIALS AND METHODS  
Redesign by ORBIT 
All residues of cysteine-free pseudo-wildtype T-4 lysozyme, referred to as WT*, 
were classified as surface, core, or boundary, using a residue classification program, 
RESCLASS (Dahiyat and Mayo 1997) RESCLASS classifies the residues based on their 
Ca and Cß distances from a solvent accessible surface, which is the calculated using the 
Connolly algorithm (Connolly, 1983).  
 We selected 26 core positions located in the C-terminal domain of WT* for design. 
The selected positions were I3, M6, A74, I78, L84, V87, Y88, L91, A97, A98, L99, I100, 
M102, V103, M106, V111, I118, Y120, L121, A129, L133, A146, V149, I150, T152 and 
F153. Positions 3 and 91 were classified as boundary residues but were nevertheless 
included in the core calculations as visual inspection showed them to be significantly 
buried. Position 6 and 3 belong to the N-terminal domain but were considered for design 
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because of their close proximity to the C-terminal core residues. The hydrophobic amino 
acids allowed at all 26 positions were Ala, Val, Phe, Leu, Ile, Phe, Tyr, Trp and Met. An 
expanded version of the backbone dependent rotamer library of Dunbrack and Karplus was 
used for the calculations (Dunbrack R. L. and Karplus M., 1993). For aromatic residues, 
the expansions included the mean c values ± 1 standard deviation about c1 and c2 
torsional angles. For other hydrophobic groups, a similar expansion was performed, but 
was limited only to the c1 torsional angle. Energies for the point mutants were calculated 
by fixing the identities of amino acids at all 26 positions while allowing their rotameric 
conformations to vary based on the rotamer library. The design calculations were run using 
an optimization procedure based on Dead-End Elimination algorithm (Desmet 1992,  
Pierce 2000).  
 
Mutagenesis, protein expression, and purification 
The two redesigns of the C-terminal core of bacteriophage T4 lysozyme, Core-7 
and Core-10, were made by iterative two stage PCR (Landt et al., 1990) using the gene for 
the cysteine-free (C54T/C97A) pseudo-wildtype (WT*) T4 lysozyme as the template.  The 
BamHI/HindIII digested PCR products were ligated into the vector PH1403.  The single 
(where they did not previously exist), double, and revertant mutants were made by the 
inverse PCR (Hemsley et al., 1989).  The gene for WT*, Core-10, or Core-7 in the vector 
PH1403 was used as the template.  The individual single site mutants (relative to WT*) 
were drawn from existing stocks except for I78V, V87I, I100V, V103I, M106I, L118I, 
M120Y, and L133F.  The double mutant V149/T152V was made in the WT* background.  
The DNA sequences of the new constructs were confirmed by automated methods 
incorporating the polymerase chain reaction (Perkin-Elmer ABI PRISM 377 DNA 
sequencer).  The vectors were transformed into E. coli RR1 cells for over-expression.  The 
mutant proteins were over-expressed and purified by standard methods (Alber & Matthews, 
1987; Muchmore et al., 1989; Poteete et al., 1991).  The molecular mass of the mutant 
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proteins were checked with a Perspective Biosystems Voyager-DE MALDI/TOF mass 
spectrometer.  The buffer used for protein storage was 0.1 M sodium phosphate pH 6.5, 
0.55 M NaCl, and 0.02% NaN3.  As judged by the fact that each lysozyme caused cell lysis 
and behaved similarly during purification we assume that all have activity similar to that of 
WT*. 
 
Thermal Unfolding 
Circular dichroism monitored thermal stability data were collected at 223 nm using 
a JASCO model J-600 spectropolarimeter and the Hewlett-Packard model HP89101 
thermal control system (Eriksson et al., 1993).  The buffer was 0.10 M sodium chloride, 1.4 
mM acetic acid, 8.6 mM sodium acetate, pH 5.35, with protein concentrations of 0.01 to 
0.03 mg/ml as determined from optical density at 280 nm (Elwell & Schellman, 1975).  
Unfolding profiles were analyzed by means of the two-state model to determine the 
temperature of melting (Tm) and the van’t Hoff enthalpy at the melting temperature (DH) 
(Zhang et al., 1995).  At least three independent trials were done for each mutant.  
Averaged values of Tm and DH were used to calculate DG° at 61°C by means of an 
integrated form of the Gibbs-Helmholtz equation (Hawkes et al., 1984) assuming a DCp of 
2.5 kcal/mol-K.  DDG values were computed as DG°(mutant) - DG°(WT*). 
 
Crystallization 
It was possible to crystallize both of the two designed proteins, selected single 
mutant back revertant proteins, and the previously unpublished single mutants.  Thirteen of 
the fifteen new proteins were crystallized in space group P3221 isomorphously with the 
wildtype protein in 2 M K/Na phosphate buffers as previous described (Eriksson et al., 
1993).  Core-7 crystallized in space group C2  in 100 mM Na/K phosphate buffer pH 6.7 
and 20% MPD.  V103I crystallized in space group P212121 in solutions of 0.1 M Hepes pH 
7.5, 20% PEG3400, and 5% isopropanol.  M87V/Core-7 crystallized in space group C2 in 
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25% PEG3400, 5% PEG600, 200 mM NaCl, 100 mM Na/K phosphate, pH 6.7 and Fos-
choline 12 at its critical micelle concentration. 
 
X-ray Data Collection 
Since the 100 K structure of the pseudo wildtype had been used as the template in 
the design process, X-ray data of the new proteins were collected at 100 K.  Crystals of 
proteins grown from the high salt solutions were mounted in paratone and flash cooled.  
Crystals of Core-7 and of V103I were flash cooled in rayon loops containing cryogenic 
reservoir solutions.  X-ray data for Core-7 and I103V/Core-10 were collected at beamline 
7-1 at SSRL with monochromatic radiation having a wavelength of 1.06 Å and a MAR 
image plate.  X-ray data for the remaining structures were collected in-house with 1.54 Å 
radiation and a Rigaku RAXIS4 image plate.  The data were integrated with Mosflm and 
scaled with Scala (Leslie, 1992; Evans, 1994 ) 
 
Structure Determination 
The structures of V103I and M87V/Core-7 were solved by molecular replacement 
using the program EPMR (Kissinger et al., 1999) while the remaining structures were 
determined by molecular substitution using the coordinates of WT* (Table A-2) as the 
starting model.   
Structure Refinement 
The crystal structures were refined using the refinement package TNT (Tronrud et al., 
1987; Tronrud, 1997) following the procedures described previously (Eriksson et al., 
1993).  The Xfit molecular graphics module of XtalView was used for model rebuilding 
(MacRee ,1992).   
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Table A-1.  Stabilities of mutant lysozymes. The first two columns give the score calculated by 
ORBIT, respectively, without and with a penalty for incorporation of methionines (see text).  DTm 
is the change in melting temperature relative to WT* which is 65.5°C under these conditions.  DH 
is the enthalpy of unfolding at Tm.  DDG is the change in the free energy of unfolding relative to 
WT*.  "Non-additivity of DDG" is the difference between DDG measured for the multiple construct 
and the sum of the DDG's for the constituent single mutants.  Uncertainties in DTm are about 
+0.2°C, in DH about +5% and in DDG about 0.15 to 0.4 kcal/mol (increasing from the more -stable 
to the least-stable mutants).  As is also explained in the text more negative ORBIT scores 
correspond to proteins that are predicted to be more stable whereas more negative DDG values 
correspond to proteins that are of lower stability.  
                                                                                                                                                        
  ORBIT    Non 
  score with                                                           additivity 
 Score penalty DTm      DH     DDG     of DDG 
           Mutant  (kcal/mol) (kcal/mol) (°C) (kcal/mol) (kcal/mol)   (kcal/mol) 
                                                                                                                                                            
 
I78V -364 -322 -2.1 127 -0.8 -- 
V87M -349 -299 -6.3a 113a -2.3a -- 
L118I -352 -321 -3.1 123 -1.2 -- 
V87I -362 -330 -0.8 127 -0.3 -- 
I100V -365 -333 -1.1 129 -0.4 -- 
M102L -316 -292 -2.3 118 -1.0 -- 
V103I -295 -263 -1.5 130 -0.5 -- 
M106I -362 -338 0.6 132 0.2 -- 
V111A -354 -322 -2.9 121 -1.1 -- 
M120Y -365 -335 -0.1 126 -0.1 -- 
L133F -368 -336 -0.7 130 -0.3 -- 
V149I -362 -323 -0.3 128 0.0 -- 
T152V -365 -333 0.8b 127b 0.2b -- 
Core-7 -382 -341 -9.8 103 -3.5 1.0 
M87V/Core-7-368 -344 -5.0 117 -3.0 -0.8 
I118L/Core-7 -381 -350 -9.5 103 -3.3 0.0 
Core-10 -371 -363 -6.4 97 -2.4 1.1 
L102M/Core-10-372 -356 -7.2 101 -2.6 -0.1 
I103V/Core-10-370 -363 -4.0 110 -1.6 1.3 
A111V/Core-10-269 -261 -4.8 106 -1.8 0.5 
WT* -345 -305 0.0 132 0.0 -- 
                                                                                                                                                           
 
aFrom Gassner et al. (1999). 
bFrom Xu et al. (2001).  Note that DH is a corrected value.
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Table A-2.  Crystal and refinement statistics. 
                                                                                                                                                                                                                       
 
  Cell dimensions  
 a,b   c Resolution Rmerge Completeness R-factor Dbonds Dangles 
Protein (Å) (Å)      (Å)  (%)        (%)    (%)  (Å)   (°) 
 
WT* 60.1 95.5 1.05 3.4 95.3 (88) 12.85 0.019 2.7 
I78V 60.0 95.23 1.58 4.6 94.6 (88) 19.6 0.017 2.5 
V87I 59.6 95.3 1.58 5.5 94.1 (77) 17.2 0.016 2.3 
I100V 59.8 95.6 1.45 6.0 97.9 (86) 19.1 0.015 2.4 
V103I (a) (a) 1.5 5.6 95.3 (78) 19.0 0.018 2.6 
M106I 60.1 95.6 1.67 4.6 96.9 (84) 18.5 0.018 2.5 
L118I 60.2 95.9 1.65 4.9 94.0 (91) 20.1 0.017 2.6 
M120Y 60.3 95.3 1.54 5.1 97.7 (96) 18.7 0.017 2.5 
L133F 60.1 96.2 1.62 4.4 96.5 (79) 18.9 0.016 2.3 
V149I/T152V 59.8 95.4 1.52 5.8 93.5 (71) 17.6 0.016 2.5 
M87V/Core-7 (b) (b) 1.56 5.2 96.0 (91) 18.6 0.020 2.9 
I118L/Core-7 60.0 95.6 1.56 4.9 91.1 (91) 19.8 0.016 2.7 
Core-10 60.0 96.6 1.65 7.6 96.9 (85) 17.8 0.016 2.7 
L102M/Core-10 59.5 96.2 1.57 6.1 90.6 (75) 17.7 0.018 2.5 
I103V/Core-10 60.0 95.9 1.55 6.0 96.7 (97) 18.7 0.015 2.3 
A111V/Core-10 59.5 95.5 1.90 6.1 99.0 (100) 18.8 0.016 2.6 
                                                                                                                                                                                                                       
 
(a) V103I crystallized in space group P212121 with cell dimensions a = 30.8 Å, b = 54.9 Å and c = 88.4 Å 
(b) M87V/Core-7 crystallized in space group C2 with cell dimensions a = 156.5 Å, b = 61.9 Å, c = 67.4 Å, b  = 112.3°. 
 
   
 A-29 
Table A-3.  Backbone shifts in designed and mutant T4 lysozymes.Each entry in the table gives the 
root-mean-square difference between the main-chain atoms of the specified structure and WT*.  The 
column labeled "C-terminal domain" gives the rms shift for essentially the whole C-terminal domain 
(i.e. for residues 81-161).  The column labeled "C-terminal domain without helices F and G" gives the 
rms shifts for residues 81-105 plus 124-161.  Superpositions were carried out using EDPDB (Zhang 
& Matthews, 1995). 
 
 
  Shift, C-terminal domain 
 Shift, C-terminal domain without helices F and G 
               Protein                 (Å)                 (Å) 
                                                                                                                                                            
 
Core-10 design 0.19 0.23 
Core-10 crystal 0.49 0.21 
L102M/Core-10 0.49 0.22 
I103V/Core-10 0.22 0.18 
A111V/Core-10 0.55 0.26 
M87V/Core-7 
     Molecule A 0.40 0.36 
     Molecule B 0.49 0.50 
     Molecule C 0.44 0.46 
I118L/Core-7 0.28 0.25 
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TableA- 4.  Comparison of temperature factors at mutated sites in WT* and Core-10.  The Wilson B-
value is 14.4 Å² for WT* and 17.9 Å² for Core-10. 
 
                                                                                                                                                            
 
          Main-chain B (Å²)                   Side-chain B (Å²)        
 
          Residue WT* Core-10 WT* Core-10 
                                                                                                                                                          
 
87 13.1 20.0 17.7 26.0 
100 11.6 17.2 13.0 15.4 
102 12.3 17.0 13.5 17.3 
103 13.5 19.9 15.7 23.3 
106 17.6 21.4 16.6 21.5 
111 18.1 33.5 16.7 27.8 
120 12.1 15.9 16.4 19.4 
133 11.1 13.9 12.3 14.4 
149 10.2 16.3 11.4 15.1 
152 11.3 19.2 11.4 14.1 
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Table A-5.  Comparison of the side-chain torsion angles at the 26 sites open to modification in T4 
lysozyme. The torsion angles are listed for the crystal structure of WT*, the energy minimized model of 
WT* used in the design process, the predicted structure of Core -10, and the observed crystal structure.  
The five sites that started as alanine and remained alanine (sites 74, 97, 98, 129, 146) are not shown.  The 
IUPAC conventions for determining c1 and c2 were followed except for the following two changes 
which were made to simplify comparison of unlike side-chains.  (1) Following Blaber et al. (1994) the c1  
torsion angle of valine was measured using the CG2 carbon atom rather than CG1 as in the standard 
IUPAC nomenclature.  This is about the same as increasing c1 by 120° and makes the gauche-, trans and 
gauche+ conformations for valine the same as for the other amino acids.  (2) For the phenylalanine and 
tyrosine side-chains marked with an asteris k the c2 value was decreased by 180°.  This change essentially 
corresponds to a renaming of the ring atoms.  c3 values are not shown but in general agree fairly well at 
any given site.  At sites 6, 102, 106 and 120 the maximum discrepancy in c3 among the structures being 
compared is, respectively, 21°, 2°, 19° and 3°. 
                                                                                                                                                           
                                             Energy 
                                                      minimized     Core-10             Core-10 crystal 
             WT*         WT*                         design       structure  
           (c1,c2)       (c1,c2)       (c1,c2)        (c1,c2) 
                                                                                                                                                            
3 Ile (183, 57)              Ile (186, 52) Ile (185, 62) Ile (186, 60) 
6    Met (184, 201)   Met (188, 197) Met (185, 191) Met (191, 213) 
78   Ile (285, 163) Ile (290, 161) Ile (285, 168) Ile (277, 163) 
84    Leu (302, 175)   Leu (305, 175) Leu (300, 174) Leu (304, 173) 
87   Val (307, --)                 Val (309, --) Ile (282, 49) Ile (307, 313) 
88   Tyr (184, 82)              Tyr (185, 82) Tyr (178, 93) Tyr (186, 85) 
91    Leu (297, 168.5)     Leu (291, 173.1) Leu (268, 32.1) Leu (292, 170.8) 
100  Ile (296, 163) Ile (305, 158) Val (303, --) Val (292, --) 
102  Met (293, 186)  Met (297, 186) Leu (193, 63) Leu (178, 68) 
103 Val (293, --)              Val (293, --) Ile (282, 49) Ile (283, 17) 
106  Met (76, 182)           Met (72, 179) Ile (65, 172) Ile (78, 183) 
111 Val (303, --)               Val (305, --) Ala (--, --) Ala (--, --) 
118  Leu (293, 169)  Leu (288, 167) Leu (289, 176) Leu (291, 167) 
120 Met (300, 175)  Met (294, 171) Tyr (276, 153*) Tyr (283, 124*) 
121 Leu (290, 172)  Leu (295, 170) Leu (282, 174) Leu (289, 177) 
133 Leu (282, 164)  Leu (286, 161) Phe (271, 104*) Phe (267, 114*) 
149 Val (296, --)               Val (299, --) Ile (298, 169) Ile (296, 280) 
150 Ile (292, 171)              Ile (289, 168) Ile (286, 169) Ile (288, 176 
152 Thr (307, --)               Thr (311, --) Val (296, --) Val (297, --) 
153 Phe (280, 303)   Phe (280, 299) Phe (275, 324) Phe (282, 308) 
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Figure A-1.  (a) Ca trace of the WT* T4 lysozyme backbone showing, in red, the 26 
sites that were allowed to vary during the design process.  The sites are identified at the 
left. 
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Figure A-1(b) Structure of T4 lysozyme showing the ten sites that were substituted in Core-10. 
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Figure A-2.  (a) Stereo view showing the superposition of the crystal structure of Core-
10 (open bonds) on the crystal structure of WT* (solid bonds).  For clarity only the 
side-chains of the ten substituted residues are shown. (b) Superposition of designed 
Core-10 (solid bonds) on to the observed crystal structure (open bonds). 
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Figure A-3.  Plots showing differences in Ca-Ca separation in different crystal 
structures.  The contours start at +0.5 Å and have 0.5 Å intervals.  The red contours 
correspond to decreased separation and the blue contours correspond to an increase in 
distance.  (a) Core-10 versus WT*.  (b) I103V/Core-10 versus WT*. 
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Figure A-4.  Comparison of the energies calculated using ORBIT with the observed 
protein stability (Table A-1).  (a) Comparison of single and multiple mutants with the 
ORBIT score determined without a penalty for incorporation of methionine.  (b) 
Comparison of single and multiple mutants with the ORBIT score determined with a 
penalty for incorporation of methionine.  (c) Comparison of single mutants with the 
ORBIT score determined without a penalty for incorporation of methionine.  The 
straight line is the best fit to the data excluding M102L, V103I and WT*.  (d) 
Comparison of single mutants with the ORBIT score determined with a penalty for 
incorporation of methionine.  The straight line is the best fit to the data excluding 
M102L, V103I and WT*.   
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Figure A-5.  Stereo views of the sites of discrepancies between the predicted and 
observed structure of Core-10.  (a) Crystal structure of WT* (open bonds) 
superimposed on the crystal structure of Core-10 (closed bonds) in the vicinity of site 
87.  (b) Design of Core-10 (open bonds) superimposed on the crystal structure of Core-
10 (closed bonds) in the vicinity of site 102.  (c) Crystal structure of WT* (open bonds) 
superimposed on the crystal structure of Core-10 (closed bonds) in the vicinity of site 
149. 
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Figure A-6.  Comparison of the observed stabilities of the multiple mutants (DDG, 
Table A-1, red bars) with the sums of the DDG's of the constituent single mutants 
(purple bars.) 
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Figure A-7.  (a) Stereo diagram showing the superposition of the single-site revertant 
A111V/Core-10 (solid bonds) on Core-10 (open bonds).  (b) Superposition of the 
structure of the single mutant, M102L (Hurley et al., 1992) (open bonds) on Core-10 
(solid bonds). 
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Appendix B 
Using Positional Bias for Minimizing Surface Charge of Ubiquitin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work was done in collaboration with Andy Robertson’s group in University of Iowa, 
The predicted ubiquitin variants are being made and tested in his group. 
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Our principal interest in minimizing charge on ubiquitin is to reduce or remove 
the effects of coulombic interactions on pKs.  The idea is that we could explore ionization 
behavior of isolated residues in a protein background where we could ident ify how 
factors such as hydrogen-bonding and solvation affect the properties of ionizable side 
chains. In "normal" proteins, charge-charge interactions probably dominate ionization 
behavior and it is thus difficult to identify the other effects with confidence.  The broader 
significance of all this is gaining a better understanding of the chemical and physical 
properties of protein surfaces. 
Ubiquitin residues were classified as core, surface and boundary using a residue 
classification program, RESCLASS. We considered only the 12 charged surface positions 
(6, 16, 18, 24, 39, 51, 52, 63, 64, 68, 72, 74) for design (Figure B-1). Amino acids 
allowed at each design position were Thr, Ser, Gln, Asn, Ala and the wild type charged 
amino acid. The non-design surface residues were fixed to have the wild type amino acid 
identity but were allowed to vary in their rotameric conformations. We used our most 
expanded rotamer library for all calculations. A Secondary structure propensity term was 
applied  to beta sheet surface positions (4, 16, 64, 68, 72) and calculations were run with 
propensity scale factors of 0.0, 1.0 and 2.0. Using this term in our calculations helps in 
selection of good ß-sheet forming residues. We used a sequence bias program (SBIAS) to 
rank order the mutations predicted in our calculations. This program can be used to direct 
the amino selection towards the wild type sequence or force the amino acid to be 
different from the wild type. This is accomplished by adding a bias energy to the design 
positions. A charged position that requires a very high bias energy to select for the wild 
 B-3 
type identity is considered less important for the structural stability of the molecule than a 
position that requires a very low energy and hence, a predicted neutral residue can 
replace it more easily. We have ranked all the 12 charged positions considered in the 
calculations by varying the bias energy from high to low. The mutations predicted in 
calculations run with different secondary structure propensity scale factors are listed in 
tables B-2, B-3 and B4. Table B-1 represents the minimum number of changes suggested 
by the calculations to neutralize the charged residues on the protein surface. It is possible 
that the protein may tend lose stability after a few mutations. At that point, it may be 
necessary to redesign some of the other surface positions that could help to accommodate 
more charged to neutral mutations. 
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Secondary structure  Secondary structure  Secondary structure  
propensity 0.0 propensity 1.0 propensity 2.0 
 
H68Q H68Q  H68T 
E18N E18N E16T 
E16N E16N E64Q 
D39T E64Q E18N 
E64Q R72T R72T 
R72Q E24Q K6T 
R74Q D39T, K63Q, R74Q E24Q 
K6N, E24Q K6Q K63Q 
K63Q D52Q D39N, R74Q 
D52Q E51N D52Q 
E51N  E51N 
 
  
 
 
 
 
 
 
Table B-1. Mutations predicted by SBIAS. The mutations are cumulative as we go down each 
column. Mutations predicted by using scale factors of 1.0 and 2.0 seem to be more interesting 
than those predicted with scale factor of 0.0 since there is a higher selection of threonines on the 
ß-sheet surface positions. 
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Table B-2. Sequences predicted from calculations with varying bias energies.  A secondary structure propensity scale factor of 
0.0 was used for the charged positions.   
 
 
 
2 4 6 8 9 12 14 16 18 20 22 24 39 49 51 52 57 60 62 63 64 66 68 70 71 72 73 74 
Wi ld type Q F K L T T T E E S T E D Q E D S N Q K E T H V L R L R 
Bias10 .0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias9.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias8.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias7.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias6.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias5.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias4.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias3.0  Q F K L T T T N E S T E D Q E D S N Q K E T Q V L R L R 
Bias2.0  Q F K L T T T N N S T E D Q E D S N Q K E T Q V L R L R 
Bias1.0  Q F K L T T T N N S T Q T Q E D S N Q Q E T Q V L Q L R 
N O B I A S  Q F Q L T T T N N S T Q T Q E D S N Q Q E T Q V L Q L Q 
Bias -1 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -2 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -3 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -4 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -5 . 0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -6 .0  Q F Q L T T T N N S T Q T Q E Q S N Q Q Q T Q V L Q L Q 
Bias -7 .0  Q F Q L T T T N N S T Q T Q N Q S N Q Q Q T Q V L Q L Q 
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Table B-3. Sequences predicted from calculations with varying bias energies.  A secondary structure propensity scale factor of 
1.0 was used for the charged positions.   
 
 
 
2 4 6 8 9 12 14 16 18 20 22 24 39 49 51 52 57 60 62 63 64 66 68 70 71 72 73 74 
Wild  type  Q F K L T T T E E S T E D Q E D S N Q K E T H V L R L R 
Bias10 .0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias9.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias8.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias7.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias6.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias5.0  Q F K L T T T E E S T E D Q E D S N Q K E T Q V L R L R 
Bias4.0  Q F K L T T T N E S T E D Q E D S N Q K E T Q V L R L R 
Bias3.0  Q F K L T T T N E S T E D Q E D S N Q K E T Q V L R L R 
Bias2.0  Q F K L T T T N E S T E D Q E D S N Q K E T Q V L R L R 
Bias1.0  Q F K L T T T N E S T E D Q E D S N Q Q E T Q V L T L R 
NO BIAS  Q F Q L T T T N N S T Q D Q E D S N Q Q Q T Q V L T L R 
Bias -1 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -2 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -3 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -4 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -5 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -6 .0  Q F Q L T T T N N S T Q T Q E D S N Q Q Q T Q V L Q L Q 
Bias -7 .0  Q F Q L T T T N N S T Q T Q N Q S N Q Q Q T Q V L Q L Q 
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Table B-4. Sequences predicted from calculations with varying bias energies.  A secondary structure propensity scale factor of 
2.0 was used for the charged positions.   
 
 
 
2 4 6 8 9 12 14 16 18 20 22 24 39 49 51 52 57 60 62 63 64 66 68 70 71 72 73 74 
Wild  type  Q F K L T T T E E S T E D Q E D S N Q K E T H V L R L R 
Bias10 .0  T F K L T T T E E S T E D Q E D S N Q K E T T V L R L R 
Bias9.0  T F K L T T T E E S T E D Q E D S N Q K E T T V L R L R 
Bias8.0  T F K L T T T E E S T E D Q E D S N Q K E T T V L R L R 
Bias7.0  T F K L T T T E E S T E D Q E D S N Q K E T T V L R L R 
Bias6.0  T F K L T T T T E S T E D Q E D S N Q K T T T V L R L R 
Bias5.0  T F K L T T T T E S T E D Q E D S N Q K T T T V L R L R 
Bias4.0  T F K L T T T T E S T E D Q E D S N Q K T T T V L R L R 
Bias3.0  T F K L T T T T E S T E D Q E D S N Q K T T T V L T L R 
Bias2.0  T F K L T T T T E S T E D Q E D S N Q K T T T V L T L R 
Bias1.0  T F T L T T T T E S T E D Q E D S N Q K T T T V L T L R 
NO BIAS  T F T L T T T T N S T Q D Q E D S N Q K T T T V L T L R 
Bias -1 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -2 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -3 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -4 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -5 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -6 .0  T F T L T T T T N S T Q N Q E D S N Q Q T T T V L T L Q 
Bias -7 .0  T F T L T T T T N S T Q N Q N Q S N Q Q T T T V L T L Q 
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Figure B-1: The twelve charged residues on Ubiquitin surface considered for 
design are shown 
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